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ABSTRACT 
Advances in modern biosciences and optical biosensor technology have 
provided exciting new insights and capabilities. The integration of these fields has 
witnessed revolutionary advances, which include the development of optical 
nanosensors. Optical nanosensors are devices based on a direct spatial coupling 
between biologically active molecules and a signal transducer element interfaced to 
electronic equipment for signal amplification, acquisition and recording. Optical 
nanosensors consist of biorecognition molecules covalently immobilized onto the 
nanotips nanoscale optical fiber that serves as the transducing element. By combining 
the specificity of biorecognition molecules and the excellent sensitivity of laser-based 
optical detection, optical nanosensors are capable of detecting and differentiating 
biochemical constituents of complex systems enabling the provision of sensitive and 
specific identification of specific molecular events inside living cells.  
This work explores and focuses on the development and application of novel 
optical nanosensors for single living cell analysis. In this context, single cell analysis 
involves the application of optical nanosensor technology to observe and possibly 
map molecular events inside single living cells. Previous studies have focused on the 
bulk response of cells and this largely increases the probability of missing critical 
underlying mechanisms specific to the single cell. The ability to perform single cell 
analysis can dramatically improve our understanding of basic cellular processes e.g., 
signal transduction as well as improving our knowledge of the intracellular transport 
and the fate of therapeutic agents at the single cell level. This is important not only 
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because of the capability to perform minimally invasive analysis, but also to 
overcome the problem of ensemble averaging. This capability to overcome ensemble 
averaging has the potential to yield new information that is not available from 
population averaged cellular measurements. 
This work involves the development and application of optical nanosensors 
for specific and sensitive chemical and protein analysis within single living cells. The 
ability of these sensors to successfully perform chemical and protein analysis at the 
single cell level, lay in their design specifications, size, specificity, sensitivity and 
eliminating interferences. With regard to their specifications, their size was in the 
nanometer regime, which is relative to the scale of a single mammalian cell (~ 10 µm) 
to allow non-invasive-to-minimally-invasive measurements in single living cells. In 
addition, they incorporated biological recognition molecules to achieve specificity 
and finally, near-field evanescent wave excitation and detection to achieve high 
sensitivity. High specificity and sensitivity allowed for precise and accurate 
identification of physicochemically detectable substances in complex matrices to 
eliminate any potential interference. 
The optical nanosensor intracellular measurement process is straightforward 
and begins with a sparsely distributed cell culture in a petri dish to allow viewing of 
single cells using an inverted fluorescence microscope. The optical nanosensor is 
secured onto the manipulating arms of the microscope and gently manipulated toward 
the single cell, interacting with the cell, penetrating but not disrupting cellular 
membranes. The optical nanosensor is briefly incubated in a single living cell and the 
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laser is turned on and excitation light is launched into the optical nanosensor and 
propagated to the near field of the nanotip where the target analyte is excited by 
evanescent optical waves. The fluorescence signal generated when the target analyte 
is excited is collected by the optical set-up of the inverted fluorescence microscope, 
passes through spectral and spatial filters before detection with a sensitive photon 
counting photomultiplier tube (PMT). The PMT signal is amplified and recorded via 
a universal counter interfaced to a personal computer (PC). Data acquisition and 
recording are controlled using an integrated custom-written program, built on 
LabView platform.  
During in vitro and in vivo measurements, the optical nanosensor response is 
determined in terms of the sensitivity, specificity, linear dynamic range, response 
time, nanosensor stability, and reproducibility. In the course of experimental 
measurements, it was evident that optical nanosensors have characteristics including 
fast response times (msec range), sensitivity (pM range), selectivity, and excellent 
reproducibility. In addition to the above figures of merit, optical nanosensors 
demonstrated biocompatibility with no observed detrimental effects on the cell under 
investigation in control growth conditions. This demonstrated the utility of optical 
nanosensor technology for minimally invasive measurement of cellular reactions 
without altering or destroying the chemical make-up of the cell. This work also 
illustrates the potential of optical nanosensors in playing an important role in 
elucidating and enhancing our understanding of cell signaling and transduction 
pathways in real-time. 
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PROJECT OVERVIEW 
By convention, we take the cell to the analysis tools, but in this work, we use 
a radical approach and take the analysis tools into the cell. The main objective of this 
dissertation project was to conduct fundamental research with the aim to develop an 
innovative approach for using Optical Nanosensor Technology for Single Cell 
Analysis. More specifically, this dissertation addresses the capability of optical 
nanosensors to analyze the workings of individual cells without causing physiological 
or biological damage that may have resultant biochemical consequences. This 
dissertation entitled, “Development and Applications of Optical Nanosensor 
Technology for Single Living Cell Analysis,” is divided into two major sections, the 
Developmental Section and the Application Section. The Developmental Section 
involves the development, optimization, evaluation, and characterization of optical 
nanosensors. The Application Section is further divided into three sub-categories 
corresponding to one of three-immunochemical assay formats used, which include, 
Direct Immunoassay Format used for chemical analysis, Indirect Immunoassay 
Format, and Peptide Substrate Immunoassay Format, used for protein analysis. These 
assay formats are based on the type of biorecognition molecule used and biosensing 
technique. The direct immunoassay format used to detect and identify fluorescent 
species, registers primary immunocomplex formation at the transducer surface by 
optical changes in fluorescent properties. The advantage of this format is that 
measurement of the antibody-antigen interaction can be accomplished quickly 
without any need for additional antibodies or markers. Indirect Immunoassay format 
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used to detect and identify poorly-to-non-fluorescent species, mainly proteins with 
very weak fluorescent properties involves the use of primary (capture) and secondary 
(reporter) antibody. Capture antibody is immobilized onto the transducer element and 
binds the target molecule to form a primary immunocomplex. Shortly afterwards, the 
primary immunocomplex is complexed to a labeled reporter antibody that binds to a 
different epitope on the target molecule, for colorimetric or fluorometric detection. 
Finally, the peptide substrate immunoassay format is used to detect and identify 
protease or enzymatic activity. The substrate consists of a tetrapeptide sequence that a 
specific enzyme recognizes and cleaves, complexed to a fluorescent molecule. The 
way this immunoassay works is the fluorescence emission of the fluorescent molecule 
is quenched by the tetrapeptide sequence. Once cleaved, the fluorescent molecule can 
be excited and fluorescence emission detected and measured.  
Corresponding to the two preceding major sections, this dissertation is divided 
into six parts each having its own abstract, introduction, description of experimental 
methods and materials, the results obtained and a summary (discussion), except for 
Part two which describes the technical aspects involved in the development of the 
optical nanosensor. Parts three, five, and six, correspond to a publication, an accepted 
manuscript and a submitted manuscript respectively. 
Part one is the introduction to the dissertation and discusses the importance of 
single cell analysis and the optical nanosensor and the importance of optical 
nanosensors for single cell analysis. It also explains why the optical nanosensor offers 
the ability to monitor with spacio-temporal resolution cellular activity in a single 
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living cell at the single cell level. Part two describes the nanofabrication, 
optimization, characterization and evaluation of the optical nanosensor. Part three 
focuses on the first application of the optical nanosensor for the measurement of the 
carcinogen Benzo[a]pyrene in single living cells using the direct immunoassay 
format. Part four demonstrates the application of the optical nanosensor for the in 
vitro and pseudo in vivo measurement of apoptosis. Part five describes the application 
of the optical nanosensor for the measurement of caspase-9 activity in single living 
cells, with emphasis on nanosensor development. Part six focuses on the application 
of the optical nanosensor for the measurement of apoptosis in single living cells with 
emphasis on photosensitizer induced apoptosis. Part six also discusses the figures of 
merit, which are criteria used to determine why optical nanosensors are best suited for 
single cell analysis. In addition, a comprehensive summary discusses both the 
advantages, limitations and potential of the optical nanosensor and the possible 
outcomes together with future direction of this work.  
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Introduction to Single Cell Analysis: Analyzing One Cell At A Time 
 2
1.0 The Cell: The Basic Unit of Life 
The main aim of this dissertation project is to try answering the fundamental 
question, “Can we probe the workings of cells without causing physiological of 
biological damage that may have resultant biochemical consequences?” [1]. As we 
have gained a better understanding the overall nature of bulk cell assays over time, 
and achieved a greater understanding of many macroscopic biological processes, we 
have been led to ponder the purpose of an increasingly smaller important entity, the 
basic unit of life, the single cell. The cell is the fundamental unit of life, a very small 
compartment with the capability to replicate itself. It is full of proteins, which support 
its life, replication, and interactions with other cells as well as its environment. 
Proteins are molecules made up of amino acids arranged in a specific order 
determined by the genetic code and are essential for all life processes.  
Since the mid-1940's, biomedical researchers have made enormous progress 
in identifying and understanding proteins and how they interact in many cellular 
processes. Much of this research was “basic”, scientific research that sought to 
discover how systems work and develop a base of knowledge that other scientists can 
use in order to achieve practical goals, such as treatments or cures for diseases[2, 3].  
In the 1950's, scientists started to develop the current picture of the cell as a 
complex and highly organized entity. They found that a typical cell is like a miniature 
body containing tiny "organs," called organelles. One organelle is the command 
center, others provide the cell with energy, while still others manufacture proteins and 
additional molecules that the cell needs to survive and to communicate with its 
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environment. The cell components are enclosed in a plasma membrane that not only 
keeps the cell intact, but it also provides channels that allow communication between 
the cell and its external environment [2, 3].  
 
1.1 The Importance of Single Living Cell Analysis 
In recent years, many details of the biochemical mechanisms involved in the 
normal cell cycle have been discovered. Scientists have found that cell signaling 
pathways are regulated by highly complex interactions between proteins in 
biochemical pathways. To understand cellular function, most scientists study parts of 
specific biochemical pathways, such as the cell cycle, that involve individual 
molecules, cells, groups of cells, and whole organisms. The ultimate goal is to be able 
to put all the parts together to understand normal cellular activities and how they 
function in normal cellular activities or how they malfunction in diseases. These 
studies are usually performed using bulk cell assays that are blind to heterogeneity of 
cells and the fact that cells in a population behave asynchronously to external stimuli. 
A good example is the apoptosis pathway. The differences between cells in their 
ability to activate caspases involved in apoptosis pathway contribute to their 
responsiveness of any given cell within a population to apoptotic stimuli. Therefore, 
to study and understand molecular mechanisms that underlie such differences it is 
necessary to measure caspase activity in intact individual living cells [4-6]. By 
measuring caspase activity in single living cells, it should be possible to test 
hypotheses and determine the molecular mechanisms that underlie cell-to-cell 
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variability in response to apoptotic stimuli. In this context, it is important to 
understand the dynamic relationships between chemicals and molecular events in 
living cells in the context of a cell as a system rather than a collection of organelles 
and individual processes. The information obtained from such studies can be used to 
accurately map biological behavior and function and in the process be used to 
effectively pursue drug discovery. It is also important to analysis cellular components 
such as proteins in their native form and environment. Protein analysis techniques 
often involve exposing proteins to pretreatment conditions such as solubilization, 
denaturation and reduction. Exposing proteins to such conditions can cause 
modification that can end up causing artifacts in the results [7]. In addition, it is 
important to have the ability to monitor slight differences in the amounts of protein 
and other biomolecules within the smallest possible detection volumes down to the 
single cell level for diagnostic and technological purposes. This can be invaluable in 
the sense that it would permit studies that would be otherwise difficult to perform, 
such as, performing experiments in primary human cells from surgical specimens that 
are only available in very small numbers. 
Accurate cellular studies can be performed if we did not have to study parts or 
components of a cell and then piece all the parts together like a jigsaw puzzle in order 
to study cell-signaling pathways. This means that we require technologies capable of 
performing sensitive and specific biochemical analysis within single living cells. 
Technologies for performing sensitive and specific biochemical analyses at the single 
cell level are mainly important for understanding intracellular signaling pathways that 
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control cell function and behavior. Such technologies should have the capability of 
penetrating cell membranes without disrupting or terminating cellular reactions. 
Disruption of the cell membrane can lead to significant changes in the parameter of 
interest which can occur during the course of cell lysis, resulting in an inaccurate 
view of the actual physiologic state of a cell [7, 8]. Cell lysis leads to disruption of the 
plasma membrane, which can result in order of magnitude changes in the 
concentrations of the analyte or proteins of interest. In addition, compartmentalized 
enzymes can be released and activated leading to a high background that can 
potentially obscure the detection of the target analyte or protein. If we could “go 
easier” on the cells, this information might become available to researchers. 
This work focuses on the development and application of optical nanosensor 
technology for possibly determining all of the many molecular interactions, their 
components, and the order in which they occur during a biochemical-signaling 
pathway. The main aim of this work is to identify and possibly catalogue components 
in the apoptosis pathway. The hope is to yield information of the processes of 
apoptosis that can potentially aid researchers seeking to study or treat diseases in 
which cellular processes go awry and are only armed with bulk cell assay information 
that is not representative of what is happening at the single cell level. This 
information can also be used by scientists seeking to learn more about the ways single 
cells respond to external signals, which are often conveyed when molecules bind to 
special receptors in cell membranes or when molecules traverse the cell membrane. 
The fundamental knowledge developed through single cell analysis studies can lead 
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to new ways to diagnose, treat, cure, or even prevent diseases such as Alzheimer’s 
Disease (AD), which involves neuronal apoptosis, or cancer, which involves a defect 
in the apoptosis machinery of a cell.  
Single cell analysis involves monitoring the activities of single cells, 
preferably live, in their physiological conditions. These types of studies are important 
due to the enhanced sensitivity of single living cells to their environment. The results 
obtained from such studies are important because they can give an additional 
dimension to standard cellular assays that rely on population-averaged studies that are 
blind to heterogeneity and the presumed existence of subpopulations. Studies on 
single cells are crucial to determine the activities and functional relationships of 
signaling molecules within the complex cellular networks that comprise biological 
systems. However, to accurately measure the complex interrelationships of the 
elements in the biological systems, measurements must be performed on individual 
cells with their signaling pathways intact. Therefore, continued progress in 
understanding cellular physiology requires technologies capable of biochemical 
measurements in solitary living cells with spacio-temporal control over the regions of 
cells interrogated, techniques that do not compromise the integrity of the cell 
membrane or cause physiological damage with biochemical consequences. The 
disruption of the cell membrane can lead to significant changes in the parameter of 
interest, resulting in an inaccurate view of the actual physiologic state of the cell. This 
means that the accurate measurement of many cellular properties will require a 
technique that is minimally invasive and does not disrupt the cell, and perhaps no 
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recent technology has greater potential for this application the optical nanosensors [2, 
3].  
 
1.2 Optical Nanosensors 
1.2.1 What Is An Optical Nanosensor? 
An optical nanosensor is a measurement device consists of two components: a 
bioreceptor and a transducer. The bioreceptor is a biomolecule that recognizes the 
target analyte whereas the transducer converts the recognition event into a measurable 
optical signal. The uniqueness of optical nanosensors is that the two components are 
integrated into one single sensor. Figure 1.1 shows the basic principle of optical 
nanosensors. This combination enables one to measure the target analyte without 
using reagents. For example, the Benzo(a)Pyrene (BaP) can be measured directly 
within a single living cell by an optical nanosensor which is made specifically for 
BaP measurement by inserting the nanosensor in the cell. This is in contrast to the 
conventional assay in which many steps are used and each step may require a reagent 
to treat the cells. The simplicity and the speed of measurement is the main advantages 
of optical nanosensors. One major requirement for optical nanosensors is that the 
bioreceptor molecule has to be immobilized in direct spatial coupling to the 
transducer. The immobilization is done either by physical entrapment or chemical 
attachment. Only minute quantities of bioreceptor molecules are needed, and they are 
used repeatedly for measurements. The transducer element should be capable of 











Figure 1.1 shows the basic principle of optical nanosensors. The analyte is 
bound by the bioreceptor (antibody) immobilized onto the optical transducer element. 
Molecular recognition leads to the production of an optical signal (fluorescence) 
which is detect by an signal transducer (photomultiplier tube). This signal is 




by measuring the change that occurs in the course of the bioreceptor reaction. The 
working requirements of optical nanosensors for single cell analysis include: 
relevance of output signal to measurement environment, accuracy and repeatability, 
sensitivity and spatial resolution, dynamic range, speed of response (temporal 
resolution), and insensitivity to electrical and other environmental interference 
In the last decade, optical nanosensors have attracted much interest for their 
unique and novel optical properties. From the standpoint of practical applications, by 
confining one or more dimensions to the nanometer scale, optical nanosensors display 
extreme photonic interactions due to the highly enhanced role of interfaces such as 
quantum confinement and efficient energy transfer over nanometer distances. Optical 
nanosensors are small devices placed directly on or in a sample and designed to 
produce an optical signal that can be correlated in a specific way with the presence 
and concentration of the target analyte. If the target analyte is present or absent in a 
sample under investigation, the optical nanosensor should accordingly follow the 
variation in both directions and should deliver analytical information similar to or at a 
rate greater than the rate of change of the system 
In recent years, two conspicuous research groups have made tremendous 
contributions and technological advances in the development of optical nanosensors 
for single cell analysis, namely, the Kopelman group at the University of Michigan, 
and the Vo-Dinh group at the Oak Ridge National Laboratory. The difference 
between the optical nanosensor technologies developed by the two groups is the type 
of analysis performed. The Kopelman group develops chemical nanosensors that use 
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a chemical mechanism for the molecular recognition step in chemical analysis, while 
the Vo-Dinh group develops biochemical nanosensors (nano-biosensors) that use a 
biochemical mechanism for the molecular recognition step in biochemical. 
 
1.2.2 Chemical Optical Nanosensors 
The development and application of chemical nanosensors was first reported 
by Kopelman and coworkers 1992 [9, 10] who produced small chemical nanosensors 
that enabled optical, spectral and chemical imaging on a nanometer scale. The optical 
nanosensors developed were for intracellular pH measurements in single living cells. 
These nanosensors reduced the sample volume and detection limit a billion-fold, and 
simultaneously the response time by a factor of a thousand [9]. Kopelman and 
coworkers used a micropipette puller to pull multimode and single-mode fibers down 
to diameters of 100-1000 nm at the tip. The pulled nanotipss were then used in the 
production of pH nanosensors that consisted of a pH sensitive dye, 
acrylofluoresceinamine, attached to the optical nanotip [11, 12]. The response time of 
the sensor (300 ms) was found to be 100-fold faster than conventional fiber-optic 
chemical sensors and was shown to be stable and reversible with respect to pH 
changes. The first reported application of optical chemical nanosensors was to 
monitor the biological process organogenesis in live rat-embryos. In this study, pH 
nanosensors similar to the ones described above were inserted into the extra-
embrionic space of a rat conceptus, with minimal damage to the surrounding viseral 
yolk sac, and pH measurements were made.  Values of the pH in the extraembrionic 
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fluid of rat conceptuses ranging in age from 10 to 12 days were then compared for 
any differences [9, 10, 13]  
Kopelman and coworkers also produced fluorescent optical nanosensors for 
the detection of zinc. This is a ratiometric sensor that was fabricated and incorporates 
two fluorescent dyes; one is sensitive to zinc and the other acts as a reference. The 
sensing components are entrapped within a polymer matrix by a microemulsion 
polymerisation process that produces sensors that are in the size region of 20 to 200 
nm. Cellular measurements are made possible by the nanoscalel sensor size and the 
biocompatibility of the cellular matrix. These nanosensors are capable of inter- and 
intra-cellular imaging and are insensitive to interference from proteins. The small size 
and inert matrix of these nanosensors allows them to be inserted into living cells with 
minimal physical and chemical perturbations to their biological functions [14].  
 
1.2.3 Biochemical Optical Nanosensors 
Due to the complexity of biological systems and the biochemical interferences 
caused by nanoparticles delivered using liposomal delivery, gene gun bombardment 
or picoinjection into single live cells, there was a need for a specific and suitable 
delivery and measurement technique. The need for a biochemical sensors that could 
be used to non-invasively-to-minimally invasively probe complex biological systems 
such as that of the mammalian cell led to the development of antibody-based optical 
nanosensors (nano-biosensors). The first application of antibody-based optical 
nanosensors to the field of biochemical analysis was reported in 1996 by Vo-Dinh 
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and coworkers [15]. The antibody-based optical nanosensor is a novel and unique 
technology first developed by the Vo-Dinh group and has the capability to perform 
qualitative and quantitative measurements in single live cells. This nanosensor has 
previously been used to successfully measure two carcinogenic compounds, benzo [a] 
pyrene (BaP) and its metabolite benzopyrene tetrol (BPT) in single cells [16, 17]. 
Using these nanosensors, it was possible to probe individual chemical species in 
specific locations within single living cells [17, 18]. The ability to monitor in vivo 
processes within living cells can dramatically improve our understanding of cellular 
function at the single cell level potentially revolutionizing cell biology [19].  
The fabrication of these optical nanosensors involves a four-step process.  
First, a 600-micron diameter fiber optic was pulled down to 50 nm at the tip and 
coated with approximately 100-200 nm of silver to prevent light leakage and 
maximise the delivery of light to the distal end of the optical nanosensor, in essence 
creating quantum confinement. Following the silver metal coating procedure, the 
nanofibers are silanized to facilitate the immobilization of antibodies. The silanized 
nanotips are activated to allow covalent coupling and immobilization of antibodies. 
This binding procedure first called for the activation of the silanized nanotips with a 
solution of carbonyl diimidazole (CDI), followed by incubation of the activated 
nanotips with the antibody of interest for 12 hours at 4 °C. Once the antibodies are 
bound, the optical nanosensors are ready for studies such as to testing for the 
retention of antibody binding as well as sensitivity and absolute detection limits.  
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In previous studies, in-vivo measurements of single cells using optical 
nanosensor have been performed [18, 20-25]. In one such study, antibody-based 
optical nanosensors for BPT were prepared and used for the measurement of 
intracellular concentrations of BPT in the cytosol of two different cell lines: (1) human 
mammary carcinoma cells; and (2) rat liver epithelial cells [18, 20] The cells in both 
lines are spherical in shape and have diameters of approximately 10 microns.  Several 
hours prior to making a measurement, the culture media of the cells was spiked with a 
known amount of BPT. Then immediately prior to measurement, the culture media 
was aspirated and the cells rinsed several times and finally replaced with BPT free 
media. The results from this work, demonstrated that the concentration of BPT in 
each of the different cell lines was the same, suggesting that the means of transport of 
the BPT into the cells was the same in both cases (probably by diffusion). By 
performing similar measurements inside various subcellular compartments, it could 
be possible to obtain critical information about the location of BPT formation within 
cells and its transport throughout the cell during the process of carcinogenesis.  It was 
also shown in this work that the insertion of a nano-biosensor into a mammalian cell 
does not effect the cell’s normal function, as was evidenced by the monitoring of cell 
division prior to and following a measurement [19]. Additional tests were performed 
by placing the nano-biosensors in a measurement system like the one described for 
chemical nanosensors and inserting the distal end of the sensor into a solution of 
BPT. From these measurements, it was found that the antibodies had retained greater 
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than 95 % of their binding affinity for BPT and that the absolute detection limit for 
BPT using these sensors was approximately 300 zeptomoles (zepto = 10-21) [18, 25].  
 
1.3 Optical Nanosensors for Single Cell Analysis  
1.3.1 Principles of Optical Nanosensors 
Despite the wide variety of bioreceptors and optical transducer elements 
employed, they are all based on the same principle (previously shown in Figure 1.1): 
General principles of optical nanosensor). Bioreceptors can be biological molecules 
such as antibodies, enzymes, non-enzymatic proteins, peptide substrates or nucleic 
acids. Optical transduction describes the measurement technique e.g., absorption, 
fluorescence, phosphorescence, Raman, surface enhanced Raman scattering (SERS), 
refraction, dispersion spectrometry, etc. These spectroscopic techniques can be used 
to measure any of many different optical properties including the amplitude, energy, 
polarization, decay time and/or phase.  The most commonly measured parameter of 
the electromagnetic spectrum is amplitude, as it can generally be correlated with the 
concentration of the analyte of interest easily. While amplitude is the most commonly 
measured, the other parameters can also provide a great deal of information about the 
analyte of interest as well. For instance, the energy of the electromagnetic radiation 
measured can often provide information about changes in the local environment 
surrounding the analyte, its intramolecular atomic vibrations (i.e. Raman or infrared 
absorption spectroscopies) or the formation of new energy levels (i.e. luminescence, 
UV-vis absorption). Therefore, the resulting interaction between the analyte and the 
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bioreceptor then produces an effect that can be measured via the transducer, which 
converts this effect into some type of measurable signal.  
 
1.3.2 Optical Nanosensor Immunoassay Formats 
One key characteristic in determining the utility of optical nanosensors is their 
ability to specifically measure the analyte of interest, without having other chemical 
species interfere with the measurement. The specificity is dependent on two factors, 
the type of biorecognition molecule and the target analyte (whether inherently 
fluorescent or not). These factors dictate the type of immunoassay that can be applied 
for analysis. In addition, the type of immunoassay format should allow measurements 
to be made in complex matrices such as that of mammalian cells. Two different types 
of immunoassay formats are described, direct and indirect immunoassay format, with 
the ultimate aim of single cell analysis (Figure 1.2). Direct and indirect immunoassay 
format register immunochemical complex formation at the transducer surface via 
optical changes. The advantage of a direct immunosensor is that measurement of the 
primary immunocomplex formation (antigen–antibody interaction) can be 
accomplished immediately without any need for additional antibodies or markers. For 
indirect immunoassay format, the measurement of the secondary immunocomplex 
formation (antigen–antibody-labeled antibody interaction) is accomplished 
immediately with additional antibodies or markers. The direct immnuoassay format 
consists of antibodies as biorecognition molecules where antibodies bind target 

















Figure 1.2 shows the direct and indirect immunoassay format used for single 
cell analysis. Immunochemical complex formation at the transducer surface was 
monitored via optical changes. 
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the antibody and target molecule produces a measurable fluorescent signal when 
excited by the appropriate wavelength. The direct assay format is the simplest, and 
often most sensitive, of the above assay formats. In a direct measurement format, the 
target molecule interacts with and binds to the immobilized antibody, at which time 
an optical property of the antigen is measured.  This direct measurement technique is 
most often used in the analysis of molecules that are intrinsically fluorescent, due to 
the high sensitivity of the fluorescence technique [26]. The challenge associated with 
direct immunoassay format is the limitation to measuring intrinsically fluorescent 
target molecules, though this can be solved by using the indirect immunoassay 
format. The indirect assay format is a versatile and sensitive assay based on the 
capture of the analyte by one antibody (capture antibody) and the subsequent 
detection by secondary antibody (reporter antibody). The target antigen must have 
two epitopes and the capture and reporter antibodies must have different antigenic 
specificities. Many proteins in fact have repeating epitopes so this is not a major 
problem. The reporter antibody is labeled with a fluorescent molecule, such as Cy5 to 
facilitate detection of target analyte when the secondary immunocomplex is formed. 
The first step is to bind the antigen using the capture antibody immobilized to the 
surface of the transducer element. The second step is to bind fluorescent-labeled 
reporter antibody to the antigen forming a “sandwich like” structure. Once bound, the 
fluorescence intensity of the labeled reporter antibody is measured when excited by 
the appropriate wavelength. and correlated to the amount of target molecule that is 
present [19].  
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The third immunoassay format, tetrapeptide enzyme-substrate assay, consists 
of an enzyme substrate complexed to an indicator dye. Tetrapeptide enzyme subsrates 
can only be cleaved by specific enzymes. An activated target enzyme would 
recognize the sequence it specifically cleaves and the resulting interaction between 
the enzyme and the enzyme substrate complex would yield a fluorescent indicator dye 
that would fluoresce when excited by the appropriate wavelength. An illustration of 
this biosensing scheme is shown in Figure 1.3. In this work, optical nanosensors are 
for the first time used that employ an enzyme-substrate system that is specifically 
used to measure caspase activity in single cells. Tetrapeptide enzyme substrates are 
specifically used to measure enzyme activity. They consist of a synthetic peptide 
sequence complexed to a fluorescent molecule. During the enzymatic response, the 
activated enzyme cleaves the tetrapeptide sequence producing a fluorescent product 
that is readily measurable by fluorescence spectroscopy. This is based upon the 
enzyme having a region whose three dimensional structure has a specific geometrical 
configuration that exactly matches the three dimensional configuration of the 
substrate of interest. Enzymes accelerate the rate of chemical reactions and each 
enzyme has a unique shape that determines its function and is complementary to its 
substrate meaning one enzyme specifically works on one type of substrate. Enzyme-
substrate-based optical nanosensors can be extremely sensitive and have extremely 
low detection limits [19]. The ultimate goal of single cell analysis studies is to offer 

















Figure 1.3 is an illustration of the tetrapeptide substrate immunoassay format. 
An activated target enzyme (caspase-9 or caspase-7) would recognize the sequence 
(LEHD = Leucine-Glutamate-Histidine-Aspartate OR DEVD = Aspasrtate-
Glutamate-Valine-Aspartate) it specifically cleaves and the resulting interaction 
between the enzyme and the enzyme substrate complex would yield a fluorescent 
indicator dye (AMC = 7-amino-4-meathylcoumarin) that would fluoresce when 
excited by 325 nm Helium-Cadmium laser.  
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with the cellular machinery intact. Optical nanosensors can be implemented in the 
direct chemical analysis of single cells whereby the internal environment of an 
individual cell is directly monitored by correlating the binding of antigen to antibody 
based on a fluorescent intensity signal as a function of time or concentration of the 
analyte. Previous methods used to analyze single cells are too slow requiring times of 
the order of seconds to remove the cell contents for analysis during which 
concentrations of metabolites of interest could undergo order-of-magnitude changes. 
Optical nanosensors have the capability to quantitate reactions that occur in sub-
second times without altering or destroying the chemical makeup of the cell. This will 
also enable measurement of cellular processes, such as apoptosis and the functioning 
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 2.0 Overview 
This chapter discusses the design and development of two classes of optical 
nanosensors (i) antibody based optical nanosensors and (ii) enzyme substrate based 
optical nanosensor. Antibody based optical nanosensors are used for two 
immunoassay formats, direct and indirect immunoassay format. Direct immunoassay 
format involves the use of antibodies on a solid-state platform to capture a target 
analyte (antibody-antigen), while indirect immunoassay format involves the use of  a 
set of antibodies to capture and identify a target analyte (antibody-antigen-
[labeled[antibody) forming a sandwich type structure. The immobilized capture 
antibodies bind one epitope of the target analyte, while the reporter antibodies bind 
another epitope of the target analyte. The enzyme substrate based technique as the 
name implies utilizes a enzyme substrate that is recognized by a specific enzyme, 
cleaved and generates a fluorescent product tat is detected. This section is divided 
into 5 sub-sections involving the (i) introduction (ii) principle of operation (iii) 
nanofabrication (iv) characterization (v) optimization and (vi) evaluation.  
 
2.1 Introduction to Optical Nanosensors 
Optical nanosensors are in general nanoscale devices consisting of two 
components, a biorecognition molecule and an optical signal transducer element in 
direct spatial coupling. The biorecognition molecule recognizes the target analyte and 
the transducer converts the recognition event into a measurable signal. The 
uniqueness of optical nanosensors lies in their size, novel optical properties, and the 
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two components (biorecognition molecule and transducer element) integrated into 
one single nanosensor. With dimensions in the nanometer range, the photonic 
interactions of optical nanosensors exhibit dramatic changes. Key contributory factors 
include confinement of light within the nanosensor and efficient energy over 
nanoscale distances, due the highly enhanced role of interfaces. The finely tailored 
scale of the optical nanosensors provides a high surface area-to-volume ratio, which 
is important for surface chemistry to facilitate immobilization of biorecognition 
molecules. At the nanoscale, in contrast to conventional assay in which many steps 
are used and each step may require a reagent to treat the sample, the optical 
nanosensor offers simplicity and speed of measurement. The general principle of an 
optical nanosensor is illustrated in Figure 2.1. The most important part is the 
biosensing element (biorecognition molecule) at which the molecular recognition 
process takes place, since this defines the overall selectivity of the entire nanosensor. 
The sensing-element surface is functionalized facilitate covalent immobilization 
process and to prevent interfering substances from reaching the sensing-element 
surface. The target analyte recognition process takes place at the surface of the 
biosensing element leading to change in an optical property that can be transformed 
into an electrical signal by an optical signal transducer e.g., photon counting 
photomultiplier tube (PMT). The optical signal transducer can improve the sensitivity 













Figure 2.1: Schematic representation of biosensing principle: The interaction 
of between the analyte and biorecognition molecule secured on the optical transducer 
is designed to produce an effect that can be converted by the optical signal transducer 
to a measurable electrical signal. Inset is an image of an optical nanosensor and single 
living MCF-7 cell 
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2.1.2 Description of Optical Nanosensors 
Optical nanosensors can be defined as analytical devices containing a sensing 
element of biological origin, which is either integrated within or in intimate contact 
with an optically transparent transducer element. The optical transducer in intimate 
contact with the sensing element in used to convert the biological recognition, 
association or dissociation, event into a measurable signal [27]. The end goal is to 
produce a continuous electronic signal, which is directly proportional to the 
fluorescence signal generated when the target chemical or biomolecule in a sample 
are excited. The sensing element of biological origin may be biocatalytic e.g., 
enzymes, or affinity systems e.g., antibodies. Figure 2.2 shows a diagrammatic 
representation of an optical nanosensor  
 
2.1.3 Optical Nanosensor Principle of Operation 
The type of physical transducers used to create optical nanosensors form the 
basis of their characterization. Optical nanosensors for example, are fabricated from 
optical fiber, which is optically transparent enabling optical measurements. They use 
fluorescence of light by a product formed or reactant depleted involving the 
biorecognition molecule. Optical nanosensors are used to relate the fluorescent 
intensity produced during the product formation or reactant depletion to the presence 
or absence of analyte. Some types of molecules when illuminated with light 
corresponding to the region of absorbance are promoted from ground state to excited 















Figure 2.2 shows a diagrammatic representation of an optical nanosensor 
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wavelength and less energy. This phenomenon is known as fluorescence and is 
described in Figure 2.3 by the Jablonski diagram. Fluorescence can be defined as an 
optical phenomenon that occurs when a molecule of substance is irradiated and 
absorbs energy in the form of a photon. The absorbed energy produces a change in 
the electronic state of the molecule, where the electron is moved to a higher energy 
level, singlet state. This is a temporary short-lived state and the electron returns to its 
normal ground state by emitting a photon of less energy (light at different 
wavelength). Due to the loss of energy, the emitted fluorescent radiation has a longer 
wavelength than that of the absorbed light. The distribution in the wavelength that the 
molecule absorbs is known as the absorption spectrum, and the distribution in the 
wavelength emitted is known as fluorescence emission spectrum [28]. 
 
2.2 The Fluorescence Phenomenon 
Fluorescence has three major advantages over other light-based investigation 
methods: high (i) sensitivity, (ii) speed of detection, and (iii) safety. Sensitivity is an 
important factor mainly because the fluorescence signal generated is proportional to 
the concentration of target analyte under investigation and relatively small changes in 
concentration within living cells that can have significant physiological effects can be 
detected and measured. Fluorescent techniques have the capability to reliably and 
accurately determine concentrations only as low as pico- and even femtomolar. In 
some cases, quantities less than an attomole (<10-18 mole) have been detected [29]. 

























Figure 2.3 Simplified Jablonski Diagram illustrating the processes involved in 
the creation of an excited electronic singlet state by optical absorption and subsequent 
emission of fluorescence.  
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concentration that occur within nanoliter to femtoliter volumes. Fluorescent 
measurements detecting changes in fluorescence intensity on the order of picoseconds 
can be detected if necessary. Furthermore, since fluorescence is a non-invasive 
technique, it does not interfere with a sample. The excitation light levels required to 
generate a fluorescence signal are low, reducing the effects of photo-bleaching, and 
single living cells can be investigated with no adverse effects on its natural 
physiological behavior. The point of safety implies that samples are not affected or 
destroyed in the process, and no hazardous byproducts are generated during 
fluorescent measurements [29]. 
Fluorescence is an established and powerful technique for studying molecular 
interactions in analytical chemistry, biochemistry, cell biology, photochemistry, and 
environmental science whilst boasting phenomenal sensitivity [30]. The levels of 
fluorescence from a single fluorophore are extremely low (hundreds to thousands of 
photons per second). The fluorescence generated is observed by imaging the 
fluorescent signal through a pinhole onto a photomultiplier tube (PMT), with which 
we can count the number of photons detected. This should give us a very high signal 
to noise ratio, and allow us clearly to determine when the fluorophore binds to the 
fluorescent molecules, and when it associates or dissociates. In this work, as in other 
optical sensors, one partner of the reaction is immobilized on the waveguide surface 
and binding a fluorescent complementary partner is monitored. The excitation light is 
guided through the wave-guide leading to an excitation of those molecules that are in 
close proximity to the wave-guide surface within the evanescent field and the emitted 
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fluorescence is monitored using PMT. Fluorescence signal is collected by the 
objective, and passes through spectral and spatial filters before detection with a PMT. 
The PMT signal is amplified and plotted vs. time on a PC to form electropherograms. 
Depending on the assay principle, fluorescent signal intensity is recorded as a 
function of time and as a function of concentration.  
 
2.3 Components of Fluorescence Measurement System 
The Fluorescence measurement systems consist of the following components; 
a light source emitting selected wavelengths to excite the fluorophore. (selected light 
sources are obtained by using lasers), optical fiber that serves as the waveguide to 
deliver light to the sensing region, the biorecognition element which is in direct 
contact with the optical device and target analyte to be analyzed, optics or an optical 
system to collect and convey the light emitted by the fluorophore to a photodetector 
e.g., photomultiplier tube (PMT), a photodetector for detecting the emitted light, 
device for signal amplification, data processing and output. 
The following section describes the basic physics behind the relationship 
between total internal reflection and evanescent optical waves. This will be followed 
by a description of the three-immunoassay formats: Direct, Indirect and tetrapeptide 
substrate, respectively, used in this work 
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2.4 Optical Nanosensor Principle of Operation 
Optical nanosensor based on evanescent fluorescence were developed and 
used in the work. They work via evanescent optical waves produced by total internal 
reflection (TIR). TIR is an optical phenomenon that occurs when light energy 
propagating in a dense medium e.g., silica, meets an interface with a less dense 
medium e.g., cytosol of a cell. However, some of the light energy propagates a short 
distance (a few hundred nanometers) into the cytosol of a cell, generating an 
evanescent wave. Evanescent optical waves travel into restricted regions of materials 
with exponentially diminishing energy. With evanescent optical waves, there is no 
free-beam propagation and the laser energy can be confined to a layer less than half 
the wavelength of the excitation source providing for near-field excitation. The 
evanescent optical waves produced enable detection of particular components of 
complex biomolecular assemblies with exquisite sensitivity and selectivity. If this 
energy is not absorbed, it passes back into the glass. However, if a fluorescent 
molecule is within the evanescent wave it can absorb photons and be promoted from 
ground to excited state. The fluorescence signal is produced at the nanotips when the 
components of the immunocomplex or complex biomolecular assemblies are excited 
with evanescent optical waves lie in the near-field of the optical nanosensor. This 
means that it is possible to capture fluorescence with a very low background of 
excitation light creating a high signal-to-noise ratio. Optical nanosensors utilize the 
formation of an evanescent field, which provides a highly localized excitation area in 
 34
the near field of the optical nanosensor, for the excitation of fluorescent molecules 
[31, 32] 
 
2.5 Total Internal Reflection and Evanescent Wave Theory 
Total internal reflection and evanescent wave theory explains that if a material 
of a higher refractive index borders a medium of lower refractive index, 
corresponding to Newton’s and Snell’s law, the light is reflected and refracted at the 
border between the two media. In the case of the optical nanosensor, the light is 
totally internally reflected, it is kept within the high refractive index material layer by 
multiple reflections on both interfaces sides and guided through the optical fiber. The 
critical angle (θ) is the minimum angle at which total internal reflection takes place 
and no light passes through the low refractive index layer except at the nanotip. Using 
Snell’s law the critical angle can be calculated using the equation [33]. Thus the 





At TIR, no wave exists traveling through the higher index medium. However, a wave 
results at the nanotip, along the interface and decaying exponentially. Thus at the 
interface of the nanotip, a electromagnetic field (evanescent field) is created. The 
n2
n1sinθ =  
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penetration depth of the evanescent field depends on the refractive indices of the 
media and the critical angle, calculated by Snell’s law [33, 34] 
 
2.6 Penetration Depth (dp) of Evanescent Wave Interaction 
A diagrammatic representation of the penetration depth (dp) of evanescent 
wave interaction is shown in Figure 2.4. The near-field light oozing out from the 
probe irradiates an area through the tip of the aperture creating an evanescent field. 
The evanescent field provides a highly localized excitation area (distances <0.5λ).The 
binding interaction event takes place and the analyte is excited by the evanescent 
wave on the surface of the waveguide. Using the penetration depth equation, the 
penetration depth (dp) of the evanescent wave of different laser wavelengths can be 
calculated. The following penetration depths were calculated for Helium-Neon laser 
(632.8nm) δ = 351.6nm, Argon-Ion laser (514nm) δ = 285.6nm, Argon Ion laser 
(488nm) δ = 271.1nm and Helium-Cadmium (325nm) δ = 180.6nm. From the 
equation to calculate the dp, it can be seen that greater differences in refractive indices 
(n1 and n2) allow greater angles of incidence for the light guide, due to the effect of 
the critical angle. The thinner the guiding layer (the high refractive index layer, n2) 
the greater the number of reflection incidences whereas dp becomes shorter. The 
result of both effects is an increase of the interacting area of the evanescent wave[33]. 
In optical nanosensors, this increases the sensitivity if the device. The penetration 

















Figure 2.4 shows the formation of an evanescent field at the nanotip when 
laser light is launched into the optical nanofiber. Inset is a representation of the 
penetration depth (dp) of the evanescent wave which is dependent of the wavelength 






2.7 Nanofabrication of Optical nanosensor 
The nanofabrication of optical nanosensors involves a number of parameters 
each of which must be optimized for efficient and effective experimental design. One 
important parameter is the method of choice for attachment of biorecognition 
molecule. Some of the issues to be considered in choosing an appropriate support and  
the associated attachment chemistry include: the level of scattering and fluorescence 
background inherent in the support material and added chemical groups; the chemical 
stability and complexity of the construct; the amenability to chemical modification or 
derivatization; surface area; loading capacity and the degree of non-specific binding 
of the final product. [35]. The solid support selected for immobilization of 
biorecognition molecule was silica-based optical fiber for the following reasons. 
Silica-based optical fiber is a readily available and inexpensive support medium, 
possessing a relatively homogeneous chemical surface whose properties have been 
well studied and which is amenable to chemical modification using very versatile and 
well developed silanization chemistry [36]. Although silanized proteins can be 
covalently linked to an unmodified silica surface, most attachment protocols involve 









Figure 2.5 outlines the multi-step nanofabrication process. Briefly, the 
nanofabrication process involves the following steps: (i) fiber preparation, polishing 
and pulling process, (ii) silver deposition process, (iii) protein immobilization 
chemistry and (iv) immunochemical assay formats for single cell analysis. The 
immobilization of the biorecognition molecule is very important for the performance 
of the optical nanosensor itself due to the influence on the stability, activity and 
reproducibility of the sensing layer. The biological recognition molecules are linked 
to the sensor surface by covalent immobilization which is achieved by modifying the 
silica surface using a four step process, that involves washing, silanization, activation 
and finally protein immobilization. Covalent attachment is more stable than physical 
absorption or photo-immobilization. Preparation of two-dimensional surfaces usually 
involves treatment silane couplng reagents for silanol modifications [35, 38]. Silanol 
modifications are chemically stable, and ussually eliminate undesired steric 
interference from the support, and are hydrophilic enough to be freely soluble in 
aqueous solution and not produce non-specific binding to the support [35]).  
The surface density of the optical nanosensor is an important parameter 
because a low surface coverage will yield a correspondingly low conjugation signal, 
and decrease the conjugation rate, while reasonably high surface densities may yield a 
high conjugation signal [35]. The relatively high surface area to volume ratio of the 
optical nanosensors greatly increases the loading capacity of biorecognition 
molecules such as antibodies. The surface area permits relatively large amounts of 
antibody to be linked to the surface resulting in strong signal intensities and a good  
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Pulling of Optical Fibers (600 µm → 50/ 100 nm)
Silver Coating (~ 100 → 200 nm)
Protein Binding – e.g.mouse IgG for BaP
Silanization of Fiber (GOPS)Glycidoxypropyltrimethoxysilane
Activation of Fiber (CDI)Carbonyldiimidazole
Cleaving fiber 8″, Polish fibers 30µm Al2O3 
 
Figure 2.5 shows the multistep process involved in the nanofabrication 
process 
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specificity though at this scale, the optical nanosensor suffer from a limited dynamic 
range. 
Immobilization of proteins to solid supports such as polystyrene or silica can 
be achieved using multiple methods. Based on previous laboratory experience and 
information in the literature, the linking reagents glycidoxypropyltrimethoxysilane 
(GOPS) and 1,1’- carbonyldiimadazole (CDI), and its associated bonding procedures 
was selected. This immobilization procedure has been thoroughly evaluated by Alarie 
et al., [39] based on two criteria, the amount of antibody that can be loaded, and the 
retention of antibody activity, i.e., the ability of the immobilized antibody to 
recognize its specific antigen after immobilization as determined by the ratio of the 
moles of antigen bound to the moles of antibody immobilized. These criteria are 
important because in direct and indirect assays, sensitivity is directly proportional to 
antibody loading [40, 41]. In addition, the preservation of the antibody activity on 
bonding to the solid silica support influences both sensitivity and selectivity. 
 
2.7.1 Cleaving, Polishing and Pulling 
600µm diameter plastic clad optical fiber was used to construct the optical 
nanosensors. Optical fiber consists of a central core and median cladding made of 
fused silica (SiO2), and an outer jacket made of a hard polymer. Lengths of optical 
fiber measuring eight inches are sectioned off a reel of optical fiber. The fiber tips are 
polished for about one to two hours to facilitate coupling of incident excitation 
radiation. The fibers are polished using a fiber polisher (UltraTech,, Santa Ana, CA) 
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with a 32 µ sized aluminum oxide (Al2O3) lapping paper. After polishing the fiber, 
the hard polymer jacket is manually stripped off using a sharp razor. The fibers are 
passed through a flame to remove parts of the jacket that were not stripped off with 
the razor. After cleaning the fibers with kimwipes, the fibers are drawn from 600 µm 
(core diameter) down to about 50 nm using Sutter P-2000 laser-based fiber puller 
(Sutter Instrument Company, Novato, CA). Figure 2.6 shows a digital image and a 
schematic profile of the fiber pulling instrument. Figure 2.7 details the fiber pulling 
process and the product of this process, a 50 nm diameter optical nanofiber.  
 
2.7.2 Silver Deposition Process 
The pulled optical nanofibers with a final tip diameter of about 50 nm were 
coated with 200 nm of silver metal (99.999% pure) using a thermal source vacuum 
evaporator (Cooke Vacuum Products, South Norwalk, CT) operating at 10-26 Torr 
achieving a final diameter of 250nm (Figure 2.8). The coating was deposited by 
placing the nanofibers on a rotating stage with the tips pointed away from the silver 
source at an angle of approximately 45°, thus preventing coating of the sensing 
region. The Thermal deposition system is equipped with a crystal for monitoring the 
metal thickness during the deposition process. This system has an on board computer 
which determines the thickness deposition rate which is typical 0.5 Å/s. Following the 
silver coating process, the optical nanosensor tips are functionalized to facilitate the 

















Sutters Instruments P-2000 
laser based fiber puller
 
Figure 2.6 shows a digital image of the fiber-pulling instrument (LEFT) and a 





















Tip size ~ 50 nm
 
Figure 2.7 (above) shows the details the fiber pulling process and (below) the 













Tip size ~ 250 nm
 
Figure 2.8 shows how the pulled optical nanofibers with a final tip diameter of 
50 nm are coated with ~200 nm of silver metal using a thermal source vacuum 
evaporator (ABOVE) achieving a final tip diameter of 250nm. Above LEFT shows 
the 45o orientation of the nanofibers in the thermal deposition chamber during the 
silver coating process. Above RIGHT is an image of the thermal vacuum deposition 
chamber without the bell jar. 
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2.7.3 Protein Immobilization Chemistry 
Immobilization of proteins onto SiO2 surfaces is of great interest for many 
applications, particularly in developing biosensors. The immobilization of proteins by 
covalent coupling usually leads to very stable preparations. The covalent binding 
method is based on the attachment of proteins to solid SiO2 supports. The reaction 
involves only functional groups of the protein that are not essential for its activity. 
The major aspects which have to be considered for the covalent immobilization of 
proteins are the following: Optical transduction principles that allow the use of the 
evanescent field has facilitated the development of optical nanosensors whereby/ in 
which one binding partner is immobilized on the transducer element followed by the 
binding of the target analyte. This generated evanescent field is used to excite the 
captured target analyte. Immobilization of protein onto solid-phase supports is thus an 
important/ essential step in the nanofabrication of optical nanosensors. The 
immobilization of antibodies/ protein on the surface of the transducer in optical 
nanosensors has to achieve the following criteria; (i) result in a reproducible amount 
of antibody on the surface, (ii) result in stable binding of the antibody to the optical 
transducer surface (iii) maintain the activity of the antibody and (iii) non-specific 
binding interactions. 
Optical nanofibers are functionalized to facilitate covalent immobilization of 
protein. Figure 2.9 describes the antibody binding chemistry procedure performed to 



















































3 hrs; 90oC; pH 3
 
Figure 2.9 describes the multistep surface chemistry procedure performed to 
functionalize the optical nanofiber tips to facilitate protein immobilization onto the 
optical nanofibers 
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immersion in a 1:1 mixture of concentrated hydrochloric acid (HCl) and methanol for 
30 minutes followed by rinsing several times in doubly distilled water. Next the 
substrates were allowed to air dry. The air-dried nanofibers were suspended in 20mL 
of 10% (v/v) aqueous (anhydrous acetonitrile) GOPS. The mixture is heated for 3h at 
90oC with the pH maintained at 3 using 1M HCl. After the activation of the silica 
nanotips and direct GOPS attachment, the silica nanotips were dried overnight in a 
vacuum oven at 105oC.  After drying in the vaccum oven, the nanotips were washed 
with anhydrous acetonitrile and then suspended in 20ml of acetonitrile and 2g of CDI 
added while stirring (30 minutes). Finally, they were washed with acetonitrile before 
immobilizing antibody. For the methods, the immobilization of 0.5-1.0 mg/ml of 
antibody was added to centrifugation vials. The nanotips were incubated for 12 hours 
at 4oC. The antibody bound to the activated aldehydic sites. The fiber tips were rinsed 
in PBS and remain in PBS overnight to hydrolyze and unreacted sites after the 
incubation step.  
A 0.05 (or 0.5) mg/ml solution of specific antibody and control antibody in 
PBS was placed on the substrate coated with silane and cross-linker and allowed to 
incubate for one hour after which the substrate was rinsed and washed in PBS. 
 
2.8 Optical Nanosensing Schemes for Single Cell Analysis 
2.8.1 Immunochemical Assay Formats 
This work describes the use of two basic immunoassay formats for single cell 
analysis based on biochemical interactions between the biorecognition molecule and 
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the target analyte. These two immunosensing formats can be distinguished as 
bioaffinity and biocatalytic reactions (Figure 2.10). Bioaffinity reactions involve 
antigen – antibody (Ag – Ab) interactions which take advantage of physicochemical 
changes that accompany complex formation e.g., changes in layer thickness, 
refractive index, light absorption or emission. Bioaffinity reactions are characterized 
by high specificity and high sensitivity that typifies an Ag – Ab reaction. Two 
different types of bioaffinity reactions have been described direct and indirect 
immunoassay. Direct immunoassay format register immunochemical complex 
formation at the transducer surface via optical changes such as fluorescence emission. 
The advantage of a direct immunoassay is that measurement of the antigen– antibody 
interaction can be accomplished immediately without any need for additional 
antibodies or markers (fluorescent tags). In contrast, indirect immunoassay format is 
based on the measurement of the antibody – antigen– antibody interaction can where 
one of the antibody partners in the immune interaction has a fluorescent label for 
detection. Indirect immunoassay format combine the high selectivity of an 
immunoreaction with the high sensitivity characteristic of the fluorescent label effect.  
On the other had, biocatalytic reactions are important in biosensing 
applications in cases where the target analyte does is not inherently fluorescent. The 
biocatalytic reaction is based on the specific recognition of an enzyme substrate and 
its subsequent chemical conversion to the corresponding products. The biocatalytic 
reaction itself accomplishes specific binding between the active site of the enzyme 












Figure 2.10: The two immunosensing formats can be distinguished as 
Bioaffinity immunoassays: (i) direct immunoassay format, (ii) indirect immunoassay 
format, and Biocatalytic immunoassay: (iii) tetrapeptide substrate format 
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from the active center, which in turn leads to regeneration of the binding affinity and 
catalytic state of the enzyme. A fluorescent molecule can be coupled to the substrate 
and upon release of product for the enzymes active center, the fluorescent molecule 
can be detected. This work exploits a tetrapeptide substrate coupled to a fluorescent 
molecule for he detection of specific enzymatic activity. The use of biocatalytic 
reaction facilitates both sensitivity and selectivity. 
The two basic approaches to sensing direct optical interaction with an analyte, 
and indirect optical interaction with an analyte were applied to optical nanosensors. 
Direct optical interaction involves the use of primary antibody to bind a fluorescent 
target analyte, while the indirect approach used indicator dye bound to biological 
substrate molecules that change their optical properties after reacting with analyte.  
 
2.8.2 Immobilization of Fluorogenic Tetrapepetide Substrate 
This approach involves the immobilization of fluorogenic tetrapepetide 
substrate onto the optical nanosensor to measure the activity of caspases (-9 and –7). 
Caspase-9 and -7 are synthesized in the cytosol of mammalian cells as inactive 
zymogens, which become active through intracellular caspase cascades. By mapping 
the cleavage site of the substrates of caspase-9 and caspase-7, tetrapeptides Leucine-
Glutamic acid-Histidine-Aspartic acid (LEHD) and Aspartatic acid-Glutamic acid-
Valine-Aspartic acid (DEVD) consensus cleavage sites were identified. Conjugation 
to a fluorimetric moiety to DEVD provides a substrate for analyzing caspase like 
protease activity. The following figure shows the cleavage reactions central to 
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fluorimetric detection method. The fluorogenic tetrapeptide is immobilized. The 
fluorimetric assay detects emission of the molecule 7-amino-4-methylcoumarin 
(AMC) after cleavage from the AMC-substrate conjugate, LEHD-AMC and DEVD-
AMC respectively (Figure 2.11). 
 
2.9 Components of Intracellular Measurement System 
The components of the intracellular fluorescent measurement system are shown in 
Figure 2.12. The components include three lasers, a Helium-Cadmium (HeCd) laser 
emitting at 325nm, Helium-Neon (HeNe) laser emitting at 632.8 nm, Argon (Ar) ion 
laser emitting at 488 nm and 514 nm, depending on the source required for excitation. 
Optical fiber for laser delivery. Band pass filters (UV fluorescence) were used to 
reject the laser-line and collect the fluorescence emission. Nikon inverted 
fluorescence microscope, fluorescence signal detector using a photomultiplier tube 
(PMT). Signal acquisition and recording using a custom written LabView software 
program and a PC. Calibration curves were prepared by measuring (over 50msec) the 
rates of fluorescence increase. 
The measurement system is designed so that the output from laser source is 
directed into an optical nanosensor. The optical nanosensor acts as a waveguide, and 
the evanescent wave generated at the nanotip excites fluorophores that are associated 
with bound protein at the surface of the nanotip. Some fluorescence is collected and is  























Figure 2.11 shows the cleavage reactions central to fluorimetric detection of 
caspase activity. The fluorogenic tetrapeptide substrate is immobilized onto the 
optical nanosensor (shown in blue) and the fluorimetric assay detects emission of the 
molecule 7-amino-4-methylcoumarin (AMC) after cleavage from the Leucine-


















Figure 2.12 shows the components of the laser-induced fluorescence measurement 
system. The excitation source (HeCd laser) is interchangeable and are chosen and 
used depending on the excitation wavelength of the target analyte  
 
 54
that are used as sensing elements are inserted into a SMA connector/collar which, 
when inserted into the cell compartment, immediately aligns the proximal end of the 
fiber to assure high efficiency of transmission of light into and back from the 
waveguide. The system has been used for the development of methods of 
immobilization of antibodies, and as a sensing platform to develop methods for 
detection of BPT [18]. The results demonstrated that our system can selectively detect 
BPT at the femtomolar concentration level for a sample of 100 ul within a 50 ms of 
exposure of the sensor to sample and 10 sample accumulations. Perhaps most 
importantly, it is now clear that this system can be used for the sensitive and specific 
analysis of protein-ligand interactions at a solid interface.  
 
2.10 Optimization of Optical Nanosensors 
This section describes the optimization of optical nanosensors, which was 
performed to improve and maximize the efficacy of the production of uniform 
nanotips. Production of uniform nanotips is important minimize the variability from 
fiber to fiber and to enhance the reproducibility factor. Optimization of nanotips was 
achieved by fine-tuning the parameters, Heat, Velocity, Delay, and Pull Strength of 
the current state-of-the-art in micropipette puller technology, the P-2000 system 
(Sutter Instruments, Novato, CA). The P-2000 integrates a CO2 laser-based heat 
source. The CO2 laser has several features that make it amendable as a heat source of 
choice. These features include nominal emission wavelength of the laser 
approximates the resonant frequency of the SiO2 lattice in glass, CO2 laser heat is 
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clean and leaves no residue on the SiO2 as do conventional heating filaments, and 
finally, laser heat can be turned off instantly, leaving no residual filament heat. The 
user can program the amount and distribution of heat supplied to the glass. The P-
2000 system has microprocessor-controlled programmability with 100 separate 
programs, each program consisting of up to 8 command lines. Programmable 
parameters include; laser power level, scan width, trip velocity, delay/ laser on time, 
and hard pull strength (heat, filament, velocity, delay and pull). These programmable 
parameters were adjusted in order to draw nanotips of different tip diameters. 
Drawn nanotips were evaluated using Hitachi S-4700 scanning electron 
microscope (SEM). In scanning electron microscopy an electron beam is focused into 
a small probe and is raster scanned across the surface of the nanotips. Several 
interactions with the nanotipse that result in the emission of electrons or photons 
occur as the electrons penetrate the surface. These emitted particles are collected with 
the appropriate detector and processed with image visualization software to yield 
measurement information about the nanotips. The Hitachi S-4700 is highly suited for 
this purpose because of its capability of high-resolution imaging with resolution of at 
least 3 nm.  
Dozens of nanotips were drawn for the optimization study by varying the 
program parameters of the Sutter Instruments P-2000 fiber-pulling instrument. The 
optical nanosensor for this optimization study were prepared using a three-step 
process. Before this process, individual programs were written and write-protected in 
order to secure them from inadvertent changes. Eight inch pieces of PCS were 
 56
cleaved using a fiber cleaver. Both ends of the optical fiber were polished using 30µm 
Al2O3 lapping paper. The fibers were then secured on the tension mounts of the P-
2000 Laser based fiber puller using clamps. For each program used, I pulled five 
eight-inch fibers resulting in a total of ten nanofibers for each program used. The 
nanofibers were labeled in order to keep track and link the fiber to the program after 
acquiring SEM images.  
 
2.10.1 Experimental Procedure 
600 µm plastic clad silica (PCS) optical fiber was purchased from Fiberguide 
Industries, Stirling, New Jersey. The benefits o PCS optical fiber include, cost 
effective, high numerical aperture (NA) for efficient light collection from extended 
sources, radiation resistant, laser damage resistant, dielectric nonmagnetic 
construction, broad operating wavelength range from 220nm to 700n, excellent laser 
beam delivery. PCS optical fibers were cut into 8 inch pieces and each end of the 
fiber was polished using Aluminium oxide lapping paper. The fibers were drawn to 
various tip diameters using Sutter P-2000 micropipette puller. The P-2000 works well 
with small diameter glasses such as PCS optical fibers. The programmable parameters 
laser power level, scan width, trip velocity, delay/ laser on time, and hard pull 
strength, were modified before each pulling to obtain nanotips of different diameters. 
After pulling the optical fiber to nanotips, they were coated with 99.999 % silver 
metal in silver thermal deposition chamber. After coating the nanotips with silver, 
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scanning electron microscope (SEM) images of the nanotips were acquired with 
Hitachi S-4700 SEM at theHigh Temperature Materials Laboratory, ORNL. 
 
2.10.2 Results and Discussion 
Table 2.1 shows the programmable parameters include; heat, trip velocity, 
delay/ laser on time, and hard pull strength (heat, filament, velocity, delay and pull) 
that were adjusted to draw nanotips of different tip diameters. This table shows the 
change in each parameter and the results obtained. Figures 2.13 show SEM 
micrographs of the nanotips acquired with Hitachi S-4700 SEM. From the results, it 
can be concluded that increasing the pull strength, decreases the tip diameters 
obtained. These results were used as guide in the production of uniform optical 
nanosensors to enhance the reproducibility factor between single cell measurements. 
 
2.11 Characterization of Optical Nanosensors 
The greatest challenge of developing nanoscale materials and structures lies in 
being able to look at what has been created and to determine the presence or absence 
of elements and their distribution. I devised a simple but straightforward method to 
characterize the optical nanosensor and in the process confirm protein immobilization 
chemistry. The optical nanosensors were characterized by immobilizing Cy-5 labeled 
antibody onto functionalized nanotips and detecting the presence or absence of Cy-5 
labeled antibody. Cy-5 was used because of its intense fluorescence, low 




Table 2.1shows the programmable parameters include; heat, trip velocity, delay/ laser 
on time, and hard pull strength that were adjusted to draw nanotips of different tip 
diameters 
 
Sutter P-2000 Input Parameters
Program Heat (oC) Velocity Delay Pull Size (nm)
40 850 20 150 200 50
10 850 60 126 130 1000
3 850 60 126 160 500
9 850 40 126 170 400
22 850 40 126 180 300
19 850 20 126 190 200














Figures 2.13 shows SEM micrographs of the nanotips of different tip 
diameters acquired with Hitachi S-4700 SEM. Note the different measurement scale 
on each micrograph. 
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single molecule fluorescence detection [43-45]. In this study, anti-cytochrome c was 
labeled according to the following protocol and immobilized on nanotips (antibody 
was labeled in a column and collected). 1mg of protein was labeled to a final average 
molar dye/ protein ratio of 8 (this assumes an average protein molecular weight of 
155 KDa). Cytochrome c antibody was labeled according to the following protocol 
and immobilized on nanotips. Protein (1mg/ml in PBS) + Coupling buffer + Reactive 
Cy-5 dye. Mixture is incubated at room temperature for 30 minutes. Separation of 
labeled protein from non-conjugated (free) dye using a gel filtration column. 
Collection tubes used to collect labeled protein. One batch of functionalized nanotips 
were incubated in the labeled protein solution while the others were incubated in 
unlabeled protein solution. Interaction between the Cy-5 labeled and unlabeled 
antibody, with the nanotip was investigated. Interaction between the Cy-5 labeled 
antibody and the nanotip was investigated. Fluorescence signal produced when the 
antibody-antigen complex is excited; is converted to a measurable electrical signal 
 
2.11.1 Experimental Procedure 
Analytical grade materials were used as long as they were commercially 
available. Cy-5 labeling kit containing, buffers, Cy-5 monofunctional dye as well as 
PD-10 columns were purchased from Amersham Pharmacia Biotech. Cytochrome c 




2.11.2 Labeling of Cytochrome c with Cy5 
In the standard procedure, the contents of 1 vial (to label 1 mg of protein) of 
Cy-5 monofunctional dye was dissolved in 50 µL of DMSO. Cytochrome c antibody 
was dissolved in buffer provided, typically at 1 mg/mL protein concentration. 10 µL 
of dye/DMSO mixture was pipetted into 200 µL cytochrome c solution under slow 
vortexing. After 30 min incubation at 25°C in the dark the reaction was terminated by 
freezing at –4oC. For separation of unbound dye, 300 µL of 100 mM NaH2PO4 (to 
suppress further labeling after thawing) was added to a frozen sample and the sample 
was incubated in a 25°C water bath until thawed. The sample was loaded on a PD-10 
column (10 mL bed of Sephadex G-25M), which had been pre-equilibrated in buffer. 
After washing the column with buffer A (2 *1 mL) the labeled protein was eluted by 
adding 2 mL of buffer to the column top. Another 10 mL of buffer was added to elute 
all unbound dye, and the column was regenerated with 20 mL of buffer. Higher Cy-5 
dye concentrations can be achieved by dissolving 2 vials of Cy-5 dye in 50 µL of 
DMSO. 
 
2.11.3 Immobilization of Labeled Anti-Cytochrome c  
Preparation of anti-cytochrome c optical nanosensors involved the 
construction of nanofibers and functionalizing the nanotips to facilitate antibody 
immobilization. PCS optical fibers were pulled using the laser based fiber puller, 
from 600 µm diameter to 50 nm diameters. The pulled fibers were coated with silver 
metal in silver thermal deposition chamber. After coating the nanotips with silver, the 
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nanotips were functionalized as described previously to allow the immobilization of 
Cy5 labeled anti-cytochrome c. The measurements were performed using labeled 
antibody for the experimental and unlabeled antibody for the control. 
 
2.11.4 Results and Discussion 
Figure 2.14 is a schematic representation of the fluorescence excitation and 
measurement procedure used for Cy5 detection during the characterization study of 
optical nanosensor. Figure 2.15 shows the results of the characterization study, which 
involved the detection of Cy5 labeled anti-cytochrome c immobilized on the nanotips. 
This study involved two treatment groups, optical nanosensor with Cy5 labeled anti-
cytochrome c and without Cy5 labeled anti-cytochrome c. These results show a 
difference of an order of magnitude in the fluorescent intensity measurements. This 
difference is significant enough to determine the successful immobilization of Cy5 
labeled anti-cytochrome c. 
 
2.12 Characterization of Optical Nanosensor: -AFM measurements 
In addition, we attempted to determine the distribution of antibody using a 
recently acquired an atomic force microscope (AFM). AFM is a method of measuring 
surface topography on a scale from angstroms to 100 microns. The technique 
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Figure 2.14 is a schematic representation of the fluorescence excitation and 
measurement procedure used to detect Cy5 labeled anti-cytochrome c in the 
evaluation study. Inset is the excitation and emission spectrum of Cy5. 
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Experimental Average = 3.6










































































Figure 2.15: shows the results of evaluation study that involved immobilizing 
Cy5 labeled anti-cytochrome c on functionalized nanotips and monitoring their 
presence. The top graph represents the detection of Cy5 labeled anti-cytochrome c 
(experimental) and the graph below represents the control group. 
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The tip is held several nanometers above the surface using a feedback mechanism that 
measures surface–tip interactions on the scale of nanoNewtons. Variations in tip 
height are recorded while the tip is scanned repeatedly across the sample, producing a 
topographic image of the surface. The AFM has the ability to image at atomic 
resolution (sub-angstrom level) and can achieve a resolution of 10 pm, and unlike 
electron microscopes, can image samples in air and under liquids. The 
AFM’sresolution combined with its ability to image a wide variety of samples under 
a wide variety of conditions such as air and in fluids. Images have appeared in the 
literature showing DNA, single proteins, structures such as gap junctions, and living 
cells [46]. AFM operates by measuring attractive or repulsive forces between a tip 
and the sample [47]. In its repulsive "contact" mode, the instrument lightly touches a 
tip at the end of a leaf spring or "cantilever" to the sample. As a raster-scan drags the 
tip over the sample, some sort of detection apparatus measures the vertical deflection 
of the cantilever, which indicates the local sample height. Thus, in contact mode the 
AFM measures hard-sphere repulsion forces between the tip and sample. In non-
contact mode, the AFM derives topographic images from measurements of attractive 
forces; the tip does not touch the sample [47].  
 
2.12.1 Experimental Procedure 
PCS optical fibers were pulled using the laser based fiber puller, from 600 µm 
diameter to 50 nm diameters. The pulled fibers were coated with 99.999 % silver 
metal in silver thermal deposition chamber. After coating the nanotips with silver, the 
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nanotips were functionalized to allow the immobilization of Cy-5 labeled cytochrome 
c antibody. After the construction of antibody-modified nanotips, we imaged the 
nanotips using contact mode to locate the distribution of the immobilized cytochrome 
c antibody. Contact mode is the most common method of operation of the AFM and 
as the name suggests the tip and sample remain in close contact as the scanning 
proceeds.  
 
2.12.2 Results and Discussion 
Figure 2.16 shows AFM images of optical nanosensor tips. The results obtained 
revealed that we were unable to achieve sub-angstrom resolution and therefore unable 
to determine the distribution of cytochrome c antibody immobilized on the 
nanotips.However, we were able to obtain, with the acquired images, the dimensions 
of the nanotips. Idealistically, if this worked and we were able to determine the 
location and distribution of cytochrome c antibody, it would essentially allow us to 
study the biophysics of molecular interactions and its role in important processes such 
as signal transduction. 
 
2.13 Evaluation of Optical Nanosensors 
Since I had already positively demonstrated the immobilization of antibody 
onto functionalized nanotips, the next step was to demonstrate that an 





























































Figure 2.16 shows AFM images of optical nanosensor tips captured using an 
atomic force microscope in contact mode. The graphs show the dimensions of the 
nanotips at different locations 
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optical nanosensors was performed to assess the reactivity of antibody immobilized 
onto the functionalized nanotips. Basically it involved determining whether or not the 
immobilized antibody could effectively and efficiently bind target analyte and in 
essence demonstrate that an antibody-antigen interaction can be detected. The 
evaluation process was performed by immobilizing antibody to fluorescein onto 
functionalized nanotips and detecting fluorescein molecules in solution. Fluorescein 
was chosen because of the following advantages: it has a relatively high absorptivity, 
an excellent fluorescence quantum yield, and excitation maxima ~494 nm closely 
matches the 488 nm spectral line of the Argon-ion laser.  
 
2.13.1 Experimental Procedure 
PCS optical fibers were pulled using the laser based fiber puller, from 600 µm 
diameter to 50 nm diameter. The pulled fibers were coated with 99.999 % silver metal 
in silver thermal deposition chamber. After coating the nanotips with silver, the 
nanotips were functionalized to facilitate the immobilization of antibody to 
fluorescien for the experimental group, and without antibody to fluorescein for the 
control group. Anti-fluorescein solution is prepared by dissolving the lyophilizate in 1 
ml double distilled water results in a concentration of 0.1 mg antibody/ml. The 
antibody is suitable for the detection of fluorescein and fluorescein-labeled 
compounds. The detection of bound antibody can be carried out directly in one step 
using an antibody to fluorescein. Both groups of optical nanosensors were incubated 
in fluorescein (10-
4
M) prepared in PBS. Both were incubated for 5 minutes in 
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fluorescein and the evaluation of optical nanosensors study involved two groups, 
experimental : antibody to fluorescein was immobilized on functionalized nanotips, 
and, control : without antibody on functionalized nanotips. Figure 2.17 shows 
fluorescence excitation and measurement process.  
 
2.13.2 Results and Discussion 
The characterization study was performed to determine the coupling and 
compatibility of the optical nanosensor fabrication process and protein binding 
chemistry procedure. This involved immobilizing anti-fluorescein onto functionalized 
nanotips to detect fluorescein in situ. Figure 2.18 shows the results of the 
characterization study involving measurerements performed using anti-fluorescein-
based optical nanosensors. The top fluorescence intensity plot represents optical 
nanosensors used to make the experimental group measurements, while the bottom 
fluorescence intensity plot shows results obtained using optical nanosensors used to 
make the control group measurements. The difference between the experimental 
group and the control group is approximately more than an order of magnitude. This 
diffrence is significant illustrating the poitive detection of fluorescein using anti-






























































Figure 2.17 is a schematic representation of the fluorescence excitation and 
measurement procedure used for fluorescein detection during the characterization 
study of optical nanosensors employing the direct immunoassay format. Inset is the 













































Control group: Average 3.5










































Figure 2.18 shows the results of characterization study for the detection of 
fluorescein using anti-fluorescein-based optical nanosensors. The top graph is the 
experimental group while the graph below is the control. 
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2.14 Summary 
This work demonstrates the successful optimization process of optical nanosensor 
fabrication performed by fine-tuning the input parameters of Sutters Instrument P-
2000. I was able to characterize the optical nanosensors by immobilizing labeled Cy-
5 labeled antibody and detecting the presence (experimental) and the discerning the 
absence (control) on the nanotips. I was unsuccessful in using the AFM to determine 
the localization and distribution of Cy-5 abeled antibody on the nanotips. It is worth 
mentioning that AFM has been used toimage single lysozyme molecules [24] and 
therefore with more effort, it will be possible to demonstrate the localization and 
distribution of immobilized antibody. I was also successful in demonstrating the 
ability to immobilized antibody to fluorescein to bind fluorescein in solution thereby 
detecting an antibody-antigen interaction. Optical Nanosensors developed in this 
work were subsequently used for the following in vitro and in vivo analyses, which 
employ different immunochemical assay formats;  
• Chemical analysis, utilizing direct antibody binding assay format for 
measuring the carcinogen benzo[a] pyrene 
• Protein interaction analysis, utilizing indirect antibody binding assay format 
for monitoring cytochrome c and caspase-9 
• Protein Analysis, utilizing tetrapeptide substrate assay format for monitoring 
caspase-9 and caspase-7 activity 
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Part three is a version of a paper published in the Journal of Nanoscience and 
Nanotechnology in December 2002 by Paul M. Kasili, Brian M. Cullum, Guy D. 
Griffin and Tuan Vo-Dinh: Kasili P.M, Cullum B.M, Griffin G.D, and Vo-Dinh T., 
Nanosensor for in vivo measurement of the carcinogen benzo[a]pyrene in a single 
cell, Journal of Nanoscience and Nanotechnology 2 (6): 653-658 DEC 2002. 
 
3.0 Abstract 
This work describes the development and application of an antibody-based 
optical nanosensor for in situ measurements of the carcinogen, benzo[a]pyrene (BaP) 
in a single cell. This antibody-based optical nanosensor is miniaturized enabling the 
detection of fluorescent analytes in single cells. In addition to measuring fluorescent 
analytes in single cells, the nanosensor has the potential to be applied for both 
diagnostic and proteomics purposes. In this work, the human breast carcinoma cell 
line, MCF-7, was used as the model system to perform BaP measurements in single 
cells. A standard concentration curve for BaP was established and used to perform 
quantitative analyses of BaP in individual cells. From these analyses, it was estimated 
that the concentration of BaP in the individual cells investigated was ~3.61 x 10-10M. 
The results obtained demonstrate the application of antibody-based nanosensors for 
performing in situ measurements inside single living MCF-7 cells. 
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3.1 Introduction 
In recent years, much research effort has been expended in trying to combine 
the two technologies of biosensors and immunoassay to produce sensors capable of 
measuring the formation of an immunochemical complex [48]. A wide range of 
techniques have been assessed in an attempt to match the performance of biosensors 
with that of conventional immunoassay techniques. Some of the techniques evaluated 
include, electrochemistry [49], solid-state devices [50, 51] and optical techniques [52, 
53]. Even though both electrochemical and solid-state immunosensors have shown to 
produce dose-response curves, they lack the sensitivity to be useful devices. In an 
attempt to overcome problems associated with sensitivity, many researchers have 
opted to use optical transducers for the construction of immunosensors. Optical 
transducers have a number of advantages in the fabrication of optical biosensors, they 
are well-characterized materials from which to fabricate the device e.g., quartz or 
silica, sensitive methods of detecting the signal produced and have rapid signal 
generation, processing and recording times [54].  
Optical biosensors represent the second major family of biosensors, after 
electrochemical biosensors. This has been made possible, mainly by progress in fiber-
optic technology, and laser miniaturization. Optical biosensors can be miniaturized to 
different scales depending on the prescribed function and can thus be categorized 
depending on their relative dimensions. In this work we use miniaturized optical 
biosensors, at the scale of a billionth of a meter, aptly named optical nanosensors 
[54]. Optical nanosensors can typically be classified into one of two broad categories, 
 81
chemical or biological, depending on the probe being used to perform the 
measurements[55]. Kopelman and coworkers have developed and used both 
biological and chemical nanosensors to perform physiological measurements of 
calcium[56] and nitric oxide [57], among other physicochemicals. They can be fully 
inserted into a single living cell and have been developed and applied for minimally 
invasive intracellular chemical analysis in cells [58-60]. Similarly, these nanosensors 
have been used to monitor biological processes such as pathogenesis due to chemical 
pollutants thereby providing a method of monitoring chemicals in 
microenvironments.  
Among the two categories of nanosensors, biological nanosensors have been 
developed and used by Vo-Dinh and coworkers to perform in situ measurements of 
the fluorescent analyte benzopyrene tetrol (BPT), a metabolite of the carcinogen 
benzo[a]pyrene (BaP) in single living cells [61, 62]. These nanosensors fall under the 
biological category of optical nanosensors based on the fact that they have antibodies 
immobilized on the optical fiber. The antibody-based nanosensors can be partially 
inserted into a single living cell without affecting the life cycle of the cell [19]. A cell 
survival study was previously performed [61] whereby an investigation was 
performed to determine whether penetration of the cell by the nanosensor resulted in 
intracellular or membrane damage of such a nature as to compromise cellular 
viability. The cell survival study was critical because it provided much needed insight 
as to whether or not penetration of the cell by the optical nanosensor affected cell 
viability. It was determined by microscopic observation that the process of mitosis 
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continued normally and that nanosensor insertion and withdrawal did not affect the 
life cycle of the cell. In retrospect, optical nanosensors that fall into the above-
mentioned categories are beneficial because they reduce sample volume and absolute 
detection limit a billion-fold, and simultaneously reduce the response time by a factor 
of a thousand [58]. It is important for analytical purposes to perform molecular 
recognition with high specificity and sensitivity to be able to detect and quantify the 
extent of the antibody-antigen interactions. The application of an antibody-based 
nanosensor for in situ measurements of BPT in a single cell was previously reported 
in our group [55, 63]. Here, we report the application of anti-benzo[a]pyrene (BaP) 
based optical nanosensors for in situ measurements of the fluorescent analyte and the 
carcinogen benzo[a]pyrene. We selected the fluorescent molecule BaP as the analyte 
model system because it is a PAH of environmental and toxicological interest as a 
result of its mutagenic/carcinogenic properties and its ubiquitous presence in the 
environment [61, 64]. Therefore, detection of BaP transport inside single cells is of 
great biomedical interest since it can serve as a means for monitoring BaP exposure, 
which can lead to DNA damage [61]. 
BaP (C20 H12) is one of the more potent carcinogens among the polynuclear 
aromatic hydrocarbons (PAH’s) and is a fundamental indicator of exposure and 
carcinogenic activity of all PAH’s. The PAH group of compounds are ubiquitous 
environmental contaminants that are formed by the incomplete combustion of organic 
materials, such as wood or fossil fuels. PAH, molecules are made up of three or more 
benzene rings, at least two of which are fused with two neighboring rings sharing two 
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adjacent carbon atoms. In addition to PAH that are composed of carbon and hydrogen 
atoms only, some PAH contain heteroatoms such as nitrogen and sulphur. PAH form 
a large and heterogeneous group, but the most toxic members of this family known 
to-date are PAH molecules that have four to seven rings. BaP is the most studied of 
this family of compounds and is a relatively large unsubstituted five-ring compound. 
BaP is lipophilic, sparingly soluble in water, and soluble in organic solvents [65]. 
Because of its relatively high environmental levels and high level of toxicity resulting 
in larger health impact than any other PAH identified in the environment, BaP is 
often selected as a surrogate for other PAH compounds and therefore it the most 
studied of the PAH family of compounds. Moreover, because of it relatively high 
environmental levels and high level of toxicity resulting in larger health impact than 
any other PAH identified in the environment. Since DNA adduct formation is the 
critical step in the process of carcinogenesis, it is important to measure BaP in order 
to determine exposure to PAH’s before DNA damage occurs [66]. Figure 3.1 
describes DNA adduct formation leading to BaP carcinogenesis. 
Measurement of BaP is dependent on the scale at which the measurement is 
being performed and the type of environment being probed. Currently, the optical 
nanosensor is the only available technology capable of measuring BaP in single living 
cells. This is possible by the small scale of the nanosensor in comparison to the scale 
of the cell under investigation. In addition, the optical nanosensor allows for 
minimally invasive cell analysis and in the process allows for the continuation of 
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Figure 3.1 shows the pathway of DNA adduct formation that ultimately leads 
to BaP carcinogenesis 
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is necessary to use antibodies targeted to BaP. With the nanosensor with immobilized 
antibodies, it is possible to specifically detect BaP molecules due to the specific 
binding of anti-BaP to BaP. The nanosensor system was designed utilizing molecular 
covalent methods where a receptor unit, the antibody, was covalently linked to the 
sensor unit, the optical fiber. The fluorescent BaP molecules are bound by interaction 
with the immobilized antibody receptor, forming a receptor-ligand complex. 
Following laser excitation of this complex, a fluorescence response from BaP 
provides a basis for the quantification of BaP concentration in the cell being 
monitored. The fluorescence signal generated allows for a high sensitivity of 
detection. By utilizing the interaction between the anti-BaP and BaP, it is possible to 
determine fluorescence differences that can determine the presence of anti-body-BaP 
complexes. 
The intracellular measurements of BaP depend on the reaction times involved. 
In a previous study, the reaction time established for antibody-BPT complexing was 5 
minutes [61]. Similarly, the reaction time established in thus study for antibody-BaP 
complexing was 5 minutes. This was used as a standard time to enable calibration 
from fiber to fiber. Additionally, the nanosensors were calibrated using standard 




3.2 Experimental Procedure 
3.2.1 Cell Lines  
Human breast cancer cell line, MCF-7, were obtained from American Type 
Culture Collection (Rockville, MD, USA, Cat-no. HTB22). MCF-7 cells were grown 
in Dulbecco's Modified Eagle's Medium ((DMEM) (Mediatech, Inc., Herndon, VA)) 
supplemented with 1 mM L-Glutamine (Gibco, Grand Island, NY) and 10% fetal 
bovine serum (Gibco, Grand Island, NY). Baseline static culture productivity for each 
cell line was established in growth medium (described above) in standard T25 flasks 
(Corning, Corning, NY). The flasks were incubated at 37°C, 5% CO2 and 86% 
humidity. Cell growth was monitored daily by microscopic observation until a 60–
70% state of confluence was achieved. The growth conditions were chosen so that the 
cells would be in log phase growth during BaP treatment, but would not be so close to 
confluence that a confluent monolayer would form by the termination of the chemical 
exposure [7]. In preparation for experiments, cells were harvested from the T25 flasks 
and 0.25ml (4.0 x 105 cells/ ml) seeded into 60mm tissue culture dishes (Corning 
Costar Corp., Corning, NY) for overnight attachment. From a 4.464 x 10-3M stock 
solution of BaP in ethanol, a range of 0.0001-1% solutions were prepared by adding 
the BaP solution in DMEM. The resultant solutions were added to multiple culture 
dishes and left in contact with the cells for a 4-hour incubation period. The amount of 
BaP in ethanol used was in small enough quantities such that normal cell growth did 
not seem affected by microscopic observation. BaP was prepared as a 1mM stock 
solution in reagent grade ethanol and further diluted before addition to the cells. 
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Following incubation of the MCF-7 cells with BaP, the medium containing BaP was 
aspirated, the dishes were rinsed once with sterile PBS, and the PBS was replaced 
with fresh growth medium before performing intracellular measurements using the 
nanosensor. 
 
3.2.2 Preparation of Antibody-based Nanosensors 
Preparation of antibody-based optical nanosensors has been previously 
described [61]. Briefly, this process involved cutting and polishing plastic clad silica 
(PCS) fibers with a 600-µm-size core (Fiberguide Industries, Stirling, New Jersey). 
Briefly, the fibers were pulled to a final tip diameter of 50 nm and then coated with 
200 nm of silver metal (99.999% pure) using a thermal evaporation deposition system 
(Cooke Vacuum Products, South Norwalk, CT) achieving a final diameter of 250nm 
(Figure 3.2). The fused silica optical fibers were acid-cleaned followed by several 
rinses with distilled water. Finally, the substrates were allowed to air dry at room 
temperature in a dust free environment. The fiber tips were then silanized and treated 
with an organic cross-linking reagent. The silanization agent covalently binds to the 
silica surface of the optical nanosensor tips modifying the hydroxyl group to a 
terminus of choice that is compatible with the organic cross-linking reagent. Silanes 
were determined to be the reagents most preferred for the attachment of antibodies 
since these silanes produced highly uniform and reproducible films and have a 
terminus amendable for use with a variety of hetero-bifunctional cross-linkers [67].  
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Tip size ~ 250 nmTip size ~ 50 nm
 
Figure 3.2 shows scanning electron micrographs of optical nanotips diameter 
of 50 nm (LEFT) and then coated with 200 nm of silver metal using a thermal 
evaporation deposition system achieving a final diameter of 250nm (RIGHT) 
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The choice of imidazole-terminal film is particularly attractive since the protein to be 
immobilized can be used without chemical modification. Antibodies bound using this 
procedure remained securely immobilized during washing and subsequent 
manipulations in immunoassay procedures, as opposed to procedures that use 
adsorption to attach proteins [68, 69]. Antibody to BaP was produced by co-author, 
Dr. G.D. Griffin. The tapered tips of the optical nanotips with silane groups and 
cross-linkers were immersed in a solution of anti-BaP in PBS and allowed to incubate 
for 3 days after which the nanosensors were inserted into single cells and used to 
detect and measure BaP.  
 
3.2.3 Measurement System and Procedure 
Figure 3.3 shows a schematic representation of the fluorescence measurement 
system. The 325 nm laser line of a HeCd laser (Omnichrome, <5mW laser power) 
was focused onto a 600-µm-delivery fiber that is terminated with a subminiature A 
(SMA) connector. The antibody-immobilized tapered fiber was coupled to the 
delivery fiber through the SMA connector and secured to the microscope with 
micromanipulators. The fluorescence emitted from the cells was collected by the 
microscope objective and passed through a 330-380 nm bandpass filter and then 
focused onto a photon-counting photomultiplier tube (PMT) for detection. The output 
from the PMT was recorded using a universal counter and a personal computer (PC) 

















Figure 3.3 shows the components of the laser-induced fluorescence measurement 
system consists of HeCd laser (325nm), optical fiber, Nikon inverted fluorescence 
microscope equipped with UV fluorescence filters (330-380nm) to reject the laser-
line and collect the fluorescence emission, a highly sensitive photomultiplier tube 
(PMT), a universal counter and a data acquisition PC 
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setup used to probe single cells was adapted to this purpose from a standard 
micromanipulation/microinjection apparatus. Figure 3.4 shows the Nikon Diaphot 
300 inverted microscope (Nikon, Inc., Melville, NY) having a Diaphot 300/Diaphot 
200 Incubator, to maintain the cell cultures at 37°C on the microscope stage, was 
used for these experiments. The micromanipulation equipment used consisted of MN-
2 (Narishige Co. Ltd., Tokyo, Japan) Narishige three-dimensional manipulators for 
coarse adjustment, and Narishige MMW-23 three-dimensional hydraulic 
micromanipulators for final movements. The optical fiber nanosensor was mounted 
on a micropipette holder (World Precision Instruments, Inc., Sarasota, FL). To record 
the fluorescence of BaP molecules bound to antibodies at the fiber tip, a Hamamatsu 
PMT detector assembly (HC125-2) was mounted in the front port of the Diaphot 300 
microscope. The fluorescence emitted by the bound BaP molecules was collected by 
the PMT and the data transmitted via a laboratory interface to a PC for data 
acquisition and processing.  
 
3.3 Results and Discussion 
Before making measurements, the cells were harvested from culture flasks 
and transferred to culture dishes. After attachment to the bases of the petri dishes, the 
MCF-7 cells were treated with a specified percentage of BaP/ ethanol in DMEM. The 
solution of BaP in DMEM was then aspirated and replaced with fresh DMEM. The 
nanosensors were gently inserted into individual living cells and incubated for about 5 
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Figure 3.4 shows an image of Nikon Diaphot inverted fluorescence 
microscope the main component of the laser-induced fluorescence measurement 
system 
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minutes to allow antibody-BaP interaction, and the fluorescence signal was recorded.  
Calibration measurements and five separate trials (each trial repeated five 
times) were conducted to determine the limit of detection and the reproducibility of 
the nanosensors. In each trial, MCF-7 cells plated in tissue culture petri dishes were 
incubated 4 hours prior to experimentation with DMEM solutions ranging from 
0.0001-1% BaP/ethanol (concentration range of 10-10 – 10-6 M BaP). In addition, for 
each trial, one petri dish (control) was incubated under normal growth conditions, 
with DMEM and without the addition of BaP.   
Detection and measurements of BaP in single cells using the nanosensor were 
carried out using the following procedure. A culture dish of cells was placed on the 
pre-warmed microscope stage set at 37oC. The nanosensor, mounted on a 
micropipette holder of a micromanipulation system, was moved into position (i.e., in 
the same plane as the cells), using bright-field phase contrast microscopic 
illumination, so that the tip was just outside of the cell to be probed. The total 
magnification used was 600×. The nanosensor was gently micromanipulated into the 
cell, past the cell membrane and extending a short way into the cytoplasm. Room 
light and microscope illumination light were switched-off; the laser shutter opened, 
and laser light allowed to illuminate the optical fiber and excitation light was 
transmitted into the fiber tip. First, a signal reading was taken with the nanosensor 
inside the cell with the laser shutter closed in order to record the dark signal. During 
these micromanipulations, great care was taken not to penetrate the nuclear envelope. 
After 5 minutes, the laser shutter was opened and fluorescence readings were 
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recorded. Figure 3.5 shows an image of an optical nanosensor prior to insertion and 
after insertion into a single MCF-7 cell illustrating how the intracellularmeasurements 
were executed and Figure 3.6 shows a schematic of the fluorescence excitation and 
detection process. 
Figure 3.7 shows the results of test-tube studies of % BaP/ethanol in DMEM 
using five nanosensors for each measurement performed in growth medium outside 
the cell. The graph consists of the logarithmic scale of the concentration of BaP in 
DMEM obtained when measured doses of BaP in ethanol were placed in DMEM, and 
the intensity counts acquired upon antibody-BaP complexing. The results showed that 
the average fluorescence intensity values increased with increasing concentration and 
reached a plateau phase as a result of saturation. Shown in the calibration curve are 
error bars that represent a 95% confidence interval (CI).  As can be seen on the curve, 
error bars of the concentrations 10-8, 10-7, 10-6 M overlap implying that the difference 
between the means is not statistically significant (P>0.05). The readings are higher in 
test-tube studies as compared to intracellular studies because there is a difference in 
diffusional kinetics as a result of the different levels of viscosity of DMEM and the 
aqueous cytoplasm. Granted that the inside of a cell is more like a scaffold, with a 
complex structure and machinery to transport proteins and other cellular components 
to specific sites, hence there is an increased diffusional limitation and this has the 
effect of decreasing the levels of BaP close to the silica surface and the rate of 
attachment of the BaP to the antibody on the surface. In comparison to the cell, the  
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Figure 3.5 shows an image of an optical nanosensor prior to insertion (LEFT) 
and after insertion (RIGHT) into a single MCF-7 cell illustrating how the single cell 




















Figure 3.6 shows schematic of the fluorescence excitation and detection 
process. A fluorescence signal is detected and measured once the anti-benzo [a] 



























Figure 3.7 shows the results of test-tube studies of % BaP/ethanol in DMEM 
using five nanosensors for each measurement performed in growth medium outside 
the cell. Each colored line represents an average of five in situ BaP measurements. 
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BaP/ ethanol in DMEM in the test-tube is an environment without diffusional 
limitations. Figure 3.8 shows the results of intracellular measurements of BaP 
performed with nanosensors using both the control and experimental groups of MCF-
7 cells. MCF-7 cells were incubated with 0.0001-1% BaP (% BaP/ethanol in 
DMEM). The graph consists of the final concentration of BaP in DMEM obtained 
when measured doses of BaP in ethanol were placed in DMEM (the final mixture was 
used for cell culture), and the intensity counts acquired upon antibody-BaP 
complexing within a single cell. Each point consists of average intensity value 
derived from five measurements performed for each concentration (10-10 – 10-6 M) of 
BaP/ ethanol in DMEM using a set of five nanosensors. The results showed that for 
the control group of cells, the fluorescence signal detected relative to the level of 
background signal was not significant.  
Although a background signal was generated, it was not significant enough to 
confound the determination of BaP. Moreover, there are no other molecules that 
appear to interfere with the fluorescence measurements that would confound the 
determination of BaP. The explanation for this is the high specificity of antibody, the 
time required for the metabolism of BaP to BPT, and the use of near field excitation. 
The application of monoclonal antibodies renders the nanosensors selective for 
measurement of BaP. These antibodies are specific against a single structural 


























Figure 3.8 shows the results of intracellular measurements of BaP performed 
using anti-BaP-based optical nanosensors in MCF-7 cells. Each colored line 
represents an average of five in situ BaP measurements. 
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exhibit very selective binding capabilities for specific structures [70]. As a result, BaP  
specific monoclonal antibodies immobilized on a nanosensor tip are useful for 
monitoring small quantities of BaP in complex matrices because of their high 
specificity for the molecular structure of BaP. These antibodies also exhibit high 
affinity. 
BaP is metabolized to 7,8-dihydrodiol-benzopyrene, which is metabolized into 
the epoxide metabolite of benzopyrene, BPDE, its carcinogenic form. The epoxide 
then binds with macromolecules such as protein and DNA (BPDE-DNA) to cause 
cytotoxicity. DNA adduct formation of 2.5 µM BaP occurs at 12 hr exposure, after 
which BPDE adducts decrease [71]. Metabolism of 3 µM BaP peaks at 9 to 16 hrs 
after exposure [72]. By exposing MCF-7 cells to varying concentrations of BaP 
(4.464 x 1010- 4.464 x 10-6M) for a 4 hr incubation period, we do not provide 
sufficient time for either BaP metabolism or DNA adduct formation. Therefore, BPT 
is an unlikely to confound the determination of BaP. 
The application of near field excitation contributes to the specificity of the 
nanosensor and virtually nullifies any effects that may confound the determination of 
BaP. Excitation of BaP lies in the strong evanescent-wave component of near-field 
excitation. The near field of the fiber (on the distal end) is where the antibody is 
immobilized and antibody-antigen complexing occurs and thus only BaP molecules 
that lie on the near-field are excited [61]. Consequently, the nanosensor used to 
monitor the cells incubated with % BaP/ ethanol in DMEM transduced a relatively 
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higher fluorescent signal as a result of BaP molecules sequestered at the tapered tip of 
the antibody-based nanosensor. 
Figure 3.9 shows the excellent degree of reproducibility achieved using the 
nanosensors to perform the intracellular detection of BaP. This figure shows the 
results obtained using five antibody-based nanosensors to probe MCF-7 cells 
incubated in 0.01% BaP in DMEM. Similarly, five antibody-based nanosensors were 
used to probe MCF-7 cells incubated without BaP/ ethanol in DMEM. The relative 
variations from nanosensor to nanosensor with or without bound BaP were 
approximately 7-10%. The fluorescence signal obtained using the nanosensors used 
to probe cells incubated with BaP/ ethanol in DMEM is relatively higher than the 
signal obtained by nanosensors used to probe cells incubated without BaP/ ethanol in 
DMEM. Despite reproducibility being a challenging aspect of this project, we 
managed to produce highly reproducible nanosensors. Excellent reproducibility was 
achieved as a result of improvements and refinements of the input parameters of the 
laser based micropipette-pulling device. Optimization of input parameters involved 
varying the user input parameters: heat, delay and pull strength. By varying the 
heating temperature as well as the tension applied to the fiber, we successfully 
produced reproducible tip diameters from fiber to fiber. This was confirmed by 
acquiring SEM images of the pulled fibers.  The optimization of the input parameters 
























w/ BaP w/o BaP
 
Figure 3.9 shows the excellent degree of reproducibility achieved using the 
nanosensors to perform the intracellular detection of BaP. This figure shows the 
results obtained using five antibody-based nanosensors to probe MCF-7 cells 
incubated in 0.01% BaP in DMEM. 
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especially essential for a technology aimed to single-use nanosensors allowing 
calibration to be done by measurement of the performance of one nanosensor. This 
study demonstrated the excellent reproducibility of antibody-based nanosensors. 
 
3.4 Shelf life and Stability of Immobilized Protein 
The stability of the immobilized antibody was determined in terms of the 
retention of activity after 21 days of storage at 4oC. No significant loss of activity 
was observed at the end of this period. In contrast, it was found that after drying, solid 
support with immobilized antibody rapidly lost activity within a few days. Therefore 
an aqueous environment is recommended for the long-term storage of these 
immobilized antibodies. Figure 3.10 shows the side-by-side comparison of 
nanosensors that have been utilized immediately after the immobilization of antibody 
and another set that have been used 21 days after preparation. The results show that 
here is no significant loss of activity by the end of the 21-day period. 
 
3.5 Conclusion 
In this work, we demonstrated the development and application of a rapid, 
selective and sensitive method for the determination of the carcinogen BaP in single 
cells using antibody-based nanosensors targeted to the fluorescent analyte, BaP. The 
results obtained in this work demonstrate in situ measurements performed inside 
single living cells using an antibody-based nanosensor and the potential application of 
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Figure 3.10 shows the side-by-side comparison of nanosensors that have been 
utilized immediately after the immobilization of antibody and another set that have 
been used 21 days after preparation. It can be seen from these results that there is no 
significant loss of activity by the end of the 21-day period. 
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previously reported [7] study involving the development and application of optical 
nanosensors for the detection of BPT. The quantification limits were extrapolated 
using linear regression and calculated to be ~3.61 x 10-10M. This is the lowest 
concentration of BaP estimated in a single MCF-7 cell. This result indicates that BaP 
can be monitored and measured using antibody-based optical nanosensors within 
single living cells. 
 
3.6 Summary 
Optical nanosensors were successfully nanofabricated and applied to measure 
BaP both in vitro and in vivo. They have a steep linear response with saturation point 
developing fast and a very narrow dynamic range (~5 – 20 nM). They have a low 
detection limit ~36.1 nM and excellent reproducibility that was determined from the 
percent 10% variability from nanosensor-to-nanosensor in measurements performed 
using the. Antibody stability after immobilization was observed when the optical 
nanosensors were stored at 4oC in an aqueous environment. Optical nanosensors have 
the potential to analyze at the single cell level the activities of specific proteins 
participating in cell signaling networks/ pathways. By monitoring these proteins we 
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Antibody-based Optical Nanosensor for the Measurement of Apoptosis 
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4.0 Abstract  
This work describes the application of optical nanosensor technology to 
measure apoptosis whereby the feasibility of antibody-based optical nanosensors for 
monitoring apoptosis by detecting protein-protein interaction and identifying protein 
activity were demonstrated. It describes the application of these nanosensors for the 
in vitro and pseudo in vivo measurement of two key apoptosis proteins cytochrome c 
and caspase-9, which are involved in the mitochondrial pathway of apoptosis. The in 
vitro and pseudo in vivo measurement involve the application of the antibody-based 
optical nanosensor employing the indirect detection scheme or sandwich type 
immunoassay whereby one of the partners in the immune interaction is labeled with a 
fluorescent molecule. The capture and reporter antibodies bind different epitopes of 
the same target biomolecule, and the interactions detected in the evanescent field of 
the optical nanosensor. This is a highly sensitive technique especially suitable for 
monitoring antibody-antigen interaction [73]. For both the in vitro and pseudo in vivo 
measurements, apoptosis was induced using a photodynamic therapy (PDT) agent δ-
aminolevulinic acid (ALA) that initiates the mitochondrial pathway of apoptosis. This 




Optical nanosensors are in general small devices, which incorporates a 
biological component onto a transducer as a key functional element. They are based 
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on a direct spatial coupling between a biologically active compound and a signal 
transducer. The biological component is usually an antibody or enzyme immobilized 
onto the transducer, the electronic or optic sensing system that detects the 
environmental changes brought about by the biological reaction. The colorimetric, 
fluorometric or chemiluminescent product of the reaction is often detected by the 
transducer [48, 74]. 
Optical nanosensors based on the antigen–antibody interaction are generally 
known as immunosensors. The high specificity and high sensitivity that defines an 
antigen–antibody reaction has been used in a vast range of laboratory-based tests 
incorporating antibody components. The analytes detected and measured have 
included many medical diagnostic molecules, clinical disease markers, bacteria, and 
such environmental pollutants as polynuclear aromatic hydrocarbons (PAH’s). There 
are two different types of immunosensors, direct and indirect immunosensors. Direct 
immunosensors are based on the immobilization of antibodies on a transducer surface 
which serve to capture target moleculecules with either colorimetric or fluorescent 
properties. Accordingly, they register immunochemical complex formation at the 
transducer surface via optical changes for direct detection of target molecules. The 
advantage of a direct immunosensor is that measurement of the antigen–antibody 
interaction can be accomplished immediately without any need for additional 
antibodies or markers such as enzymes or fluorescent labels. On the other hand, 
Indirect immunosensors involves the use of antibodies involved in an immune 
interaction which includes a capture and reporter antibody. As the naming suggests, 
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the capture antibody functions to bind and immobilize the target molecule, while the 
labeled reporter antibody binds to another epitope of the target molecule to “report” 
the binding event. These combine the high selectivity of immunoreactions with the 
high sensitivity characteristic of the fluorescence effect [73, 75].  
In this work, the indirect immunosensing method was used to perform the in 
vitro and pseudo in vivo measure two important apoptosis proteins, cytochrome c and 
caspase-9. This involved measuring cytochrome c and caspase-9 in cytosolic cell 
extract (in vitro) obtained from two cell groups; one in which apoptosis had been 
induced and the other in which apoptosis had not been induced. Optical nanosensor 
with capture antibody was incubated in cytosolic extract to initially form a primary 
immunocomplex. Following primary immunocomplex formation, the optical 
nanosensors incubated with Cy5 labeled reporter antibody forming a secondary 
immunocomplex. Similarly, pseudo in vivo measurement involved inserting and 
incubating an optical nanosensor with capture antibody into a single living cell. The 
optical nanosensor was gently withdrawn from within the living cell and incubated in 
a phosphate buffered saline (PBS) containing Cy5 labeled reporter antibody resulting 
in the formation of a secondary immunocomplex. In both cases, Cy5 label was 
excited using evanescent optical waves at the near-field of the optical nanosensors 
generated from the 632.8 nm of HeNe and the fluorescence intensity is recorded as a 




4.2 Antibody-based Optical Nanosensors 
Optical nanosensors used in this work exploit antibodies to monitor apoptosis 
proteins. One of the key factors in determining the usefulness of any biosensor is its 
specificity, which can be defined as its ability to specifically measure the analyte of 
interest, without having other biochemical species interfere with the measurement. 
Specificity is an important characteristic because it allows measurements to be made 
in complex environments. Since their first use in antibody-based optical biosensors 
for the measurement of the carcinogen benzo[a]pyrene[26], antibodies have gained 
increasing importance as bioreceptor molecules for optical biosensing applications 
[76-83]. Antibodies are immunoglobulins capable of specific combinations with 
antigenic molecules that caused their production. They exhibit very selective binding 
capabilities for specific structures and can posses both high specificity and binding 
affinity for a given antigen or hapten [84]. Two classes of antibodies exist, both of 
which have been used in constructing optical biosensors, (i) monoclonal antibodies, 
and (ii) polyclonal antibodies. Monoclonal antibodies are often used when the 
measurement of a very specific analyte is desired, while polyclonal antibodies exhibit 
less specificity. Specificity of monoclonal antibodies makes them extremely efficient 
for binding within complex matrices. On the other hand, polyclonal antibodies often 
recognize multiple epitopes, making them more tolerant to small changes in the 
nature of the antigen. Due to the complex nature of biological systems, the specific 
binding abilities of antibodies make them one of the most powerful biorecognition 
molecules to be used for constructing nanosensors [19].  
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The use of antibodies as biorecognition molecules on optical nanosensors for 
measuring apoptosis proteins was performed using the direct and indirect 
immunoassay formats respectively. The simpler of the two assay formats is the direct 
immunoassay format, which is most compatible when working with molecules that 
have intrinsic fluorescent properties. The main advantage of this format is that there is 
no need to label the interactants. The working principle of the direct immunoassay 
format, involves binding the target biomolecule to immobilized primary antibody, at 
which time an optical property e.g., fluorescence intensity, of the target molecule is 
measured. The direct immunoassay format is not applicable in cases where an optical 
property of a target molecule cannot be measured or is not intrinsically fluorescent 
[26], presenting a challenge and limitation. In such cases, this limitation can be 
overcome by using the indirect immunoassay format. This immunoassay format is 
straightforward and involves a capture antibody and a labeled reporter antibody, 
which bind to the non-fluorescent target molecule forming a sandwich type structure 
assay. After the sandwich type structure or secondary immunocomplex is formed, the 
fluorophore on the reporter antibody can be excited and detected. Typically, the 
fluorescent signal produced is representative of the binding event. Therefore, the 
indirect immunoassay format enables the measurement of biomolecules that are not 
intrinsically fluorescent and in a way makes it possible to study biomolecules in 





Apoptosis or programmed cell death (PCD) is a highly ordered, genetically 
controlled process that plays a fundamental role in both normal biological processes 
and disease states. Apoptosis is a combination of the Greek words apo, off, and 
ptosis, falling) or programmed cell death, is an orderly and genetically controlled 
form of cell death defined distinct morphological and biochemical features. It usually 
affects single cells or small groups of cells in an asynchronous fashion. Apoptosis 
consist of four key phases [85]; 
• The Initiation Phase 
• Decision Phase 
• The Committed or Effector phase 
• The Cellular Degradation Phase 
 
4.3.1 The Initiation Phase 
The molecular pathway includes an initiation phase, which starts after 
signaling by internal triggers, (a) increases in intracellular Ca2+ (b) activation of 
protein kinases A and C (c) increases in protein synthesis C, changes in gene 
regulation (d). external triggers such as (a) ligation to distinct receptors or (b). 






4.3.2 The Decision Phase 
During the decision phase transduction occurs of the apoptotic signal to 
nuclear and cytoplasmic target enzymes, which includes activation of endonucleases 
and enzymatic alterations of the cytoskeleton. There are numerous proteins and lipid-
derived moieties that modulate the apoptotic mechanism in positive or negative 
direction. 
 
4.3.3 The Committed or Effector Phase 
The committed or effector phase is started when the cell has arrived at a stage 
of no return. The nuclear DNA is cleaved in multiples of 180-200 base pairs, the 
plasma membrane, integrity and the mitochondria remain initially intact, the cell 
splits up into apoptotic bodies, small vesicles which enclose the nuclear and cellular 
remnants. 
 
4.3.4 The Cellular Degradation Phase 
The cellular degradation phase is arrived, when the apoptotic bodies are 
phagocytosed by adjacent cells and macrophages. It is thought that the 
pharmacodynamics of anticancer drugs consists of two distinct steps. The first step 
includes the interaction with its cellular target; which is not lethal per se. The 
commitment of the cell to undergo apoptosis forms the second step. The efficacy of 
anticancer drugs is determined by the ability to selectively sensitize tumor cells to 
apoptosis.  
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4.4 The Importance of Measuring Apoptosis 
Specific morphological and biochemical features characterize apoptosis. It is a 
normal and abnormal component of the development and health of multi-cellular 
organisms. Cells die in response to a variety of stimuli and during apoptosis, they do 
so in a controlled, regulated fashion. This makes apoptosis distinct from another form 
of cell death called necrosis in which uncontrolled cell death leads to lysis of cells, 
inflammatory responses and, potentially, to serious health problems. Apoptosis, by 
contrast, is a process in which cells play an active role in their own death, which is 
why apoptosis is often referred to as cell suicide.  
Over the past decade, the importance of apoptosis has been appreciated, and it 
is now thought to be the main mode of cell death in liver diseases, neuronal cell death 
in neurodegenerative disease (e.g., Alzheimer’s disease). Apoptosis has been found to 
have a role in one mechanism leading neuronal cell death associated with Alzheimer's 
disease and in liver disease. On the other hand, the loss of ability of cells to undergo 
apoptosis is one of the causes of uncontrollable cell growth leading to cancer. Tumor 
growth is determined not only by increased cell division, but also by decreased 
tumor-cell attrition. Therefore most, if not all, cancer cells acquire resistance to the 
various mechanisms that lead to apoptosis [86, 87]. 
 
4.5 Apoptosis Pathways 
There are three major apoptosis pathways: 
• Mitochondrial Pathway 
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• Death Receptor Pathway 
• Endoplasmic Reticulum Pathway 
The first, Mitochondria Pathway is triggered when mitochondria are irreversibly 
damaged. It is mediated by mitochondria, which release apoptogenic proteins, mainly 
cytochrome c. Cytochrome c once released into the cytosol binds to a cytosolic 
protein apoptotic protease-activating factor (Apaf-1) and this complex in the presence 
of dATP or ATP facilitates activation of caspase-9, which in turn activates 
downstream caspases [88, 89]  
The Death Receptor Pathway triggered by the binding of extracellular ligand, 
tumor necrosis factor alpha (TNF-α), Lymphotoxin, Fas ligand (FasL) to their cell 
surface receptors leading to caspase-8 activation [90]. 
The third pathway is initiated by Endoplasmic Reticulum (ER) stress (due to 
depletion of ER calcium or accumulation of unfolded proteins) and causes activation 
of caspase-12 [91], which recently has been shown to activate caspase-9 [92]. It is 
unclear whether this pathway may operate in human cells because a human 
homologue of murine caspase-12 has not been found. 
 
4.5.1 Mitochondrial Pathway of Apoptosis 
This work is focuses on the mitochondrial pathway of apoptosis (Figure 4.1) 














Figure 4.1 shows the Mitochondria Pathway of Apoptosis which is triggered 
when mitochondria are irreversibly damaged. It is mediated by mitochondria, which 
release apoptosis proteins, cytochrome c into the cytosol. Once released into the 
cytosol, cytochrome c binds to a cytosolic protein apoptotic protease-activating factor 
(Apaf-1) and this complex in the presence of dATP or ATP facilitates activation of 
caspase-9, which in turn activates downstream caspases such as caspase-7 
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photodynamic therapy (PDT) drugs are realized. The mitochondrial pathway of 
apoptosis can be activated by a variety of agents including PDT drugs or 
photosensitizers e.g., ALA, reactive oxygen species e.g., H2O2, and 
certainchemotherapy drugs e.g., Tamoxifen. These therapeutic agents cause 
mitochondrial damage, which results in lowering of mitochondrial membrane 
potential and subsequently altered membrane permeability leading to the release of 
cytochrome-c form intermembrane space of mitochondria. Cytochrome c binds to 
apoptosis protease activating factor –1 (Apaf-1) and caspase-9, in the process 
activating capse-9. Activated caspase-9 cleaves either caspase-3 or caspase-7 
resulting in downstream events involved in cell death [93]. Caspase-9, caspase-7 and 
caspase-3 are Cysteine aspartate-specific proteases (Caspases) involved in highly 
specific proteolytic cleavage events in dying cells. Caspases are specialized cysteine-
dependent proteases that cleave major structural proteins of the cytoplasm and 
nucleus [93] and activation of caspases is often considered a key biochemical 
hallmark of apoptosis.  
In normal healthy cells caspases exist as poorly active or inactive zymogens 
that can be activated by autocleavage or processing by other proteases. Mitochondria 
contain both the pro-caspase-9 and comparatively little of the processed, mature form 
of caspase-9 and cytochrome c. Upon the induction of apoptosis, cytochrome c is 
exported from the mitochondria to the cytoplasm and mitochondrial pro-caspase-9 
translocates to the cytosol and to the nucleus. Mitochondria also release mature 
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caspase-9 upon induction of permeability transition in vitro. Cytochrome c and 
caspase-9 appear to be equally and functionally important initiators of the apoptosis.  
 
4.5.2 Cytochrome c 
Cytochrome c is a protein that is important to the process of creating cellular 
energy, the main function of mitochondria. Cytochrome c is an essential component 
of the mitochondrial respiratory chain. It is a 15KDa soluble protein, localized in the 
intermembrane space and loosely attached to the surface of the inner mitochondrial 
membrane. In response to a variety of apoptosis-inducing agents, cytochrome c is 
released from mitochondria to the cytosol [94]. When mitochondria are damaged, 
cytochrome c is released into the main body of the cell, and if the cell itself is 
damaged, into the surrounding tissue. The release of cytochrome c is part of the 
cascade of cellular events that lead to apoptosis, or programmed cell death. Apoptosis 
is triggered by the genes a cell carries, and differs from necrosis, cell death from 
catastrophic outside forces. When some trigger sets off the cycle that leads to 
apoptosis, cytochrome c appears outside the mitochondria within one hour. 
Cytochrome c is not a factor in necrosis. Cytochrome c release from mitochondrion is 
indicative of apoptosis and can be used as evidence that apoptosis is occurring [95].  
 
4.5.3 Caspase-9  
Caspase-9 is one of the most important cysteinyl aspartate specific protease 
(caspase) among the caspase family members. Caspase-9 is synthesized as inactive 
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pro-enzyme that is processed in cells undergoing apoptosis. The processed form 
consists of large (35Kda) and small (11Kda) subunits. Antibody can detect the 35Kda 
protein corresponding to the large subunit. Caspase-9 is thought to trigger a caspase-
cascade leading to apoptosis [96]. As a result of mitochondrial membrane 
permeabilization, which may set the point-of-no-return of the death process [97, 98] 
caspase activators including cytochrome c and caspase-9, are released from the 
mitochondria intermembrane space into the cytosol. Cytochrome c release triggers the 
assembly of the cytochrome c/ Apaf-A/ pro-caspase-9 activation complex, the 
apoptosome [99, 100], moreover, caspases-9 is processed in response to cytochrome 
c. 
 
4.6 Photodynamic Therapy (PDT) 
Because the focus of this work is the mitochondrial pathway of apoptosis, the 
PDT agent or photosensitizer ALA was used to induce apoptosis. PDT is a treatment 
modality for various cancers and other diseases associated with selective 
accumulation or production of photosensitizers in diseased tissue and cells [101]. 
PDT induces apoptosis in human carcinoma cells (MCF-7 cells) when the combined 
administration of a photosensitizer followed by its activation by light of the 
appropriate wavelength is used [102]. Photodamage to mitochondria caused by the 
production of reactive oxygen species from the reaction of PDT agents and light 
results in immediate loss of mitochondrial membrane potential together with the 
release of cytochrome c into the cytosol. This is followed by a rapid activation of  
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caspases [103]. Figure 4.2 shows a diagrammatic representation outlining the PDT 
process while the photophysics PDT sensitization. The photosensitizer possesses an 
absorption maximum at a wavelength corresponding with that of the incident laser 
light, and shining light on the photosensitizer causes excitation to the singlet excited 
state (1P*). The singlet excited photosensitizer can decay back to the ground state 
with release of energy in the form of fluorescence - enabling identification of tumor 
tissue. If the singlet state lifetime is suitable (and this is true for many 
photosensitizers) it is possible for the singlet to be converted into the triplet excited 
state (3P*) which is able to transfer energy to another triplet. One of the very few 
molecules with a triplet ground state is oxygen, which is found in most cells. Energy 
transfer therefore takes place to afford highly toxic singlet oxygen (1O2) from ground 
state oxygen (3O2), provided the energy of the 3P* molecule is higher than that of the 
product 1O2. As a result, the reactive oxygen species produced destroys cancer cells. 
 
4.6.1 Photodynamic Therapy Agents or Photosensitizers: δ-Aminolevulinic Acid 
Photodynamic therapy agents or photosensitizers are chemical substances or 
medications that increase the sensitivity of cells, tissues or organs to irradiation by 
optical radiation. Photosensitizers used for PDT are capable of inducing cancer cell 
death through apoptosis. Cancer cells are injured by the photosensitizing action of the  

























Figure 4.2 (i) shows the photodynamic therapy process leading up to 
apoptosis. A photosensitizing agent or dye (D) is exposed to light of a particular 
wavelength for activation. The excited form of the dye (D*) transfers the energy 
acquired from excitation light to molecular oxygen forming oxygen radicals that 
causes oxidative damage to cancer cells ultimately destroying them. (ii) shows a 
simplified Jablonski diagram of the photophysics of photosensitization (vibrational 
levels omitted). 
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apoptosis machinery [104]. The photosensitizer used to induce the mitochondrial 
pathway of apoptosis is δ-Aminolevulinic (ALA). The photosensitizer ALA is a 
precursor of protoporphyrin IX (PpIX) [105]. ALA is converted into PpIX by cells, 
which can then be activated by blue or red light [102]. Following light activation, 
PpIX is excited to a high-energy triplet state that can transfer its energy to molecular 
oxygen to form highly reactive oxygen species [106]. Reactive oxygen species can 
induce a number of biological processes including apoptosis [107, 108]. ALA 
induced PpIX causes mitochondrial damage and induce apoptosis through release of 
cytochrome c and caspase-9 though, some cells, may survive PDT [109]. The 
consequence of cytochrome c release is the activation of a series of proteases known 
as caspases. The caspase cascade commences with the cleavage of procaspase-9.  
Apoptosis has been shown to occur following ALA administration and 
photoactivation in pancreatic carcinoma cells [110], V79 Chinese hamster fibroblast 
cells, [111], colonic adenocarcinoma cells [111] and MCF-7 cells[112]. ALA 
generates signals to the mitochondria that induce the release of cytochrome c [113].  
Following its release from the mitochondria, cytochrome c activates the initiator 
procaspase-9 producing the activated form, caspase-9, which in turn activates other 
effector caspases such as caspae-7 and caspase-3. ALA-PDT induces rapid apoptosis 
as early as 2-3 hours after light exposure. This observation and the known localization 
of PpIX to the mitochondria following incubation with ALA suggests that ALA-PDT 
induces apoptosis by disrupting the mitochondrial transmembrane potential followed 
by cytochrome C and subsequent induction of caspases [114].   
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4.7 Human Mammary Adenocarcinoma Cells: MCF-7 cells 
For this work, the human mammary adenocarcinoma cell line, MCF-7 was 
used. MCF-7 is a tumorigenic cell line (American Type Culture Collection (ATCC), 
Rockford, MD), derived from human breast tumor. These cell are self-adherent and 
amendable to manipulation. These cells are maintained as monolayers and are 
commonly used to study apoptosis in breast cancer cells. MCF7 cells are significant 
because they are known to cause breast cancer in 8-10 percent of the female 
population in the US. Breast cancer is the most common malignancy and the most 
frequent cause of cancer related death among women (Cancer Facts & Figures- 2001, 
American Cancer Society (ACS). The MCF7 cells are also one of the most commonly 
used cells for breast cancer research, are well characterized, and have been found to 
be tumorigenic in nude mice. In addition, the initiation of apoptosis in MCF-7 cells 
has been reported using photosensitizers in combination with laser irradiation doses 
[115]. Another reason for opting to work with MCF-7 cells is that some have been 
found to lose their ability to bind chemotherapeutic agents such as tamoxifen [116]. It 
is also important to look for alternative forms of inducing apoptosis tat can lead to the 
discovery and development of new therapies to treat cancer cells that have developed 
resistance to chemotherapy drugs.  
Induction of apoptosis by photosensitizers has been previously examined 
using MCF-7 cells, which have been reported to extensively release large amounts of 
cytochrome c and subsequently activate caspase-9 2-3h after exposure to ALA and 
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photoactivation. It has been shown the response to photosensitizer-induced apoptosis 
in MCF-7 cells is due to activation of the caspase cascade downstream of cytochrome 
c release [117].  
MCF-7 cells are self-adherent and usually for adherent cells, mechanical 
stresses applied to cells, such as scraping them from the surface or using trypsin-
EDTA, can trigger a variety of cellular responses. Additionally, most cells express 
abundant adhesion proteins that provide a structural link between the cytoskeleton 
and extracellular surfaces (extra cellular matrix). Forces applied to remove cells can 
trigger immediate and long-term changes in cellular physiology. For adherent cells, 
mechanical manipulation prior to the time of sampling can interfere with 
measurements of cellular biochemistry. If perturbations occur before sampling, 
substantial changes in the physiology of the cell can occur for instance changes in ion 
concentration or enzyme activation, especially enzymes that are normally confined to 
cellular sub-compartments. For example proteases often escape from damaged 
lysosomes and once in the cytosol, the proteases cleave inappropriate targets, i.e., 
proteins or peptides to which they normally do not have access. In addition 
compartmentalized enzymes that released into the cytoplasm may have sufficient time 
to encounter and modify inappropriate substrates [118]. Spatial localization of 
proteins particularly enzymes has been identified as a mechanism to regulate the flow 
of information through signaling cascades in cells [119]. The absence of manipulation 
prior to performing cell measurements results in minimal effects on the cell [8]. For 
this reason, the ability to perform minimally invasive measurements within intact 
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single living cells with temporal and spatial resolution is important for the analysis of 
a cell as a system. Optical nanosensors can perform such measurements and reveal 
the intricacies of biochemical pathways in intact living cells. 
 
4.7.1 Cell Culture: Maintaining and Propagating MCF-7 Cells 
MCF-7 cells obtained from American Type Culture Collection (Rockville, 
MD, USA, Cat-no. HTB22) were cultured as monolayers in T-25 plastic tissue 
culture flask. Cells were maintained in Dulbecco's minimally essential media 
(DMEM) with phenol red, supplemented with 10% fetal calf serum, 1% L-glutamine, 
3.5 g/l glucose, and 1% penicillin and streptomycin, and incubated at 37 oC in 
humidified air with 5% CO2. MCF-7 cells were routinely monitored under a phase 
contrast microscope until they achieved confluency (80-90%) to warrant propagation.  
MCF-7 cells were split and propagated every 3-5 days. The process involves 
emptying the culture medium from the respective T-25 tissue culture flasks, rinsing 
with 5ml PBS and then gently resuspending the cells in the T-25 flask surface using 
trypsin (sterile process). The proteolytic enzyme trypsin was brought to room 
temperature and a 1ml was pipetted into each of the T-25 culture flasks. The trypsin 
was left to sit in flasks for about 3-5 minutes at 37oC giving sufficient time for the 
trypsin to detach the adherent MCF-7 cells from the base of the tissue culture flask. 
After the 3-5 minute period expired, the cells are briefly visualized under the inverted 
phase contrast microscope to ensure the cells are fully detached. At this point the cells 
appear circular in shape. Into each of the flasks, 5ml of DMEM is pipetted to 
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neutralize the action of trypsin. From the total 6 ml of each tissue culture flask, 
0.25ml is transferred into two T-25 tissue culture flasks, each containing 5 ml. The 
cells are then incubated at 37oC, 5% CO2 and 86% humidity. The cells were 
examined daily using the inverted phase contrast microscope to determine the degree 
of confluency. The DMEM medium should appear red as a result of phenol red. In 
cases where DMEM turns yellow before achieving at least 75% confluency, the 
acidic medium is replaced with fresh DMEM. After 3-5 days the cells are split and 
propagated. Some of the cells are harvested and preserved at –70oC for future use. 
Freezing can be lethal to the cells due to the effects of damage by ice crystals, 
dehydration, alterations in concentration of analytes and changes in pH. To minimize 
the effects of freezing, the cryoprotective agent DMSO is used. The freezing medium 
consists of 90% DMEM and 10% DMSO. 
 
4.8 Experimental Protocol 
As stated previously, the objective of this project is to use optical nanosensor 
based on evanescent fluorescence to measure apoptosis in single living cells by 
monitoring cytochrome c and caspase-9. Prior to measuring cytochrome c and 
caspase-9, preliminary experiments were performed to determine the photocytoxicity 
of ALA and to confirm if ALA induced the mitochondrial pathway of apoptosis. 
After completing the preliminary studies, experiments were performed whereby 
apoptosis was induced using ALA and both cytochrome c and caspase-9 were 
detected and identified using the antibody-based optical nanosensor. These 
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experiments were first performed in vitro and second, pseudo in vivo using the 
sandwich immunoassay format. The in vitro measurement were performed in 
cytosolic cell extract while the pseudo in vivo measurements were performed in the 
following way; the optical nanosensors with capture antibody were incubated in 
single cells, withdrawn and then incubated in a solution containing labeled reporter 
antibody. For both measurement formats, evanescent optical waves generated in the 
near field of the optical nanosensor were used to excite the fluorophore labeled 
reporter antibody after secondary immunocomplex formation. The fluorescent signal 
generated was recorded and is representative of the binding events.  
 
4.8.1 Photocytotoxicity Study  
The cellular events occurring after mitochondria receive the apoptotic signal, 
involve the mitochondrial outer membrane becoming permeable (lowering of 
mitochondrial membrane potential) to cytochrome c, which is translocated from 
mitochondria to the cytosol. Once released into the cytosol, cytochrome c activates 
downstream caspases, leading to the rapid disintegration of the cell [88]. The 
objective of this study was to explore the in vitro photosensitizing potential of ALA 
generated PpIX and its capacity to induce apoptosis in human mammary carcinoma 
cells, MCF-7. The photosensitizing process involves the combination of light and 
light sensitive ALA, in an oxygen-rich environment. ALA absorbs energy from 
photons and transfers this energy to surrounding oxygen molecules. This leads to the 
formation of toxic oxygen species such as singlet oxygen and free radicals. These are 
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very reactive and can damage proteins, lipids, nucleic acids and other cellular 
components leading to cell death. MCF-7 cells were incubated with ALA for two 
hours followed by exposure to 11 J cm–2 of visible light from a HeNe laser. 
Photocytotoxicity was assessed at 24 hours, 48 hours, 72 hours, and 96 hours using a 
coulter counter to perform dead cell count assay.  
 
4.8.2 Experimental Procedure: Photocytotoxicity Study of ALA 
MCF-7 cells were grown in Dulbecco's Modified Eagle's Medium ((DMEM) 
(Mediatech, Inc., Herndon, VA)) supplemented with 1 mM L-Glutamine (Gibco, 
Grand Island, NY) and 10% fetal bovine serum (Gibco, Grand Island, NY). Baseline 
static culture productivity for each cell line was established in growth medium 
(described above) in standard T25 flasks (Corning, Corning, NY). The flasks were 
incubated at 37°C, 5% CO2 and 86% humidity. Cell growth was monitored daily by 
microscopic observation until a 75% state of confluence was achieved. The growth 
conditions were chosen so that the cells would be in log phase growth during 
photosensitizer treatment. The cells were harvested from the T25 flasks and 0.25ml 
(4.0 x 105 cells/ ml) seeded into T-75 flasks. From a 1mM stock solution of δ-
aminolevulinic acid, 0.5mM [120] solutions was prepared by adding the δ-
aminolevulinic acid, solution in DMEM. The prepared solutions were added to 
multiple T-25 culture flasks of the experimental group and treated control group left 
in contact with the cells for a 2-3-hour incubation period. Following incubation of the 
MCF-7 cells with δ-aminolevulinic acid; the medium containing δ-aminolevulinic 
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acid was replaced with fresh DMEM. The ALA taken up by the MCF-7 cells was 
activated using 632.8 nm HeNe laser. Photocytotoxicity was assessed 24 hours, 48 
hours, 72 hours, 96 hours and 120 hours using dead cell count assay.  
 
4.8.3 Experimental Section 
The photocytotoxicity test was performed to determine the effect of the 
photosensitizer ALA on cell growth. This was accomplished by performing a series 
of tests were performed whereby MCF-7 cells were exposed to the following 
experimental conditions; Group I MCF-7 cells were incubated in the dark at 37°C 
with 0.5 mM ALA in DMEM for 2-3 hours followed by exposure to 632.8 nm red 
light from a HeNe laser at (2.22 J/cm2) in DMEM with 10% FCS. To determine the 
influence of light on MCF-7 cells, Group II were incubated with 0.5 mM ALA in 
DMEM for 2-3 hours, exposed to red light from a HeNe laser at (2.22 J/cm2). To 
determine the influence of ALA on MCF-7 cells, Group III MCF-7 cells were 
incubated in the dark at 37°C with 0.5 mM ALA in DMEM for 2-3 hours. Group IV, 
MCF-7 cells were incubated in the dark at 37°C without ALA and were not exposed 
to 632.8 nm red light from a HeNe laser. All procedures after addition of ALA were 
performed in the dark. For statistical significance, five T-25 flasks were used for each 
treatment group The dead cell count data obtained using the coulter counter were 
compared for Groups I – IV. Typically, dead MCF-7 cells detach from the base of 
tissue culture flasks and remain suspended in growth medium because, when they die, 
they lose their self-adherence capability. Therefore, after administering the various 
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cell treatments, cells in the experimental groups die and lose their capability for self-
adherence. The media containing un-bound MCF-7 cells are passed through a G20 
syringe to generate a single cell suspension. Fresh growth media is introduced into the 
tissue culture flasks after aspirating un-bound cells to be counted. Cell mortality was 
compared for Groups I - IV and expressed as the effect of the different forms of 
treatment they received. To statistically validate the dead cell count results obtained 
from the replicate experiments performed, a student t-test was performed.  
 
4.9 Student’s t-test 
As mentioned above, the dead cell count was obtained routinely at set time 
points on successive days from the flasks with the treatment Groups I - IV. Each 
treatment was performed in replicate to statistically validate the outcome. As 
mentioned previously, in order to validate the results obtained from Groups I – IV, of 
the photocytotoxicity study a student’s t-test was performed. The t-test was used to 
determine if the results of Groups I -IV differ on a single variable, photodynamic 
treatment. This study was used to determine whether cell death differs among cells 
exposed to different experimental treatment regiments of ALA-PDT. Here, it was 
particularly useful in analyzing scores of Groups I – IV on the particular variable, 
ALA-PDT. The null hypothesis (H0) was stated based on the assumption that there is 
no difference in parameters (mean, variance) for Groups I – IV. According to the null 
hypothesis, any observed difference in samples is due to chance or sampling error and 
not the variable ALA-PDT. 
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The software application program, MS Excel was used to calculate the p-
values of the t-tests and determine the significance of the results. Data points obtained 
from Groups I – IV acquired using LabView data acquisition program were converted 
using MS Excel Text Wizard to obtain a data format compatible with the MS Excel 
interface. The type of t-test used was two sample unequal variance and a 2-tailed 
distribution with a threshold of 0.05 (5%). This means that if the p-value is less than 
0.05, then the null hypothesis is rejected and it can be stated with a 95% level of 
confidence that the two parameters are not the same. The calculated p-value is 
compared with the desired significance level set for the t-test and, if it is smaller, the 
result is significant. That is, if the null hypothesis will be rejected at the 5% 
significance level, and this is reported as "p < 0.05". 
 
4.10 Results and Discussion: Photocytotoxicity Study 
The aim of the photocytoxicity study of ALA was to determine the effect of 
ALA on MCF-7 cells. The outcome of the treatments administered, Groups I – IV 
were determined by dead cell count using a coulter counter. These results were 
plotted and are shown in Figure 4.3. The outcome of the photocytotoxicity study 
revealed that in the first five days following treatment, cell death was observed only  
in the experimental treatment Group I, ALA(+) PDT(+). Increasing cell death is 
evident from the graph peaking on day three. However, from the dead cell count 
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Figure 4.3 shows the results of the dead cell count assay. On five successive 
days, three T-25 flasks were obtained from the incubator and the unbound (dead) 
MCF-7 cells counted. Each bar shows the average MCF-7 cells obtained and counted 
from three T-25 flasks. The calculated p-values for the students t-test are 0.039972, 
0.039906, 0.039914 (ALL p<0.05). These p-value results obtained from the student-t 
test indicate that (+)ALA(+)PDT treatment significantly affects MCF-7 cell 
proliferation compared to (+)ALA(-)PDT, (-)ALA(+)PDT and (-)ALA(-)PDT. The 
error bars represent 95% confidence interval (CI). 
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IV -ALA(-) PDT(-), there was no significant increase cell mortality. Using the t-test, 
it was confirmed that the results of Groups I -IV differ on the single variable, 
photodynamic treatment. The calculated p-values determine the null hypothesis is 
unlikely to be true. It indicates the strength of evidence for rejecting the null 
hypothesis rather than simple concluding that apoptosis is a concerted effect of ALA 
and photoactivation. The finding that apoptosis is a concerted effect of ALA and 
photoactivation achieved statistical significance as shown by the results obtained 
using the t-test. The calculated p-values of students t-test were 0.039972, 0.039906, 
0.039914 (p<0.05). These p-value results obtained from the student-t test indicate that 
(+)ALA(+)PDT significantly affect MCF-7 cell proliferation compared to (+)ALA(-
)PDT, (-)ALA(+)PDT and (-)ALA(-)PDT. In summary, no photocytotoxicity was 
observed for either laser irradiation without ALA, or ALA without laser radiation, but  
cell death was observed and determined for the combination of ALA and laser 
radiation. Additionally, Groups II and III, ALA(+) PDT(-) and ALA(-) PDT(+) reveal 
the absence of dark and light toxicity. Therefore, it can be concluded that incubation 
of MCF-7 cells with 0.5 mM ALA for 3 h and subsequent photoactivation with light 
from a HeNe laser results in a significant increase in cell death compared with Groups 
II – IV. 
 
4.11 In Vitro and Pseudo In Vivo Measurement of Apoptosis 
Optical nanosensors based on evanescent fluorescence sandwich type 
immunoassay were developed and used for the in vitro and pseudo in-vivo analysis of  
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cytochrome c and caspase-9. In vitro analysis of cytochrome c and caspase-9 was 
performed using cytosolic cell extract. However, pseudo-in vivo analysis involves 
probing a single cell with antibody-based optical nanosensor and then withdrawing 
the optical nanosensor from within the cell and incubating it with Cy5 labeled 
reporter antibody. The two measurement schemes employ the indirect immunoassay  
technique that involves using primary (capture) and dye conjugated secondary 
(reporter) antibody. The distinction of the two techniques lies in the first step of 
binding the target molecule with capture antibody. The pseudo in vivo technique 
involves incubating optical nanosensor in single living cells and then incubating the 
optical nanosensors with Cy5 labeled reporter antibody solution in a microfuge tubes. 
Based on the previous photocytotoxicity study, two groups were used for in vitro and 
pseudo in vivo studies: Group I, control group of cells PDT(-) ALA(-), and Group II, 
experimental group of cells PDT(+) ALA(+). For these studies, cytochrome c and 
caspase-9 antibody were immobilized on optical nanosensors to bind cytochrome c 
and caspase-9 respectively. Optical nanosensors were then incubated in the cytosolic 
cell extract obtained from Group I, (+)ALA (+)PDT, and Group II, (-)ALA (-)PDT. 
This was be followed by binding Cy5 labeled reporter antibody which facilitates the 
fluorescence detection of the secondary immunocomplex formed after excitation 
using a 632.8 nm HeNe laser. The fluorescence signals generated are detected using a 




4.11.1Materials and Methods 
Plastic clad silica (PCS) fibers with a 600-µm-size core (Fiberguide 
Industries, Stirling, New Jersey). Indirect immunoassay capture and reporter antibody 
for cytochrome c and caspase-9 measurement, cytochrome c (Ab-3): capture Ab, 
cytochrome c (Ab-4): reporter Ab, caspase-9 (Ab-1): capture Ab, caspase-9 (Ab-2): 
reporter Ab were purchased from purchased from Santa Cruz Biotechnology, Santa 
Cruz, CA. 
 
4.11.2 Cytosolic Cell Extraction (Cell Fractionation Protocol) 
MCF-7 cells were grown to 70–80% confluency and exposed to 0.5mM ALA 
to induce apoptosis. Concurrently control groups of MCF-7 cells were cultured 
without induction. Cytosolic protein was extracted as described Tikkanen et al. [121]. 
Briefly, cells were rinsed in calcium- and magnesium-free Hanks’ balanced salt 
solution and lifted with 3mM EDTA. Detached cells were rinsed and collected by 
centrifugation at 3000 RPM for 5 minutes at 4oC and washed in ice cold PBS. The 
cells were centrifuged again at 3000 RPM for 5 minutes at 4oC and the supernatant 
removed. The cells were then lysed in hypotonic buffer containing 10 mM Tris-Cl, 
pH 7.5, 1 mM EDTA, 1 mM DTT, 0.5 mM 4-(2-aminoethyl) benzenesulfonyl 
fluoride, 10 mM leupeptin, 2 µg/ml aprotinin, and 4 µM pepstatin and incubated on 
ice for 10 minutes. The cells were immediately centrifuged at 3000 rpm for 10 min at 
4 °C and the supernatant was collected as cytosol.  
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4.11.3 Fluorescent Measurement System and Procedure 
Figure 4.4 shows a schematic representation of the fluorescence measurement 
system. The 632.8 nm laser line of a HeNe laser (Melles Griot, <15mW laser power) 
was focused onto a 600-µm-delivery fiber that is terminated with a subminiature A 
(SMA) connector. The antibody-immobilized nanosensor was coupled to the delivery 
fiber through the SMA connector and secured to the microscope with 
micromanipulators. The fluorescence emitted from the tip of the nanosensor was 
collected by the microscope objective and passed through a Cy5 long pass filter 
(Chroma, Brattleboro, VT) and then focused onto a PMT for detection. The output 
from the PMT was recorded using a universal counter, and a personal computer (PC) 
with custom-designed software (LabView platform) for data treatment and 
processing. The experimental setup used to probe single cells was adapted to this 
purpose from a standard micromanipulation/microinjection apparatus. The 
micromanipulation equipment used consisted of MN-2 (Narishige Co. Ltd., Tokyo, 
Japan) Narishige three-dimensional manipulators for coarse adjustment, and 
Narishige MMW-23 three-dimensional hydraulic micromanipulators for final 
movements. The optical fiber nanosensor was mounted on a micropipette holder 
(World Precision Instruments, Inc., Sarasota, FL). To record the fluorescence of Cy5 
labeled secondary immunocomplex, a Hamamatsu PMT detector assembly (HC125-























 The fluorescence emitted when Cy5 fluoresced was collected using the optical 
configuration in the inverted fluorescent microscope and delivered to a PMT mounted 
on the frontal port. The fluorescent signal detected was converted to a measurable 
electrical signal and transmitted to a PC for data acquisition and processing. 
 
4.11.4 In Vitro Measurement of Apoptosis using Cytosolic Cell Extract 
The functionalized tips of the nanosensor were divided into Group I, (+)ALA 
(+)PDT, and Group II, (-)ALA (-)PDT, corresponding to the treatment groups and the 
measurements performed in replicate. The nanotips were immersed in solutions of 
capture antibody, cytochrome c (Ab-3) and caspase-9 (Ab-1) respectively, and 
allowed to incubate for 12 hours at 4oC. The nanosensors were then inserted into 
microfuge tubes containing cytosolic cell extract in PBS and incubated for 5-10 
minutes. The microfuge tubes contained cell lysates from both Group I, (+)ALA 
(+)PDT, and Group II, (-)ALA (-)PDT. Finally, the nanosensors were incubated in 
microfuge tubes containing either Cy5 labeled cytochrome c (Ab-4) reporter antibody 
or Cy5 labeled caspase-9 (Ab-2) reporter antibody 30 minutes. The nanosensors were 
sequentially secured onto an x-y-z micromanipulator mounted on an inverted 
fluorescence microscope (Figure 4.5). Using the microscope eyepiece for observation 
the nanosensor was positioned using an x-y-z micromanipulator to within the field of 
view and the excitation source tuned on. The Cy5 labeled reporter antibody is excited 




Figure 4.5 shows an image of Nikon Inverted fluorescence microscope, the 
main component of the laser-induced fluorescence measurement system. Red (LEFT 
and RIGHT) arrows point to the fine x-y-z micromanipulator mounted on the inverted 
fluorescence microscope. Yellow (LEFT and RIGHT) arrows point to the coarse x-y-
z micromanipulator. The white arrow points to the plexiglass incubator. Orange 
(LEFT) arrow points to the optical nanosensor. Green (RIGHT) arrow points to the 
petri dish with cells 
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using the fluorescence microscope optics, and detected with a PMT and recorded. 
Figure 4.6 shows a diagrammatic representation of the fluorescence excitation and 
detection process. 
 
4.11.5 Results of In Vitro Studies using Cytosolic Cell Extract 
Figure 4.7 shows the results. The first bar represents the averaged results of 
Group II while the second bar represents the averaged results of Group I. In the case 
of Group II, it is evident that secondary immunocomplex formation did not occur 
because Cy5 fluorescence was not detected and thus it can be said that apoptosis was 
not induced. For Group I, secondary immunocomplex formation was evident by the 
detection of Cy5 fluorescence. These results (Figure 4.11) indicate that positive 
detection and identification of cytochrome c and caspase-9. 
 
4.11.6 Pseudo In Vivo Measurement of Apoptosis 
The functionalized nanotips were used for experimental and control 
measurements, which were performed in replicates. The nanotips were incubated in 
solutions of capture antibody, cytochrome c (Ab-3) and caspase-9 (Ab-1) 
respectively, and allowed to incubate for 12 hours at 4oC. The nanosensors were 




































































Figure 4.6 shows a schematic representation of the components of the laser-
induced fluorescence measurement system and outlining the fluorescence excitation 
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Figure 4.7 shows the collective mean results of the in vitro measurement of 
cytochrome c and caspase-9, including the background signal (scattered room light) 
and with the detector off. Each bar represents the mean of replicate measurements 










Figure 4.8 shows the intracellular measurement of apoptosis in a single MCF-7 cell. 
The top image (i) shows an optical nanosensor prior to insertion and a single MCF-7 
cell while the BOTTOM image (ii) shows the optical nanosensor inserted into the 
MCF-7 cell.  
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MCF-7 cells used were from both the experimental (apoptosis induced) and control 
(without apoptosis induction) study groups. Finally, the nanosensors were incubated 
in microfuge tubes containing either Cy5 labeled cytochrome c (Ab-4) reporter 
antibody or Cy5 labeled caspase-9 (Ab-2) reporter antibody 30 minutes. The 
nanosensors were sequentially secured onto an x-y-z micromanipulator mounted on 
an inverted fluorescence microscope. Using the microscope eyepiece for observation, 
the nanosensor was positioned using an x-y-z micromanipulator to within the field of 
view and the excitation source tuned on. The Cy5 labeled reporter antibody is excited 
using evanescent optical waves and the fluorescence signal generated is collected 
using the optical configuration of the fluorescence microscope and detected with a 
PMT. 
 
4.11.7 Results for Pseudo In Vivo Measurement of Apoptosis 
Figure 4.9 shows the comprehensive results of the measurement of 
cytochrome c and caspase-9 obtained using the pseudo in vivo measurement 
technique. The results are represent averages obtained from a series of replicate 
measurements performed. As can be seen from the results obtained from the control 
cells (-)ALA (-)PDT and experimental cells, (+)ALA (+)PDT, there is no significant 
increase in the fluorescence signal obtained for the experimental cells therefore 
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Figure 4.9 shows the results obtained for pseudo in vivo measurement of 
apoptosis. Each bar represents the mean of replicate measurements with the error bars 
represent 95% confidence interval (CI).  
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In this case, the pseudo in vivo immunoassay technique did not facilitate the detection 
of secondary immunocomplex formation of either cytochrome c or caspse-9, 
suggesting that secondary antibody binding was unsuccessful. The results revealed 
that secondary immunocomplex formation did not occur and therefore the inability to 
detect Cy5 fluorescence that would have been emitted if the reporter antibody was 
bound. This suggests one of two possible scenarios. One, the physical action of 
withdrawing the optical nanosensors from within the cells after incubation could have 
disrupted the structural stability of the bound target molecule (cytochrome c or 
caspase-9) and as a consequence, direct spatial coupling could not be achieved. On 
the other hand, it could have been the effect of insufficient cytochrome c or caspase-9 
bound to the capture antibody during primary immunocomplex formation and this 




This work described the application of optical nanosensors for the sensitive 
and selective recognition of cytochrome c and caspase-9 in situ in cytosolic cell 
extracts. Apoptosis was induced using a photodynamic therapy (PDT) agent δ-
aminolevulinic acid (ALA) that initiates the mitochondrial pathway of apoptosis. This 
pathway involves cytochrome c release from mitochondrial followed by the activation 
of caspase-9. To measure cytochrome c and caspase-9, capture antibody targeted 
towards cytochrome c or capase-9, is immobilized onto functionalized nanotips to 
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bind these respective proteins. Once these proteins are bound, the nanotips containing 
the primary immunocomplex are complexed with Cy5 labeled reporter antibody 
forming a secondary immunocomplex. The Cy5 labeled reporter antibody facilitates 
the detection and identification of secondary immunocomplex formation when Cy5 is 
excited using 632.8 nm light from helium/neon (HeNe) laser and fluorescence 
emission occurs in the far-red at about 667 nm. Fluorescence signals were detected 
for in vitro studies providing for sensitive and selective recognition of both 
cytochrome c and caspase-9 while the same did not occur for the pseudo in vivo 
studies. Unfortunately, I was unable to detect cytochrome c and caspase-9 within 
single living cells using the pseudo in vivo technique. The experimental data obtained 
from in vitro measurement of apoptosis indicated that optical nanosensor coupled 
with the indirect fluorescent immunoassay can be used to detect and identify specific 
antibodies directed against cytochrome c and caspase-9. However, the experimental 
data obtained from pseudo in vivo studies reveal that the pseudo in vivo immunoassay 
technique is not capable of measuring of apoptosis. This was demonstrated by the 
inability of the technique to detect and identify cytochrome c and caspase-9 and 
therefore, I could not implicate these proteins involved in the regulation of 
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5.0 Abstract 
We demonstrate for the first time, the application and utility of a unique 
optical nanosensor for monitoring the onset of the mitochondrial pathway of 
apoptosis in a single living cell by detecting enzymatic activities of caspase-9. 
Minimally invasive analysis of single live MCF-7 cells for caspase-9 activity is 
demonstrated using the optical nanosensor which employs a modification of an 
immunochemical assay format for the immobilization of non-fluorescent enzyme 
substrate, Leucine-GlutamicAcid-Histidine-AsparticAcid-7-amino-4-methyl 
coumarin (LEHD-AMC). LEHD-AMC covalently attached on the tip of an optical 
nanosensor is cleaved during apoptosis by caspase-9 generating free AMC. An 
evanescent field is used to excite cleaved AMC and the resulting fluorescence signal 
is detected. By quantitatively monitoring the changes in fluorescence signals, 
caspase-9 activity within a single living MCF-7 cell was detected. By comparing of 
the fluorescence signals from apoptotic cells induced by photodynamic treatment, and 
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non-apoptotic cells, we successfully detected caspase-9 activity, which indicates the 
onset of apoptosis in the cells.  
5.1 Introduction 
In this work, we describe the optical nanosensor for the in vivo measurement 
of apoptosis. The basic optical technique used by optical nanosensors, is total internal 
reflection excitation through the transmission of fluorophore excitation along optical 
nanosensor followed by filtering the signal in order to separate out the higher 
wavelengths of interest. TIR excitation is typically used to study the interaction of 
materials on optically transparent surfaces as well as serving the purpose of being the 
basis of optical nanosensors. The principle of TIR excitation occurs at the interface of 
two optically transparent media of different refractive indices. Light is typically 
introduced into the medium of greater refractive index (n1). At the interface of the 
two media, all energy associated with the light beam is not confined to the nanotips, 
some energy, evanescent optical waves, is lost from this beam into the less dense 
medium (n2) which could be the cytoplasm of a cell under investigation, with the 
intensity of the energy decaying rapidly with the penetration depth of the energy into 
the less dense medium. Evanescent optical waves are used to excite surface bound 
fluorophores which subsequently emit radiation at a different wavelength. This 
technique is very well suited for the investigation of surface association or 
dissociation events that occur at the distal ends of the optical nanosensors as the 
material in the cytoplasm or bulk solution at distances of greater than several hundred 
of nanometers away from the surface are not interrogated by the evanescent wave 
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[54]. This means that good discrimination between species bound to the nanotips over 
unbound material is achieved. 
Minimally invasive analysis of cellular signaling pathways inside single live 
cells is becoming increasingly important fundamentally because cells in a population 
respond asynchronously to external stimuli [122]. There is a need to further our 
understanding of basic cellular signaling processes in order to yield new information 
that is not available from population-averaged cellular measurements. In addition, 
many cellular signaling pathways act on timescales of a few seconds and there is 
critical need for single-cell measurement techniques with similar time resolution. Not 
only is there a need to temporally resolve such measurements, there is also a need to 
spatially resolve them. For these reasons, continued progress in cellular physiology 
requires new measurement strategies, which can be applied to individual cells [7] 
with great temporal and spatial resolution. For this purpose, the optical nanosensor is 
a suitable technology with great potential for obtaining intracellular measurements of 
biological entities as will be demonstrated in this work.  
Biosensors have played a key role in the development of minimally invasive, 
highly sensitive, and selective technologies for biochemical analysis [19]. One of the 
most recent advances in the field of biosensors has been the development of optical 
nanosensors capable of detecting and responding to the interaction between analytes 
of biomedical interest and their corresponding antibody within single live cells [16-
18]. Minimally invasive analysis of living cells involves penetrating individual live 
cells without causing physiological or biological damage with resultant biochemical 
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consequences. Intracellular measurements are made possible by the small scale of the 
nanosensor in comparison to the dimensions of the cell, typically one to two orders of 
magnitude. Optical nanosensors are thus crucial for minimally invasive analysis 
because they allow the penetration and sampling of individual live cells in their 
physiological state without disrupting their normal functions, hence allowing the 
continuation of vital cellular processes such as mitosis [123]. These antibody-based 
optical nanosensors rely on excitation using the evanescent field generated by total 
internal reflection at the tip of the nanosensor, thus exciting only molecules in close 
proximity to the boundary interface of the optical nanosensor tip. The evanescent 
field generated at the tip of the nanosensor is a result of the nanosensor tip being 
smaller than the wavelength of the laser beam, leading to a diffraction-limited 
condition that does not allow photons from the laser beam to be transmitted through 
the tip of the nanosensor, but rather allows energy to be transmitted in the form of an 
interfacial leaky surface mode, which is propagated as the evanescent field exciting 
only molecules on the periphery of the tip.  
We have developed a unique enzyme optical nanosensor based on an enzyme-
substrate probe to detect and identify surface dependent cleavage events of caspase-9 
in a single live MCF-7 cell. The modified assay format consists of a solid phase for 
the immobilization of caspase-9 substrate, Leucine-GlutamicAcid-Histidine-
AsparticAcid-7-amino-4-methyl coumarin (LEHD-AMC), which consists of a 
tetrapeptide, LEHD, coupled to a fluorescent molecule, AMC. LEHD-AMC exists as 
a non-fluorescent substrate prior to cleavage by caspase-9, and after cleavage, free 
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AMC fluoresces when excited at 325nm. Figure 5.1 shows the excitation and 
emission spectrum of AMC and cleavage process of LEHD-AMC to produce free 
fluorescent AMC. 
The excitation and emission spectra of AMC were acquired using a 
Fluoromax-3 spectrofluorimeter (Jobin Yvon Inc, Edison, NJ). The excitation 
spectrum represents the relative ability of various wavelengths to stimulate AMC 
fluorescence emission, while the emission spectrum represents the relative 
fluorescence intensity when AMC is excited. In contrast to traditional, discontinuous, 
non-equilibrium ELISA-type cleavage assays that cannot accurately model dynamic 
binding mechanisms, the optical nanosensor permits investigation of surface cleavage 
phenomena, in addition to providing a simple way to detect caspase-9 in single cells. 
Caspase-9 is a prominent member of a family of death-specific enzymes known as 
cysteine-dependent aspartate-specific proteases, the caspases [124]. Caspase-9 is 
activated via mitochondrial involvement in the apoptotic pathway. Cells exposed to 
apoptotic stimuli release cytochrome c from mitochondria into the cytosol. In the 
cytosol, cytochrome c interacts with apoptotic protease activating factor-1 (Apaf-1) 
[125]. The cytochrome c/Apaf-1 complex cleaves the inactive caspase-9 proenzyme 
to generate active caspase-9 enzyme [114]. Activated caspase-9 exhibits distinct 
substrate recognition properties and initiates the proteolytic activities of other 
downstream caspases, which degrade a variety of substrates, resulting in the 
























Figure 5.1 (i) shows the absorption spectrum of AMC (10-3 M), while (ii) 
shows the emission spectrum of AMC (10-3 M). Excitation and emission spectra were 
acquired to determine where to excite and detect AMC. (iii) shows a diagrammatic 
representation of ALA induced apoptosis, involving the activation of caspase-9 
followed by the cleavage of Leucine-Glutamate-Histidine-Aspartate-7-amino-4-
methyl coumarin (LEHD-AMC) and subsequent detection of free AMC. 
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The enzyme substrate-based optical nanosensor works on the same principle 
of evanescent field excitation by means of an exponentially decaying surface energy 
wave with a penetration depth that allows only AMC molecules in close proximity to 
the boundary interface of the optical nanosensor tip to be excited and detected. This 
feature is important because it underlines the operating principle of the nanosensor in 
the sense that only the cleaved AMC will be excited in the near field of the optical 
nanosensor. An additional feature of the nanosensor is its selectivity. Selectivity is 
dependent upon the selective cleavage capabilities for specific sequences by caspase-
9. Another advantage of the optical nanosensors’ feature of excitation and detection 
in the evanescent field is the reduction of sources of background, particularly specular 
scattering, Rayleigh scattering, and Raman scattering from regions outside the 
nearfield. The optical nanosensors’ mode of excitation and detection unlike other 
techniques for molecular detection does not compromise throughput and signal-to-
noise ratio. Furthermore, due to its nanoscale size, the optical nanosensor does not 
compromise the integrity of the cell when performing intracellular analysis. This has 
been illustrated in a previous study whereby a single cell was microscopically 
monitored after probing the cytoplasm of the cell with an optical nanosensor. The cell 
was observed and it was found that the cell carried out normal cellular activities, 
specifically mitosis [123]. 
In this work, we demonstrate for the first time, the application and utility of 
optical nanosensors for the detection and identification the onset of the mitochondrial 
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pathway of apoptosis in a single live MCF-7 cell by detecting the enzymatic activity 
of caspase-9. To perform these measurements, we covalently immobilized caspase-9 
substrate, LEHD-AMC onto the tip of the nanofiber. Photodynamic therapy (PDT) 
protocols (Figure 5.2) employing δ-aminolevulinic acid (ALA) were used to induce 
apoptosis [129] in MCF-7 cells. Briefly, caspase-9 is present in the cell after 
apoptosis has been induced. It typically exists in a proenzyme form procaspase-9, 
prior to apoptosis induction. MCF-7 cells exposed to apoptotic stimuli release 
cytochrome c from mitochondria into the cytosol. In the cytosol, cytochrome c 
interacts with apoptotic protease activating factor-1 (Apaf-1) [125]. The cytochrome 
c/Apaf-1 complex cleaves the inactive procaspase-9, a proenzyme to generate the 
active enzyme, caspase-9 [114]. Activated caspase-9 then initiates the proteolytic 
activities of other downstream caspases. These caspases degrade a variety of 
substrates, resulting in the systematic disintegration of the cell. Caspase-9 is capable 
of cleaving multiple LEHD-AMC substrates. This is a typical mechanism of action 
characteristic of enzymes, the ability to hydrolyze multiple substrates because they do 
not undergo change when they are involved in the cleavage reactions and they can 
therefore be applied to multiple substrates. Our measurement system consists of the 
tetrapeptide substrate Leucine-Glutamic Acid-Histidine-Aspartic Acid-7-amino-4-
methoxy coumarin (LEHD-AMC), which is selectively cleaved by activated caspase-
9. The principle of this system is the selective detection of caspase-9 activity by 


















Figure 5.2 shows a diagrammatic representation of the aminolevulinic acid 
(ALA) photoactivation process in a MCF-7 cell. On the left is representation of a 
MCF-7 cell prior to the induction of apoptosis and similarly on the right is a 
representation of a MCF-7 cell shortly after the induction of apoptosis showing the 
activation of caspase-9 which ultimately leading to apoptosis. 
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AMC is cleaved by activated caspase-9, AMC is no longer tethered to the tetrapeptide 
LEHD that effectively quenches the fluorescence of AMC. Free AMC can therefore 
be excited in the near-field of the optical nanosensors and the fluorescence signal 
generated can be detected and measured. By comparing the fluorescence from an 
apoptotic MCF-7 cell and uninduced control MCF-7 cell, caspase activity can be 
detected. In this context, caspases-9 recognizes the specific tetrapeptide sequence 
LEHD and cleaves the substrate LEHD-AMC. The substrate LEHD-AMC is cleaved 
by caspase-9 and the released AMC molecules are excited and emitted a fluorescence 
signal. By comparing the fluorescence from an apoptotic cell and an uninduced 
control, we detected and identified caspase-9 activity. 
 
5.2 Materials and Methods  
5.2.1 Chemicals and Reagents 
δ-aminolevulinic acid (ALA), phosphate buffered saline (PBS), hydrochloric 
acid  (HCl), nitric acid (HNO3), glycidoxypropyltrimethoxysilane (GOPS), 1,1’- 
carbonyldiimidazole (CDI), and anhydrous acetonitrile were purchased from Sigma-
Aldrich, St. Louis, MO. Caspase-9 substrate, LEHD-7-amino-4-methyl coumarin 
(AMC), 2x reaction buffer, dithiothreitol (DTT), and dimethylsulfoxide (DMSO) 





5.2.2 Cell Lines 
Human breast cancer cell line, MCF-7, was obtained from American Type 
Culture Collection (Rockville, MD, USA, Cat-no. HTB22). MCF-7 cells were grown 
in Dulbecco's Modified Eagle's Medium ((DMEM) (Mediatech, Inc., Herndon, VA)) 
supplemented with 1 mM L-glutamine (Gibco, Grand Island, NY) and 10% fetal 
bovine serum (Gibco, Grand Island, NY). Baseline static culture productivity for each 
cell line was established in growth medium (described above) in standard T25 tissue 
culture flasks (Corning, Corning, NY). The flasks were incubated in a humidified 
incubator at 37°C, 5% CO2 and 86% humidity. Cell growth was monitored daily by 
microscopic observation until a 60–70% state of confluence was achieved. The 
growth conditions were chosen so that the cells would be in log phase growth during 
photosensitizer treatment with ALA, but would not be so close to confluence that a 
confluent monolayer would form by the termination of the chemical exposure [25]. In 
preparation for experiments, cells were harvested from the T25 flasks and 0.1ml (105 
cells/ ml) aliquots were seeded into 60 mm tissue culture dishes (Corning Costar 
Corp., Corning, NY) for overnight attachment. The MCF-7 cells were studied as three 
separate groups with the first group being the experimental, exposed to 0.5 mM ALA 
for 3 h followed by photoactivation [120]. This involved incubating the cells at 37o C in 
5% CO2 for 3 h with 0.5mM ALA. Following incubation the MCF-7 cells were 
exposed to red light from a HeNe laser (λ 632.8 nm, <15mW, Melles Griot, Carlsbad, 
CA) positioned about 5.0 cm above the cells for five minutes at a fluence of 5.0 
mJ/cm2 to photoactivate ALA and subsequently induce apoptosis. The second group 
 171
was the “treated control” and was exposed to 0.5 mM ALA for 3 hours without 
photoactivation. The third group was the “untreated control,” which received neither 
ALA nor photoactivation.  
 
5.2.3 Preparation of Enzyme Substrate-based Nanosensors 
Preparation of enzyme substrate-based optical nanosensors involves cutting 
and polishing plastic clad silica (PCS) fibers with a 600-µm-diameter core 
(Fiberguide Industries, Stirling, New Jersey). The optical fibers were pulled to a final 
tip diameter of 50 nm using the current state-of-the-art in micropipette pulling 
technology, the P-2000 system (Sutter Instruments, Novato, CA), and then coated 
with 100 nm of silver metal (99.999% pure) using a thermal evaporation deposition 
system (Cooke Vacuum Products, South Norwalk, CT) achieving a final diameter of 
150nm. Figure 5.3 (ii) shows an image of silver-coated optical nanofiber. The 
nanotips were derivatized to allow the immobilization of enzyme substrate. 
Derivatization involved a multistep procedure. The fused silica optical fibers were 
acid-cleaned followed by several rinses with distilled water and then allowed to air 
dry at room temperature in a dust free environment. The nanotips were silanized by 
treatment with an organic cross-linking reagent, 10% GOPS in H2O (v/v) at 90oC for 
3 h. The silanized fibers were washed with anhydrous acetonitrile and dried overnight 
in a vacuum oven at 105oC. Soon after overnight incubation, the nanotips were 





















Figure 5.3: (i) Schematic diagram of fluorescence measurement system used 
for data acquisition and processing (ii) Scanning electron micrograph of a nanotip 
after coating with 100nm of silver metal, achieving a final tip diameter of 150 nm (iii) 
Image of optical nanosensor inserted into a single live MCF-7 cell. This image shows 
how we performed the intracellular measurements of MCF-7 cells. 
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rinsing with acetonitrile. The silanized and activated nanotips were immersed in a 
solution containing DMSO, 2X reaction buffer, PBS, and LEHD-AMC, and allowed 
to incubate for 3 h at 37oC. The LEHD-AMC bound using this procedure remained 
securely immobilized during washing and subsequent manipulations in immunoassay 
procedures, in contrast to procedures that would use adsorption to attach proteins [130, 
131]. The optical nanosensors prepared were subdivided into groups to perform parallel 
experimental and control measurements using MCF-7 cells.  
 
5.2.4 Measurement System and Procedure 
Figure 5.3(i) shows (above) a schematic representation of the fluorescence 
measurement system. The major components of this system include a HeCd laser 
(Omnichrome, <5mW laser power), a Nikon Diaphot 300 inverted microscope 
(Nikon, Inc., Melville, NY), Hamamatsu PMT detector assembly (HC125-2), and a 
personal computer (PC). To perform the intracellular fluorescence measurements, the 
325 nm laser line of a HeCd laser was focused onto a 600-µm-delivery fiber that was 
terminated with a subminiature A (SMA) connector. The optical nanosensor was 
coupled to the delivery fiber through the SMA connector and secured to the 
microscope with micromanipulators. The fluorescence emitted from the cells was 
collected by the microscope objective and passed through a 330nm barrier filter and 
then focused using the internal optics of the microscope onto the PMT for detection. 
The output from the PMT was recorded using a universal counter and a PC with 
custom-designed software for data acquisition and processing.  
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The experimental setup used to probe single cells was adapted to this purpose 
from a standard micromanipulation/microinjection apparatus. The Nikon Diaphot 300 
inverted microscope, having a Diaphot 300/Diaphot 200 Incubator to maintain the 
cell cultures at 37°C on the microscope stage, was used for these experiments. The 
micromanipulation equipment consisted of MN-2 (Narishige Co. Ltd., Tokyo, Japan) 
Narishige three-dimensional manipulators for coarse adjustment, and Narishige 
MMW-23 three-dimensional hydraulic micromanipulators for fine movements. The 
optical nanosensor was mounted on a micropipette holder (World Precision 
Instruments, Inc., Sarasota, FL). To record the fluorescence of AMC in the 
evanescent field of the optical nanosensor, a Hamamatsu PMT detector assembly 
(HC125-2) was mounted in the front port of the Diaphot 300 microscope.  
Before making measurements, the cells were harvested from culture flasks 
and transferred to culture dishes. After attachment to the bases of the petri dishes, the 
experimental group of MCF-7 cells was treated with 0.5 mM ALA with subsequent 
photoactivation, the treated control received 0.5 mM ALA without photoactivation 
while the untreated control group did not receive any treatment.  For the experimental 
and treated control group, the solution of ALA was aspirated after a 3-hour incubation 
period and replaced with fresh cell culture media. The experimental group of cells 
was then irradiated with HeNe laser to photoactivate ALA for a period of five 
minutes.  
Using the experimental group of cells, three separate trials were conducted to 
determine the presence of caspase-9 activity. In addition, three separate trials were 
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performed for the treated control and untreated control respectively. Determination of 
the presence or absence of caspase-9 activity using the nanosensor was carried out 
using the following procedure. A culture dish of cells was placed on the pre-warmed 
microscope stage set at 37oC. The enzyme optical nanosensor shown in figure 5.3(ii) 
(above) is mounted on a micropipette holder of a micromanipulation system, was 
moved into position (i.e., in the same plane as the cells), using bright-field phase 
contrast microscopic illumination, so that the tip was just outside of the cell to be 
probed. The total magnification was 600×. The nanosensor was gently 
micromanipulated into the cell, past the cell membrane and extending a short way 
into the cytoplasm. During these micromanipulations, great care was taken not to 
penetrate the nuclear envelope and compromise the integrity of the nucleus. Room 
light and microscope illumination light were switched-off; the laser shutter opened, 
and laser light allowed to illuminate the optical fiber and excitation light was 
transmitted into the fiber tip. First, a signal reading was taken with the nanosensor 
inside the cell with the laser shutter closed in order to record the dark signal. After 
five min, the laser shutter was opened allowing the excitation light to be transmitted 
to the nanosensor tip and fluorescence readings were recorded. Figure 5.3 (iii) 
(above) shows an image illustrating an intracellular measurement performed in a 





5.3 In Vitro Determination of Caspase-9 Activity 
We performed a calibration measurement of caspase-9 outside the cell using 
caspase-9 obtained from cytosolic cell extract of cell groups after apoptosis was 
induced and without the induction of apoptosis. This was done by inducing apoptosis 
in a group of cells using ALA-PDT and having a control group without ALA-PDT. 
The cells were harvested and the cytosolic extract placed in picofuge tubes. Optical 
nanosensors were incubated in the picofuges containing the cytosolic cell extract, one 
set presumably containing activated caspase-9 while the other set devoid caspse-9. 
After incubating MCF-cells using the following treatment groups, 
experimental group [+]ALA[+]PDT (with ALA-PDT), and the control group [-
]ALA[-]PDT (without ALA-PDT), MCF-7 cells were washed with PBS solution, pH 
7.4, and then resuspended in lysis buffer (100 mM HEPES, pH 7.4, 10% sucrose, 
0.1% 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS), 1 
mM EDTA, 10 mM dithiothreitol (DTT), 1 mM phenylmethylsulphonyl fluoride 
(PMSF), 10 mg/ml pepstatin, 10 mg/ml leupeptin) and left on ice for 45 minutes. The 
cells were then repeatedly passed through a syringe with a 25-gauge needle until most 
of the cell membrane was disrupted, and centrifuged at 1500 RPM for 10 min. 
Activity of caspases was measured using fluorogenic substrate peptides; LEHD-AMC 
for caspase-9 immobilized on the nanotips of the optical nanosensors. The release of 
AMC was measured after incubating optical nanosensors in picofuge tubes containing 
the cell lysates from the various treatment groups and using a HeCd laser (excitation 
325 nm) to excite AMC. Caspase activity was expressed as fluorescence intensity of 
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AMC as a function of equivalent nanomoles of LEHD-AMC. We plotted the results 
of the in vitro measurement of caspase-9 activity. The curves for each fluorescent 
measurement of AMC were plotted for each as a function of nanomoles of AMC. 
Caspase-9 activity was determined by incubation of optical nanosensors with the 
substrate LEHD-7-amino-4-methylcoumarin (AMC) in cell lysate (~105 cells) 
obtained from the following treatment groups; experimental group (with ALA-PDT), 
and the control group (without ALA-PDT), and measured the release of AMC. The 
release of AMC was measured after excitation using HeCd laser (325 nm) and 
collecting the fluorescence signal using a 380 nm longpass filter. Peak emission 
wavelength of AMC is about 440 nm.  
 
5.4 In Vivo Determination of Caspase-9 Activity 
To perform the intracellular measurements, the optical nanosensor was 
positioned using the 3-dimensional micromanipulator mounted on the inverted 
microscope. Using the microscope eyepiece for observation the optical nanosensor 
was micropositioned within the field of view and, once within the same plane as the 
cell under investigation, micromanipulated into the cytoplasm of the cell. After 
incubation at 37°C for 5 min, the HeCd laser excitation source was turned on and 
fluorescence at λmax 380 nm was measured using a 330nm barrier filter. About 1.5-2.0 
h after the induction of apoptosis, the cleavage of LEHD-AMC by caspase-9 occurs 
and the released AMC molecules were excited at 325nm and the fluorescence 
emission was measured. The fluorescence signal emitted by AMC was collected by 
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the fluorescence microscope optics and detected with the PMT. The fluorescence 
emission was collected as a function of time and the data is transmitted via a HP 
53131A (225 MHz) universal counter that serves as an interface, to a PC for data 
acquisition and processing. Data acquisition and processing is performed using 
custom software built on LabView platform. 
 
5.5 Results and Discussion  
The examination of caspase-9 activity was first performed in vitro using cell 
lysate, and in vivo¸ within single MCF-7 cells using enzyme optical nanosensors. 
Caspase-9 cleaves the substrate tetrapeptide (LEHD-AMC) between D and AMC, 
releasing the fluorophore AMC that is measured upon excitation by HeCd laser. 
Figure 5.4 shows the results in vitro study of the experimental group (with ALA-
PDT) and the control group (without ALA-PDT). These results show a difference of 
about an order of magnitude in the mean fluorescence intensity measurements we 
obtained for the experimental group and the control group. This difference is 
significant enough to detect and positively identify caspase-9 activity in vitro. These 
results were expected because it is the collective effect of ALA and photoactivation 
that result in the induction of apoptosis and neither ALA nor photoactivation.  
Figure 5.5 shows the background-subtracted results of a series of three 
intracellular measurements performed with enzyme optical nanosensors using the 
experimental and control group of MCF-7 cells. This graph consists of the  
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Experimental group: with ALA-PDT treatment Control group: without ALA-PDT treatment
 
Figure 5.4: shows the background-corrected fluorescence intensity 
measurements of AMC for the in vitro detection of caspase-9 activity in experimental 
group of MCF-7 cells, which received both ALA and photoactivation and the control 
measurements for the in vitro detection of caspase-9 activity in control group of 
MCF-7 cells, which received neither ALA nor photoactivation. These results 
represent replicate studies for the measurement of caspase-9 activity with the error 
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Figure 5.5: (i) Graph showing the background-corrected fluorescence intensity 
measurements of AMC for the intracellular detection of caspase-9 activity in 
experimental group of MCF-7 cells, which received both ALA and photoactivation. 
These results represent replicate studies for the measurement of caspase-9 activity. 
(ii) Graph showing the background-corrected control measurements for the 
intracellular detection of caspase-9 activity in control group of MCF-7 cells, which 
received neither ALA nor photoactivation. These results represent replicate studies 
for the control measurement of caspase-9 activity 
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fluorescence intensity of AMC fluorescence as a function of time. The results show 
that for the control group of cells, the fluorescence signal relative to the experimental 
group was not significant enough to confound the determination of AMC. Moreover, 
there are no other molecules that appear to interfere with the fluorescence 
measurements that would confound the determination of AMC due to the use of near-
field excitation and detection. The application of near-field excitation contributes to 
the specificity of the nanosensor and virtually diminishes any background effects that 
may confound the determination of AMC because excitation of AMC occurs only in 
the evanescent-wave component of near-field excitation. Furthermore, the likelihood 
of interfering species existing within the near field is extremely small in comparison 
to AMC. Accordingly, the nanosensor used to monitor the experimental group of cells 
transduced a higher fluorescent signal as a result of the detection of AMC molecules 
momentarily sequestered at the tip of the optical nanosensor. 
Figure 5.6 shows the results of intracellular measurements performed using 
the enzyme optical nanosensors on the treated control groups of MCF-7 cells. The 
first treatment group received ALA without photoactivation while the second group 
received photoactivation without ALA. These graphs consist of the fluorescence 
intensity of AMC acquired as a function of time using three optical nanosensors 
toperform three independent measurements on MCF-7 cells. The results show that for 
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Figure 5.6: (i) shows the background-corrected treated control measurements 
for the intracellular detection of caspase-9 activity in MCF-7 cells, which received 
ALA without photoactivation. These results represent replicate studies for the treated 
control measurement of caspase-9 activity within single live MCF-7 cells. (ii) Graph 
showing the background-corrected treated control measurements of for the 
intracellular detection of caspase-9 activity in MCF-7 cells, which did not receive 
ALA but were photoactived. These results represent replicate studies for the treated 
control measurement of caspase-9 activity within single live MCF-7 cells. 
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experimental group was not significant enough to confound the determination of 
AMC. Once again, these results affirm the excellent degree of reproducibility 
achieved using optical nanosensors for the intracellular detection of AMC.  
Excellent reproducibility was achieved as a result of optimization of the input 
parameters of the laser-based micropipette-pulling device. For instance, after 
determining the optimum heating temperature as well as tension applied to pull the 
fiber, we successfully produced reproducible tip diameters from nanofiber to 
nanofiber (Figure 5.7). This was confirmed by acquiring several scanning electron 
microscope (SEM) images of the pulled fibers using a Hitachi S-4700 field emission 
SEM.  The optimization of the input parameters of the micropipette pulling device 
enables very good batch-to-batch reproducibility, which is especially essential for a 
technology aimed to single-use nanosensors. 
For the in vivo studies, caspase-9 activities were analyzed in ALA-PDT 
treated cells (Experimental group 1 in Figure 5.7) by measuring the fluorescence 
signal from AMC generated after the cleavage of the peptide substrate LEHD-AMC. 
Likewise, the same was done for the control groups (Experimental group 2, 3, 4 in 
Figure 5.7) of cells which received either  [+]ALA[-]PDT, [-]ALA[+]PDT or [-
]ALA[-]PDT. Figure 5.7 (ii) shows the background-subtracted results of the 
intracellular determination of caspase-9 activity using six replicate nanosensors, one 



























Experimental group: ALA + photoactivation
Control group: Without ALA and photoactivation
Treated control group: Photoactivation without ALA



























Figure 5.7: (i) shows the reproducibility study performed using optical 
nanosensors. The calculated percent variability from optical nanosensor to optical 
nanosensor is within 10%. (ii) Graph showing a side-by-side comparison of 
intracellular measurement of caspase-9 activity in experimental group of MCF-7 cells 
and control groups. 
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fluorescence as a function of illumination time. The fluorescent intensity 
measurements obtained for these treatment groups were then compared. As shown in 
Figure 5.7, in untreated cells, [-]ALA[-]PDT, no level of LEHD-AMC cleavage 
activity was detected. Likewise, the same was observed for the treated control groups, 
[+]ALA[-]PDT and [-]ALA[+]PDT. However, in treated cells, [+]ALA[+]PDT, 
significant LEHD-AMC cleavage activity via the measurement of AMC fluorescence 
was detected. As shown in Figure 5.7, the initiator substrates (LEHD-AMC) of 
caspase-9 were cleaved into the fluorogenic AMC forms in cells treated with ALA-
PDT. This demonstrates the involvement of caspase-9, a member of the family of 
cysteine proteases that cleave after aspartic acid, in mediating apoptosis. The results 
obtained here demonstrated the presence of active pathways of caspase-9 during 
ALA-PDT induced apoptosis in MCF-7 cells.  
The fluorescence signals obtained from the cells that were both incubated with 
ALA and photoactivated were much higher than the signal obtained from both control 
groups. Statistical analysis was performed on the three sets of results. The mean value 
of these analyses revealed that the fluorescence signal obtained using the nanosensors 
used to probe cells incubated with photoactivated ALA was much higher than the 
signal obtained by nanosensors used to probe untreated and treated control cell 
groups. A larger mean value for the experimental group affirms the detection of AMC 
and hence the detection of caspase-9 activity.  
The results obtained in this work demonstrate measurements performed inside 
single living cells using an enzyme substrate-based optical nanosensor and the 
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potential application of such a nanosensor in protein-protein profiling in biochemical 
pathways. 
We have prepared enzyme substrate-based optical nanosensors using covalent 
coupling of enzyme substrate to nanotips and demonstrated the application of these 
sensors for the determination of the cleavage product of LEHD-AMC, AMC, in 
single live MCF-7 cells. The presence and detection of cleaved AMC in single live 
MCF-7 cells as a result of this design is representative of caspase-9 activity and a 
hallmark of apoptosis. These results indicate that AMC, and hence apoptosis, can be 
monitored and measured using optical nanosensors within single living cells. These 
results also show the possibility of cataloging cellular components, which can play an 
important role in understanding the role of these components, and how they work 
together in a cell.  
The studies performed in this work show the possibility of studying individual 
cells without having to disrupt their physiological make-up, which in the process can 
negatively interfere with cellular biochemistry. Mechanical and electrical 
manipulations such as cell lysis that can lead to cell disruption prior to the time of 
sampling may interfere with measurements of cellular biochemistry by initiating 
cellular repair mechanisms. Since many cellular signaling pathways act on timescales 
of a few seconds, there is critical need for single cell measurement techniques with 
time resolution to perform intracellular measurements. The optical nanosensor is a 
suitable technology that can be applied to solitary cells and has great potential for 
intracellular measurement of biological entities as demonstrated in this work.  
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In this work, an optical nanosensor enabled the measurement of a cellular 
process, in this case the functioning of an apoptosis enzyme, caspase-9, in its native 
environment. This work demonstrated a tool that has the potential to shed light on the 
principles that govern cell-signaling organization. Future work will involve studies 
that will attempt to carry out similar analysis on other proteins involved in 
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This work demonstrates the application of tetrapeptide-based optical 
nanosensors for bioanalysis and measuring apoptosis in single living cells. The 
activation of caspases is one of the earliest biomarkers of apoptosis, making caspases 
an early and ideal target for measuring apoptosis. Tetrapeptide-based optical 
nanosensors are a new class of biosensors that are capable of reporting the activity of 
specific caspases with high sensitivity and specificity. These properties make them 
promising for the detection and visualization of target caspases in single living cells 
during apoptosis. By detecting and identifying specific caspases, we confirm proteins 
involved in the regulation of apoptosis at the lowest possible levels. This article 
focuses on our recent research in exploring the potential of using tetrapeptide-based 
optical nanosensors for monitoring of apoptosis in single living cells.  
 
6.1 Introduction 
In the past decade, we have witnessed unprecedented advances in fields such 
as biosciences and optical biosensor technology. Although advances in each of these 
fields have provided exciting new insights and capabilities, it is the integration of 
these fields that revolutionary advances are being made. This work is an 
amalgamation of these fields and focuses on the development of novel optical 
nanosensors for single cell analysis. These biosensors are devices having cross-
section of less than 250 nm and are capable of detecting a chemical or biological 
event using an optical signal. Furthermore, they are capable of monitoring single live 
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cells with the potential for subcellular analysis. They consist of nanoscale optical 
fiber equipped with covalently immobilized profluorescent tetrapeptide 
biorecognition molecules. At this scale, optical nanosensors are capable of playing a 
significant role in single cell analysis for example, analyzing proteins or protein-
protein interactions within living cells, thereby enabling minimally invasive dynamic 
monitoring and visualization of molecular events within single living cells. This 
advantage is important because we can only obtain the most representative 
information of a cell as a system in vivo when the intracellular machinery is intact. In 
this context, optical nanosensors can play a significant role in helping to understand 
cell signaling and transduction and, in so doing, advancing the capability and 
technologies available for single cell analysis. 
As we have gained a better understanding of bulk cell assays over time, and 
achieved a greater understanding of many macroscopic biological processes, we have 
been driven to rethink the purpose of an increasingly smaller entity -the single cell. 
Technologies for performing sensitive and selective biochemical analyses of single 
living cells still remain one of the key challenges in cell biology. Monitoring key 
cellular events and conquering functional biochemical pathways of a single cell, as 
heterogeneous as it is, would be an accomplishment in itself at this present time. This 
is mainly because of the scale required for analysis, and second, for the inability to 
achieve spatial and temporal resolution at the single cell level scale. The development 
of new technologies for single cell analysis is important because native biochemical 
events and reactions within living cells can be deciphered only if we have access to 
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their cellular distribution and location in a non-destructive and minimally invasive 
manner. Similarly, as our desire to visualize and decipher biochemical events 
progresses from bulk cell assays to single cell studies, high demands are placed on 
measurement technologies. Perhaps no recent technology has greater potential for this 
application than optical nanosensors. Previous work in our group has demonstrated 
the functionality and suitability of optical nanosensors for performing measurements 
in single living cells based on such figures of merit as sensitivity, reproducibility and 
selectivity [17-19]. These characteristics are important mainly for applications in 
areas of protein detection, protein-protein interaction profiling, and possibly 
measurement of critical cellular processes such as apoptosis.  
The overall nature of apoptosis in bulk cell assays has been studied over time 
and is a fairly well understood process in vitro [108, 126, 129, 132]. It is also well 
known and widely accepted that cells in a population behave asynchronously to 
external stimuli such as chemically induced apoptosis. This is a result of the operation 
of the cell cycle, and the fact that the single-cell growth rates and cell division rates 
depend on cellular content; each cell contains different quantities of proteins, DNA, 
and RNA. Consequently, cell properties are distributed among the cells of the 
population leading to asynchronous behavior [133]. Hence, a cell population is a 
heterogeneous system and to study the nature of apoptosis in vivo in single living 
cells requires a measurement technology capable of performing minimally-to-non-
invasive analysis of single cells with their biochemical pathways intact. Optical 
nanosensors are capable of minimally-to-non-invasive analysis of single living cells 
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as demonstrated in their application in the measurement of carcinogenic compounds 
within single living cells [17, 18]. This work will involve the application of a similar 
nanosensor though with a different type of immunochemical format. We adapted the 
previously used antibody-based optical nanosensor and developed a second-
generation tetrapeptide-based optical nanosensor to measure apoptosis in single 
MCF-7 cells. The focus of this work is in exploring the potential of the second-
generation tetrapeptide-based optical nanosensor for measuring apoptosis in single 
living MCF-7 cells. 
In the classical model of apoptosis [134], caspases are divided into initiator 
caspases and effector caspases according to their function and their sequence of 
activation. Initiator caspases include caspase-8, -9, while effector caspases include, 
caspases-3, -6 and –7 [127, 135]. The activation of caspases is one of the earliest 
biomarkers of apoptosis making caspases an early and ideal target for measuring 
apoptosis. Apoptosis, or programmed cell death, is a mode of cell death characterized 
by specific morphological and biochemical features. It is both a normal and abnormal 
component of the development and health of multi-cellular organisms. Cells die in 
response to a variety of stimuli and during apoptosis they do so in a controlled, 
regulated fashion. This makes apoptosis distinct from another form of cell death 
called necrosis in which uncontrolled cell death leads to lysis of cells, inflammatory 
responses and, potentially, to serious health problems. Apoptosis, by contrast, is a 
process in which cells play an active role in their own death, which is why apoptosis 
is often referred to as cell suicide. Over the past decade, the importance of apoptosis 
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has been appreciated, and it is now thought to be the main mode of cell death in liver 
diseases, and neuronal cell death in neurodegenerative disease. Apoptosis has been 
found to have a role in one mechanism leading neuronal cell death associated with 
Alzheimer's disease and in liver disease. [86, 87, 136]. On the other hand, the loss of 
ability of cells to undergo apoptosis is one of the causes of uncontrollable cell growth 
leading to cancer. Tumor growth is determined not only by increased cell division, 
but also by decreased tumor-cell attrition. Therefore most, if not all, cancer cells 
acquire resistance to the various mechanisms that lead to apoptosis. In this context, 
optical nanosensors would open the way to monitoring caspase activity and in the 
process measure apoptosis in single living cells. This would be especially useful for a 
number of reasons. For example, we will be treating the cell as a system and not as a 
component of a system. Since the single cell is in its own capacity an individual 
entity, we will be able to obtain more representative information about intracellular 
biochemical events as opposed to if the cell was part of a population of cells. In 
addition, we will be analyzing proteins in their native form and environment. This is 
essential for cataloging the functional and hierarchical organization of proteins in 
various cellular pathways such as caspases in apoptosis. The results obtained in these 
experiments can be used to complement data obtained from in vitro studies or 
computational modeling studies. 
Since caspases play a central role in the induction of apoptosis, tetrapeptide-
based optical nanosensors were used to determine their role in response to a 
photodynamic therapy (PDT) agent, δ-aminolevulinic acid (ALA) in the well-
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characterized human breast carcinoma cell line, MCF-7. MCF-7 cells were exposed 
to the photosensitizer ALA to explore ALA-PDT induced apoptosis by monitoring 
caspase-9 and caspase-7 activity. Caspase-9 and caspase-7 protease activity was 
assessed in single living MCF-7 cells with the known caspase-9 and caspase-7 
substrates, Leucine-aspartic-histidine-glutamic acid 7-amino-4-methylcoumarin 
(LEHD-AMC) and aspartic-glutamic acid-valine-aspasrtic acid 7-amino-4-
methylcoumarin (DEVD-AMC) respectively, covalently immobilized to the nanotips 
of optical nanosensors. Upon the induction of apoptosis, activated target caspases 
recognize the tetrapeptide sequence it specifically cleaves. The recognition of 
substrate by caspases is immediately followed by a cleavage reaction yielding the 
fluorescent AMC which can be excited with a Helium-Cadmium (HeCd) laser to 
generate a measurable fluorescence signal (Figure 6.1). By comparing the 
fluorescence signal generated from AMC within cells with activated caspases and 
from those with inactive caspases, we are able to successfully detect caspase activity 
within a single living MCF-7 cell.  
 
6.2 Material and Methods 
6.2.1 Chemicals and Reagents 
δ-aminolevulinic acid (ALA), phosphate buffered saline (PBS), hydrochloric 
acid  (HCl), nitric acid (HNO3), Glycidoxypropyltrimethoxysilane (GOPS), 1,1’- 
Carbonyldiimidazole (CDI), and anhydrous acetonitrile were purchased from Sigma-




















Figure 6.1 shows an illustration of caspase-9 substrate, Leucine-Glutamate-
Histidine-Aspartate-7-amino-4-methylcoumarin (LEHD-AMC), and caspase-7 
substrate, Aspartate-Glutamte-Valine-Aspartate-7-amino-4-methylcoumarin (DEVD-
AMC) cleavage reaction. Free AMC can be excited and the fluorescence emitted is 
representation of the enzymatic cleavage reaction 
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7-amino-4-methylcoumarin (LEHD-AMC), Caspase-7 substrate, Aspartate-Glutamte-
Valine-Aspartate-7-amino-4-methylcoumarin (DEVD-AMC), 2x reaction buffer, 
dithiothreitol (DTT), and dimethylsulfoxide (DMSO) were purchased from BD 
Biosciences, Palo Alto. CA. 
 
6.2.2 Cell Lines 
Human breast cancer cell line, MCF-7, was obtained from American Type 
Culture Collection (Rockville, MD, USA, Cat-no. HTB22). MCF-7 cells were grown 
in Dulbecco's Modified Eagle's Medium ((DMEM) (Mediatech, Inc., Herndon, VA)) 
supplemented with 1 mM L-glutamine (Gibco, Grand Island, NY) and 10% fetal 
bovine serum (Gibco, Grand Island, NY). Baseline cell culture was established in 
growth medium (described above) in standard T25 tissue culture flasks (Corning, 
Corning, NY). The flasks were incubated in a humidified incubator at 37°C, 5% CO2 
and 86% humidity. Cell growth was monitored daily by microscopic observation until 
a 60–70% state of confluence was achieved. The growth conditions were chosen so 
that the cells would be in log phase growth during photosensitizer treatment with 
ALA, but would not be so close to confluence that a confluent monolayer would form 
by the termination of the chemical exposure [18]. In preparation for experiments, 
cells were harvested from the T25 flasks and 0.1ml (105 cells/ ml) aliquots were 
seeded into 60 mm tissue culture dishes (Corning Costar Corp., Corning, NY) for 
overnight attachment. The MCF-7 cells were studied as four separate groups with the 
first group, Group I, being the experimental, exposed to 0.5 mM ALA for 3 h 
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followed by photoactivation ([+]ALA[+]PDT) [120, 129]. This involved incubating 
the cells at 37o C in 5% CO2 for 3 h with 0.5mM ALA. Following incubation the 
MCF-7 cells were exposed to red light from a HeNe laser (λ 632.8 nm, <15mW, 
Melles Griot, Carlsbad, CA) positioned about 5.0 cm above the cells for five minutes 
at a fluence of 5.0 mJ/cm2 to photoactivate ALA and subsequently induce apoptosis. 
The second and third groups, Group II and III respectively, served as the “treated 
control” and were exposed to 0.5 mM ALA for 3 hours without photoactivation 
([+]ALA[-]PDT) and photoactivation without 0.5 mM ALA ([-]ALA[+]PDT]) 
respectively. The fourth group, Group IV was the “untreated control,” which received 
neither ALA nor photoactivation ([-]ALA[-]PDT). 
 
6.3 Experimental Protocol 
6.3.1 Preparation of Enzyme Substrate-based Optical Nanosensors  
Preparation of similar optical nanosensors has been previously described [16, 
36, 61, 123]. Briefly, this process involved cutting and polishing plastic clad silica 
(PCS) fibers with a 600-µm-size core (Fiberguide Industries, Stirling, New Jersey). 
The fibers were pulled to a final tip diameter of 50 nm and then coated with ~100 nm 
of silver metal (99.999% pure) using a thermal evaporation deposition system (Cooke 
Vacuum Products, South Norwalk, CT) achieving a final diameter of 150 nm. The 
fused silica nanotips were acid-cleaned followed by several rinses with distilled 
water. Finally, the substrates were allowed to air dry at room temperature in a dust 
free environment. The nanotips were then silanized and treated with an organic 
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coupling agent, 10% Glycidoxypropyltrimethoxysilane (GOPS) in distilled water. 
The silanization agent covalently binds to the silica surface of the nanotips modifying 
the hydroxyl group to a terminus that is compatible with the organic cross-linking 
reagent, 1’1, Carbonyldiimidazole (CDI). The use of CDI for activation introducing 
an imidazole-terminal group was particularly attractive since the protein to be 
immobilized could be used without chemical modification. Proteins bound using this 
procedure remained securely immobilized during washing or subsequent 
manipulations in immunoassay procedures, as opposed to procedures that use 
adsorption to attach proteins [130, 131]. The silanized and activated nanotips for 
measuring caspase-9 activity were immersed in a solution containing DMSO, 2X 
reaction buffer, PBS, and LEHD-AMC, and allowed to incubate for 3 h at 37oC, 
while those for measuring caspase-7 activity were immersed in a solution containing 
DMSO, 2X reaction buffer, PBS, and DEVD-AMC, and allowed to incubate for 3 h 
at 37oC.  
 
6.3.2 Measurement System and Procedure 
A schematic representation of the experimental setup used in this work is 
shown in Figure 6.2 .The components included a HeCd laser (Omnichrome, <5mW 
laser power) for excitation, an optical fiber for delivery of excitation light to the 
optical nanosensor, a Nikon Diaphot 300 inverted fluorescence microscope (Nikon, 
Inc., Melville, NY), a photon counting photomultiplier tube (PMT) and a PC for data 
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Figure 6.2 (i) Laser-induced fluorescence measurement system used for 
fluorescence signal acquisition, data recording and processing. (ii) Scanning electron 
micrograph of optical nanosensor after coating with ~100nm of silver metal. 
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acquisition and processing. This experimental set-up, used to probe single cells, was 
adapted for this purpose from a standard micromanipulation and microinjection 
apparatus. The Nikon Diaphot 300 inverted microscope was equipped with a Diaphot 
300/Diaphot 200 Incubator to maintain the cell cultures at 37°C on the microscope 
stage, during these experiments. The micromanipulation equipment consisted of MN-
2 (Narishige Co. Ltd., Tokyo, Japan) Narishige three-dimensional manipulators for 
coarse adjustment, and Narishige MMW-23 three-dimensional hydraulic 
micromanipulators for fine adjustments. The optical nanosensor was gently mounted 
on a micropipette holder (World Precision Instruments, Inc., Sarasota, FL). The 325 
nm laser line of a HeCd laser was focused onto a 600-µm-delivery fiber that is 
terminated with a subminiature A (SMA) connector. The enzyme substrate-based 
optical nanosensor was coupled to the delivery fiber through the SMA connector and 
secured to a Nikon inverted microscope with micromanipulators. To record the 
fluorescence generated by AMC molecules at the nanotips, a Hamamatsu PMT 
detector assembly (HC125-2) was mounted in the front port of the Diaphot 300 
microscope. The fluorescence emitted by AMC from the measurement made using 
single live cells was collected by the microscope objective and passed through a 330-
380 nm filter set and then focused onto a PMT for detection. The output from the 
PMT was recorded using a universal counter interfaced to a personal computer (PC) 




6.3.3 In Vitro Determination of Caspase Activity 
After incubation using the following treatment groups, group (I) -
[+]ALA[+]PDT, group II -[+]ALA[-]PDT, group III -[-]ALA[+]PDT, and group IV -
[-]ALA[-]PDT, MCF-7 cells were washed with PBS solution, pH 7.4, and then 
resuspended in lysis buffer (100 mM HEPES, pH 7.4, 10% sucrose, 0.1% 3-[(3-
cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS), 1 mM EDTA, 
10 mM dithiothreitol (DTT), 1 mM phenylmethylsulphonyl fluoride (PMSF), 10 
mg/ml pepstatin, 10 mg/ml leupeptin) and left on ice for 45 minutes. The cells were 
then repeatedly passed through a syringe with a 25-gauge needle until most of the cell 
membrane was disrupted, and centrifuged at 1500 RPM for 10 min. Activity of 
caspases was measured using fluorogenic substrate peptides; LEHD-AMC for 
caspase-9 and DEVD-AMC for caspase-7. The release of AMC was measured after 
incubating optical nanosensors in picofuge tubes containing the cell lysates from the 
various treatment groups and using a HeCd laser (excitation 325 nm) to excite AMC. 
Caspase activity was expressed as fluorescence intensity of AMC as a function of 
equivalent nanomoles of LEHD-AMC and DEVD-AMC respectively. 
We plotted the results of the in vitro measurement of caspase-9 and caspase-7 
activity. The curves for each fluorescent measurement of AMC were plotted for each 
as a function of AMC concentration. Caspase-9 activity was determined by 
incubation of optical nanosensors with the substrate LEHD-7-amino-4-
methylcoumarin (AMC) in cell lysate (~105 cells) obtained from the following 
treatment groups; group I, II, III and IV, described earlier in the article. The release of 
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AMC was measured after excitation using HeCd laser (325 nm) and collecting the 
fluorescence signal using a 380 nm longpass filter. The peak emission wavelength of 
AMC is about 440 nm. Likewise, Caspase-7 activity was determined by incubation in 
cell lysate (~105 cells) obtained from the following treatment groups I, II, III, and IV. 
The release of AMC was measured after excitation using a HeCd laser (325 nm) and 
collecting the fluorescence signal using a 380 nm longpass filter. 
 
6.3.4 In Vivo Determination of Caspase Activity 
Using the treatment group I and the control group IV from above, replicate 
experiment and control measurements were conducted to measure caspase-9 and 
caspase-7 activity in vivo. Determination of the presence or absence of caspase-9 and 
-7 activities using the optical nanosensor was carried out using the following 
procedure. A culture dish with sparsely distributed MCF-7 cells was placed on the 
pre-warmed microscope stage set at 37oC. The optical nanosensor, mounted on a 
micropipette holder of a micromanipulation system, was moved into position, in the 
same plane as the cells, using bright-field phase contrast microscopic illumination, so 
that the tip was just outside of the cell to be probed. The total magnification was 
600×. The optical nanosensor was gently micromanipulated into the cell using the 
hydraulic fine adjustments, past the cell membrane and extending a short way into the 
cytoplasm. During these micromanipulations, great care was taken not to penetrate 
the nuclear envelope and compromise the integrity of the nucleus. Room light and 
microscope illumination light were switched-off; the laser shutter opened, and laser 
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light allowed illuminating the optical nanosensor with excitation light being 
transmitted into the nanotip. First, a signal reading was taken with the nanosensor 
inside the cell with the laser shutter closed in order to record the dark signal. After 
five min, the laser shutter was opened, allowing the excitation light to be transmitted 
to the nanosensor tip, and fluorescence readings were recorded. Figure 6.3 (i-iv) 
shows images illustrating intracellular measurements performed in a single MCF-7 
cell using micromanipulation. Once inside the cell, the nanosensor detects and 
identifies the activity of caspase-9. The fluorescence signal generated is collected by 
the objective, and passes through spectral and spatial filters before detection with a 
photomultiplier tube (PMT). The PMT signal is amplified and recorded via a 
universal counter on a personal computer. Data acquisition and recording are 
controlled using a LabView custom-written program. Additionally, the entire 
experiment is imaged using a CCD camera coupled to the side port of the Nikon 
inverted fluorescence microscope to verify that individual cells are probed. A typical 
experiment measurement takes ~ 5 minutes. 
 
6.4 Results and Discussion  
The examination of caspase-9 and caspase-7 activity was first performed in 
vitro using cell lysate, and in vivo¸ within single MCF-7 cells using optical 
nanosensors. Caspase-9 cleaves the substrate tetrapeptide (LEHD-AMC) between D 





Figure 6.3: shows digital images of the single cell measurement procedure. 
LEFT TO RIGHT, (i) optical nanosensor outside MCF-7 cell (ii) right before 




HeCd laser. Similarly, caspase-7 cleaves the substrate tetrapeptide (DEVD-AMC) 
between D and AMC, releasing the same fluorophore AMC for measurement. 
Apoptotic cells containing activated caspase-9 or caspase-7 yield a fluorescence 
emission as opposed to non-apoptotic cells, which do not yield a fluorescent signal. 
Briefly, for the in vitro study, to measure caspase-9 and caspase-7 activity, MCF-7 
cells were harvested and centrifuged at 1500 RPM for 10 minutes. The cell 
suspension (~105 cells) was mixed with PBS followed by addition of 1:10, 1:20, 
1:100 and 1:200 dilutions of 1mM LEHD-AMC and DEVD-AMC respectively, to 
each cellular reaction. The liberated AMC fluorescence was measured using 
tetrapeptide-based optical nanosensors.  
Figure 6.4 shows the results of the in vitro study of caspase-9 and caspase-7 
involving the treatment groups, Group I and Group IV. These results show a disparity 
of an order of magnitude in the mean fluorescent intensity measurements we observed 
for Group I and IV. This difference is significant enough to determine caspase-9 and 
caspase-7 activity in vitro. Group II and III which were the treated control groups had 
mean fluorescent measurements similar to the control, Group IV. This result was 
expected because it is the collective effect of ALA and photoactivation that results in 
the induction of apoptosis and neither ALA nor photoactivation alone. For the in vivo 
studies, caspase-9 activities were analyzed in ALA-PDT treated cells (group I) by 
measuring the fluorescence signal from AMC generated after the cleavage of the 
peptide substrate LEHD-AMC. Likewise, the same was done for the control groups  
 208
Caspase-9: [+]ALA [+]PDT Control group: [-]ALA [-]PDT Caspase-7: [+]ALA [+]PDT

















































Figure 6.4 shows the results of the in vitro study of caspase-9 and caspase-7 
involving the treatment groups, Group I: [+]ALA [+]PDT, and Group IV: [-]ALA [-
]PDT. These results represent Caspase-9 and Caspase-7 activity of MCF-7 cells with 
aminolevulinic acid (ALA) induced apoptosis. Following ALA treatment and 
apoptosis induction, MCF-7 cells were harvested and analyzed for caspase activity. 
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(II, III and IV) of cells which received either [+]ALA[-]PDT, [-]ALA[+]PDT or [-
]ALA[-]PDT. The fluorescent intensity measurements obtained for these treatment 
groups were then compared. As shown in Figure 6.5, there was no level of LEHD-
AMC cleavage activity was detected for the untreated cells, [-]ALA[-]PDT. Likewise, 
the same was observed for the treated control groups, [+]ALA[-]PDT and [-
]ALA[+]PDT. However, in treated cells, [+]ALA[+]PDT, significant LEHD-AMC 
cleavage activity was detected via the measurement of AMC fluorescence. As shown 
in Figure 6.5, the initiator substrates (LEHD-AMC) of caspase-9 are cleaved into the 
fluorogenic AMC forms in cells treated with ALA-PDT. This demonstrates the 
involvement of caspase-9, which cleaves after aspartic acid residue, in mediating 
apoptosis. The results obtained here demonstrated the presence of active pathways of 
caspase-9 during ALA-PDT induced apoptosis in MCF-7 cells. The fluorescence 
signals obtained from the cells that were both incubated with ALA and photoactivated 
were significantly higher than the signals obtained from the untreated control and the 
two treated control groups. Statistical analysis was performed on the three sets of 
results. The mean value of this analysis revealed that the fluorescence signal obtained 
using optical nanosensors used to probe the experimental group of cells (Group I) was 
about 4.59 (± 0.02). The mean value of these analyses revealed that the fluorescence 
signal obtained using optical nanosensors used to probe the control group of cells 
(Group II, III and IV) was about 3.56 (± 0.02). The mean value of this analysis 






















Group I: (+)ALA (+)PDT Group II: (+)ALA (-)PDT Group III: (-)ALA (+)PDT Group IV: (-)ALA (-)PDT  
Figure 6.5 shows the result of in vivo measurement of caspase-9 activity. The 
Experiment type refers to the four different treatment groups, Group I 
[+]ALA[+]PDT, Group II [+]ALA[-]PDT, Group III [-]ALA[+]PDT, Group IV [-
]ALA[-]PDT. Each bar represents an average of three intracellular measurements of 
caspase-9 activity in MCF-7 cells done in triplicate. The error bars shown represent a 
95% confidence interval (CI). 
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cells in Group I was up to an order of magnitude higher than the signal obtained by 
nanosensors used to probe the control (Group IV), untreated (Group II) and treated 
(Group III) control cell groups. A larger mean value for the experimental group 
confirms the detection of AMC and hence the detection of caspase-9 activity. 
For the in vivo studies to assay caspase-7 activity, MCF-7 cells were treated 
with ALA-PDT, and caspase-7 activity was monitored by measuring the fluorescence 
generated by AMC after cleavage of DEVD-AMC. After exposure to ALA- PDT, 
AMC fluorescence was detected and measured using optical nanosensors. As shown 
in Figure 6.6, in untreated cells, no level of DEVD-AMC cleavage activity was 
detected with [+]ALA[-]PDT, [-]ALA[+]PDT or [-]ALA[-]PDT. However, a 
significant DEVD-AMC cleavage activity via the detection of AMC fluorescence was 
observed after [+]ALA[+]PDT treatment. Figure 6.6 also shows the background-
subtracted results of intracellular measurements performed with nanosensors on two 
treated control groups (Group II and III) of MCF-7 cells. The first group was treated 
with [+]ALA[-]PDT, while the second was treated with [-]ALA[+]PDT. These results 
were similar on average meaning that neither of the two treated control groups were 
capable of inducing apoptosis. This is in total agreement with the expected outcome 
of this experiment, as photodynamic therapy is a cooperative effort of the 
photosensitizer and light. When comparing these results to those obtained from the 
experimental group, [+]ALA[+]PDT, the fluorescence intensity was almost an order 
of magnitude lower than that of the experimental group. These results clearly 






















Group I: (+)ALA (+)PDT Group II: (+)ALA (-)PDT Group III: (-)ALA (+)PDT Group IV: (-)ALA (-)PDT  
Figure 6.6: shows the result of the in vivo measurement of caspase-7 activity. 
The Experiment type refers to the four different treatment groups, Group I 
[+]ALA[+]PDT, Group II [+]ALA[-]PDT, Group III [-]ALA[+]PDT, Group IV [-
]ALA[-]PDT. Each bar represents an average of three intracellular measurements of 
caspase-7 activity in MCF-7 cells done in triplicate. The error bars shown represent a 





We successfully prepared tetrapeptide-based optical nanosensors using a 
covalent coupling technique to immobilize profluorescent substrates onto nanotips 
and demonstrated their application in the determination of the cleavage products of 
LEHD-AMC and DEVD-AMC, AMC, in single living MCF-7 cells. The presence 
and detection of cleaved fluorogenic AMC in single live MCF-7 cells as a result of 
this design is representative of caspase-9 and -7 activity, hallmarks of apoptosis or 
programmed cell death [127]. These results indicate that AMC, and hence apoptosis, 
can be monitored and measured using optical nanosensors within single living cells 
during apoptosis. These results also demonstrate the capability of performing 
measurements inside single living cells consequently with the potential application in 
protein detection and protein-protein profiling in cellular biochemical pathways.  
Due to its nanoscale size, the optical nanosensor does not compromise the 
integrity of the cell when performing intracellular analysis [123]. This advantage is 
evident this work which demonstrates the capability of optical nanosensors to study 
cells without having to disrupt the physiological make-up, thereby not interfering 
with cellular biochemistry. Mechanical manipulation can lead to cell disruption prior 
to sampling and this may interfere with measurements of cellular biochemistry. With 
the optical nanosensors, absence of cell manipulation prior to measurement results in 
no effects on the cell at the time of sampling. Tetrapeptide-based optical nanosensors 
are extremely sensitive and have very specific activities, since a single enzyme along 
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with its respective cofactor or coenzyme can catalyze many reactions and in the 
process produce a sufficient quantity of the fluorogenic reaction product AMC. This 
feature together with excitation and detection in the near-field of the optical 
nanosensor are important because they underline the sensitivity and spatial selectivity 
conferred by the operating principle of the nanosensor in the sense that only the AMC 
produced will be excited in the near field of the optical nanosensor. An additional 
feature of the nanosensor is its biochemical selectivity. Selectivity is dependent upon 
the selective cleavage capabilities for specific sequences by either caspase-9 or 
caspase-7.  
Tetrapeptide-based optical nanosensors for investigating intact living cells 
hold promise for minimally invasive dynamic analyses of proteins in biochemical 
pathways within single living cells. Optical nanosensors provide a new method in 
cell-based assays offering highly miniaturized, hands-on, nano-scaled devices that 
make cell-based analysis accessible at the single cell level. Future work will involve 
studies that will attempt to diversify the application of the optical nanosensor for 
analysis of protein-protein interactions and similar analyses of other proteins involved 
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